View:
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 15, 2001
CENDANT CORPORATION
------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 1-10308 06-0918165
---------- --------- ------------
(State or Other Jurisdiction of (Commission (IRS Employer
Incorporation) File Number) Identification No.)
9 West 57th Street New York, New York 10019
--------------------------------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: (212) 314-1800
Not Applicable
------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On June 18, 2001, Cendant Corporation ("Cendant") and Galileo
International, Inc. ("Galileo") issued a joint press release announcing
that they had entered into an Agreement and Plan of Merger (the "Merger
Agreement"), dated as of June 15, 2001, pursuant to which Galaxy
Acquisition Corp., a subsidiary of Cendant ("Merger Sub"), will merge with
and into Galileo with Galileo as the surviving corporation (the "Merger").
Following the Merger, Galileo will be a wholly owned subsidiary of Cendant.
In the Merger, Cendant will acquire all of the outstanding common
stock of Galileo at an expected value of $33 per share, or approximately
$2.9 billion. Cendant will also assume about $600 million of Galileo net
debt. The transaction, which is expected to close in the fall of 2001, is
subject to customary regulatory approvals and the approval of Galileo's
stockholders.
Under the terms of the Merger Agreement, Galileo stockholders will
receive a combination of Cendant common stock and cash with an expected
value of $33 per Galileo share. Galileo stockholders will receive 80.5
percent of the purchase price through a tax-free exchange of Cendant common
stock with a market value of $26.565 per Galileo share, subject to a
collar. The number of shares will fluctuate within a collar of $17 to $20
per Cendant share from 1.563 Cendant shares per Galileo share if the
average price of Cendant shares is $17 per share during the measurement
period to 1.328 Cendant shares per Galileo share if the average price per
Cendant share is $20 during the measurement period.
The remainder of the purchase price, $6.435 per Galileo share or
approximately $562 million in the aggregate, will be paid in cash. The cash
portion of the consideration is limited to 19.5 percent of the value of the
transaction on the closing date of the total consideration to be paid to
Galileo stockholders. The effect of the 19.5 percent limitation is that the
cash portion of the consideration will be reduced if it ever exceeds 19.5
percent of the value on the closing date of the total consideration to be
paid to Galileo stockholders. This limitation is intended to preserve the
tax-free nature of the stock portion of the consideration being paid to
Galileo stockholders.
If the average Cendant stock price per share is at or below $14
over the period that is used to measure the exchange ratio, Galileo will
have a right to terminate the transaction.
United Air Lines, Inc. ("UAL"), the largest stockholder of Galileo
with approximately 18% of the outstanding shares, and a wholly owned
subsidiary of UAL, have entered into a Transaction Support Agreement, dated
June 15, 2001 (the "Support Agreement") with Cendant to support the
transaction and has provided Cendant with a proxy to vote the Galileo
shares owned by UAL in favor of the transaction. United may terminate the
Support Agreement and revoke its proxy if Galileo's Board of Directors
withdraws its recommendation of the Merger Agreement in favor of a Superior
Proposal (as defined in the Merger Agreement) or if the Merger Agreement is
amended and United determines that the amendment is adverse in a material
respect to it.
Galileo and Cendant also entered into a Stock Option Agreement,
dated June 15, 2001 (the "Option Agreement") pursuant to which Galileo
granted to Cendant an irrevocable option to purchase under certain
circumstances up to 19.5% of Galileo's outstanding common stock, subject to
customary adjustments, at a purchase price per share equal to $33.00.
Cendant may exercise the option in the event that the Support Agreement is
terminated in accordance with its terms.
The foregoing description of the Merger Agreement, the Stock
Option Agreement and the Support Agreement is qualified in its entirety by
reference to the full text of the Merger Agreement, the Stock Option
Agreement and the Support Agreement, copies of which are filed as exhibits
to this report and incorporated herein by this reference.
A copy of the joint press release issued in connection with the
execution of the Merger Agreement is attached hereto as Exhibit 99.3 and
incorporated herein by reference.
Free copies of Cendant Corporation's filings with the SEC may also
be obtained from Cendant Corporation via its web site at
http://www.cendant.com or by directing a request to Investor Relations,
Cendant Corporation, 9 West 57th Street, New York, NY 10019, telephone:
(212) 413-1845.
ITEM 7. Financial Statements and Exhibits.
(a) Exhibits:
Number Description
2.1 Agreement and Plan of Merger, dated as of June 15, 2001,
by and among Cendant Corporation, Galaxy Acquisition
Corp. and Galileo International, Inc.
99.1 Stock Option Agreement, dated as of June 15, 2001, by and
between Galileo International, Inc. and Cendant
Corporation.
99.2 Transaction Support Agreement, dated as of June 15, 2001,
by and among Cendant Corporation, United Air Lines, Inc.
and Covia, LLC.
99.3 Joint Press Release, dated June 18, 2001, of Cendant
Corporation and Galileo International, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
CENDANT CORPORATION
By: /s/ James E. Buckman
------------------------------
Name: James E. Buckman
Title: Vice Chairman, General Counsel
and Assistant Secretary
Date: June 18, 2001
INDEX TO EXHIBITS
Number Description
2.1 Agreement and Plan of Merger, dated as of June 15, 2001,
by and among Cendant Corporation, Galaxy Acquisition
Corp. and Galileo International, Inc.
99.1 Stock Option Agreement, dated as of June 15, 2001, by and
between Galileo International, Inc. and Cendant
Corporation.
99.2 Transaction Support Agreement, dated as of June 15, 2001,
by and among Cendant Corporation, United Air Lines, Inc.
and Covia, LLC.
99.3 Joint Press Release, dated June 18, 2001, of Cendant
Corporation and Galileo International, Inc.
AGREEMENT AND PLAN OF MERGER
by and among
CENDANT CORPORATION,
GALAXY ACQUISITION CORP.
and
GALILEO INTERNATIONAL, INC.
Dated as of June 15, 2001
TABLE OF CONTENTS
Page
INDEX OF DEFINED TERMS........................................................v
- ----------------------
AGREEMENT AND PLAN OF MERGER..................................................1
RECITALS...................................................................1
ARTICLE I The Merger..........................................................2
1.1 The Merger...................................................2
1.2 The Closing..................................................2
1.3 Effective Time...............................................2
1.4 Certificate of Incorporation, Bylaws, Directors and
Officers of the Surviving Corporation;
Directors of Parent..........................................2
1.5 Directors of Parent..........................................3
ARTICLE II Effect of the Merger on Securities of Purchaser and the Company....3
2.1 Purchaser Securities.........................................3
2.2 Company Securities...........................................4
2.3 Exchange of Certificates Representing Company
Common Stock................................................11
2.4 Adjustment of Merger Consideration..........................14
2.5 Dissenting Company Stockholders.............................15
ARTICLE III Representations and Warranties of the Company....................16
3.1 Existence; Good Standing; Corporate Authority...............16
3.2 Authorization, Validity and Effect of Agreements............17
3.3 Compliance with Laws........................................17
3.4 Capitalization..............................................18
3.5 Subsidiaries................................................19
3.6 No Violation; Consents......................................20
3.7 Company Reports; Financial Statements.......................21
3.8 Litigation..................................................21
3.9 Absence of Certain Changes..................................21
3.10 Taxes......................................................22
3.11 Employee Benefit Plans.....................................23
3.12 Labor and Employment Matters...............................25
3.13 Intellectual Property Rights...............................26
3.14 Permits....................................................27
3.15 Environmental Compliance...................................28
3.16 Material Contracts.........................................28
3.17 Title to Property..........................................31
3.18 Brokers....................................................31
3.19 Opinion of Financial Advisor...............................31
3.20 Rights Agreement...........................................31
3.21 State Takeover Statutes....................................31
3.22 No Undisclosed Liabilities.................................32
3.23 Vote Required..............................................32
3.24 Form S-4; Proxy Statement..................................32
ARTICLE IV Representations and Warranties of Parent and Purchaser............33
4.1 Existence; Good Standing; Corporate Authority...............33
4.2 Authorization, Validity and Effect of Agreements............33
4.3 Compliance with Laws........................................34
4.4 Capitalization..............................................34
4.5 No Violation; Consents......................................35
4.6 Parent Reports..............................................36
4.7 Litigation..................................................36
4.8 Absence of Certain Changes..................................37
4.9 Interim Operations of Purchaser.............................37
4.10 Form S-4; Proxy Statement..................................37
4.11 Tax Matters................................................37
4.12 State Takeover Statutes....................................37
4.13 No Undisclosed Liabilities.................................38
4.14 Parent Shareholder Approval................................38
4.15 Parent Common Stock........................................38
4.16 Ownership of Company Common Stock..........................38
ARTICLE V Covenants..........................................................38
5.1 Alternative Proposals.......................................38
5.2 Interim Operations..........................................41
5.3 Preparation of the Form S-4 and the Proxy Statement;
Company Stockholder Approval................................45
5.4 Filings; Other Action.......................................47
5.5 Access to Information.......................................49
5.6 Publicity...................................................51
5.7 Further Action..............................................51
5.8 Insurance; Indemnity........................................52
5.9 Employee Benefit Plans......................................53
5.10 Conveyance Taxes...........................................55
5.11 Certain Tax Matters........................................56
5.12 Section 16 Matters.........................................56
5.13 Stock Options and SARs.....................................57
5.14 Stock Exchange Listing.....................................57
5.15 Amendments to the Rights Agreement; Section 203............57
5.16 Affiliates.................................................57
ARTICLE VI Conditions........................................................57
6.1 Conditions to Each Party's Obligation to Effect
the Merger..................................................57
6.2 Conditions to Obligation of Parent and Purchaser to Effect
the Merger..................................................59
6.3 Conditions to Obligations of the Company to Effect
the Merger..................................................60
ARTICLE VII Termination......................................................60
7.1 Termination by Mutual Consent...............................60
7.2 Termination by Either Parent or Company.....................61
7.3 Termination by the Company..................................61
7.4 Termination by Parent.......................................62
7.5 Effect of Termination and Abandonment; Termination Fee......62
7.6 Fees and Expenses...........................................63
7.7 Extension; Waiver...........................................64
ARTICLE VIII General Provisions..............................................64
8.1 Nonsurvival of Representations and Warranties...............64
8.2 Notices.....................................................64
8.3 Assignment; Binding Effect; No Third-Party Beneficiaries....65
8.4 Entire Agreement............................................66
8.5 Governing Law...............................................66
8.6 Fee and Expenses............................................66
8.7 Certain Definitions.........................................66
8.8 Headings....................................................67
8.9 Interpretation..............................................67
8.10 Waivers....................................................68
8.11 Severability...............................................68
8.12 Parent Actions.............................................68
8.13 Enforcement of Agreement...................................68
8.14 Amendment..................................................69
8.15 Waiver of Jury Trial.......................................69
8.16 Execution..................................................69
8.17 Date for Any Action........................................69
8.18 Counterparts...............................................69
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GALILEO
INTERNATIONAL, INC.......................................................1
Form of Affiliate Letter...................................................1
EXHIBITS
Exhibit Description
------ -----------
A Certificate of Incorporation of the Surviving Corporation
B Form of Affiliate Letter
index of defined terms
Definition Page
2000 Annual Report............................................................0
2001 Proxy Statement.........................................................18
2001 Quarterly Report........................................................30
280G Persons.................................................................53
Action.......................................................................49
Actual Aggregate Cash Consideration...........................................4
Actual Aggregate Parent Shares................................................4
Adjusted Actual Aggregate Cash Consideration..................................5
Adjusted High-End Price......................................................14
Adjusted Low-End Price.......................................................14
Adjustment Factor............................................................14
affiliate....................................................................63
Agreement.....................................................................1
Ancillary Documents..........................................................16
Assumed Options...............................................................8
Australian Approval..........................................................55
Average Company Trading Price.................................................9
Average Parent Trading Price..................................................5
Board Recommendation.........................................................16
business day.................................................................63
Cap..........................................................................49
Capital Plan.................................................................40
Cash Limitation Amount........................................................5
Cash Limitation Percentage....................................................5
Certificate of Merger.........................................................2
Certificates.................................................................11
Change in Control Contracts..................................................28
Change in the Company Recommendation.........................................44
Closing.......................................................................2
Closing Date Parent Stock Price...............................................5
Closing Date..................................................................2
Code..........................................................................1
Company.......................................................................1
Company Acquisition Agreement................................................36
Company Benefit Plans........................................................22
Company Common Stock..........................................................1
Company Disclosure Letter....................................................16
Company ESPP..................................................................9
Company Material Adverse Effect..............................................16
Company Permits..............................................................26
Company Recommendation.......................................................43
Company Reports..............................................................20
Company Stock Option Plans....................................................8
Company Stockholder Approval.................................................16
Confidentiality Agreement....................................................37
Confidentiality Contracts....................................................28
Contract.....................................................................19
Contracts....................................................................19
Control Requirement Percentage................................................5
Controlling Company Shares....................................................5
Covia.........................................................................1
Delaware Courts..............................................................63
Designated Number............................................................52
DGCL..........................................................................2
Dissenting Common Stock......................................................15
Distribution Value...........................................................14
DOJ..........................................................................45
EC Merger Regulation.........................................................46
Effective Time................................................................2
Environmental Liability......................................................27
Environmental Matters........................................................27
ERISA........................................................................63
ERISA Affiliate..............................................................24
Excess Costs.................................................................39
Exchange Act..................................................................8
Exchange Agent...............................................................11
Exchange Fund................................................................11
Exchange Ratio................................................................4
Exclusivity Contracts........................................................28
FCC Act......................................................................19
Fee..........................................................................59
Fee Determination............................................................59
Financial Advisor............................................................29
Foreign Benefit Plan.........................................................23
Form S-4.....................................................................30
FTC..........................................................................45
GAAP.........................................................................20
Governmental Entity..........................................................17
Guarantees...................................................................28
High-End Ratio................................................................5
HSR Act......................................................................19
Hyperion.....................................................................47
incentive stock options.......................................................8
Indemnified Party............................................................49
Independent Director..........................................................3
Intellectual Property Rights.................................................24
Jones Day.....................................................................2
knowledge....................................................................63
Laws.........................................................................17
Leases.......................................................................29
Liens........................................................................18
Litigation...................................................................20
Loan Contracts...............................................................28
Low-End Ratio.................................................................5
Material Contracts...........................................................27
Material Intellectual Property Rights........................................25
Merger........................................................................1
Merger Consideration..........................................................3
Miscellaneous Contracts......................................................29
Move.com Common Stock........................................................32
Non-Competition Contracts....................................................27
NYSE..........................................................................5
Option........................................................................1
Option Agreement..............................................................1
Option Exchange Ratio.........................................................9
Options.......................................................................8
Ordinary Preferred Stock.....................................................17
Parent........................................................................1
Parent 2000 Annual Report....................................................34
Parent Authorized Preferred Stock............................................32
Parent Common Stock...........................................................1
Parent Disclosure Letter.....................................................33
Parent Employee Stock Options................................................33
Parent Expenses..............................................................60
Parent Material Adverse Effect...............................................31
Parent Reports...............................................................34
Parent Stock Plans...........................................................33
Parent Warrants..............................................................33
Participating Company Shares..................................................5
Partnership Contracts........................................................28
Per Share Additional Stock Consideration......................................5
Per Share Cash Consideration................................................. 6
Per Share Stock Amount........................................................6
Per Share Stock Consideration.................................................4
person.......................................................................63
Post Signing Returns.........................................................53
Preferred Redemption Price....................................................7
Preferred Stock..............................................................17
Preliminary Aggregate Cash Consideration......................................6
Pricing Period................................................................6
Proxy Statement..............................................................31
Proxy Statement/Prospectus...................................................42
Purchaser.....................................................................1
Qualifying Amendment.........................................................43
Quantitude...................................................................10
Quantitude Common Stock......................................................10
Quantitude Stock Option Plans................................................10
Regulatory Challenge.........................................................46
Regulatory Law...............................................................46
Regulatory Restrictions......................................................45
Reporting Requirements.......................................................41
Restraints...................................................................55
Rights........................................................................1
Rights Agreement..............................................................1
SAirGroup....................................................................28
SEC..........................................................................20
Section 2.4(b) Transaction...................................................14
Securities Act................................................................9
Series A Special Voting Preferred Stock......................................17
Series B Special Voting Preferred Stock......................................17
Series C Special Voting Preferred Stock......................................17
Series D Special Voting Preferred Stock......................................17
Series E Special Voting Preferred Stock......................................17
Series F Special Voting Preferred Stock......................................17
Series G Special Voting Preferred Stock......................................17
Series H Preferred Stock.....................................................17
Skadden Arps.................................................................53
Special Voting Preferred Stock................................................7
Spin-Off.....................................................................14
Stock Repurchase Program.....................................................36
Stockholders Meeting.........................................................16
Subsidiaries,................................................................16
Subsidiary Plans.............................................................10
Superior Proposal............................................................38
Surviving Corporation.........................................................2
Tax..........................................................................21
Tax Return...................................................................21
Taxes........................................................................21
Terminating Breach...........................................................58
Third Party..................................................................38
Third-Party Acquisition......................................................38
Total Cash In Lieu............................................................6
Total Closing Date Stock Consideration Value..................................6
Total Dissenting Cash.........................................................6
Total Outstanding Company Shares..............................................6
Total Parent Owned Company Shares.............................................6
Transaction Support Agreement.................................................1
Trip.........................................................................10
Trip Common Stock............................................................10
Trip Stock Option Plans......................................................10
UAL...........................................................................1
United........................................................................1
WARN Act.....................................................................24
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of June
15, 2001, by and among Cendant Corporation, a Delaware corporation
("Parent"), Galaxy Acquisition Corp., a Delaware corporation and a wholly
owned subsidiary of Parent ("Purchaser"), and Galileo International, Inc.,
a Delaware corporation (the "Company").
RECITALS
WHEREAS, the respective Boards of Directors of Parent, Purchaser
and the Company each have approved and declared advisable this Agreement
and the merger of Purchaser with and into the Company (the "Merger"), upon
the terms and subject to the conditions set forth in this Agreement,
whereby each issued and outstanding share of common stock, par value $.01
per share, of the Company (together with the associated Preferred Stock
Purchase Rights (the "Rights") issued pursuant to the Company's Rights
Agreement, dated as of February 22, 2001, between the Company and LaSalle
Bank National Association (the "Rights Agreement," the "Company Common
Stock"), other than shares of Company Common Stock owned by Parent,
Purchaser or the Company and other than Dissenting Common Stock (as
hereinafter defined), will be converted into the right to receive common
stock, par value $.01 per share, of Parent ("Parent Common Stock") and cash
as provided herein;
WHEREAS, simultaneously with the execution and delivery of this
Agreement, and as a condition to Parent's willingness to enter into this
Agreement, Parent and United Air Lines, Inc., a Delaware corporation
("UAL"), and Covia LLC, a Delaware limited liability company ("Covia" and
together with UAL, "United") are entering into a transaction support
agreement (the "Transaction Support Agreement"), pursuant to which United
has agreed, among other things, to grant Parent a proxy to vote its shares
of Company Common Stock in favor of the Merger, upon the terms and subject
to the conditions set forth therein;
WHEREAS, simultaneously with the execution and delivery of this
Agreement, Parent and the Company are entering into a stock option
agreement (the "Option Agreement"), pursuant to the which the Company will
grant to Parent an option (the "Option") to purchase shares of Company
Common Stock, upon the terms and subject to the conditions set forth
therein;
WHEREAS, for federal income tax purposes, it is intended that the
Merger shall qualify as a reorganization within the meaning of Section
368(a) of the Internal Revenue Code of 1986, as amended (the "Code"), and
that this Agreement constitutes a plan of reorganization; and
WHEREAS, Parent, Purchaser and the Company desire to make certain
representations, warranties, covenants and agreements in connection with
the Merger and also to prescribe various conditions to the Merger;
NOW, THEREFORE, in consideration of the foregoing, and of the
representations, warranties, covenants and agreements contained herein, the
parties hereto hereby agree as follows:
ARTICLE I
The Merger
1.1 The Merger. At the Effective Time (as hereinafter defined),
upon the terms and subject to the conditions of this Agreement and the
applicable provisions of the General Corporation Law of the State of
Delaware (the "DGCL"), Purchaser shall be merged with and into the Company
and the separate corporate existence of Purchaser shall thereupon cease.
The Company shall be the surviving corporation in the Merger (sometimes
hereinafter referred to as the "Surviving Corporation") and shall become a
wholly owned subsidiary of Parent. The Merger shall have the effects
specified in the DGCL. Without limiting the generality of the foregoing and
subject thereto, at the Effective Time, all of the property, rights,
privileges, immunities, powers and franchises of the Company and Purchaser
shall vest in the Surviving Corporation, and all debts, liabilities, and
duties of the Company and Purchaser shall become the debts, liabilities and
duties of the Surviving Corporation.
1.2 The Closing. Subject to the terms and conditions of this
Agreement, the closing of the Merger (the "Closing") shall take place at
the offices of Jones, Day, Reavis & Pogue, 77 W. Wacker, Chicago, Illinois
("Jones Day"), at 10:00 a.m., local time, as soon as practicable following
the satisfaction (or waiver, if permissible) of the conditions set forth in
Article VI. The date on which the Closing occurs is hereinafter referred to
as the "Closing Date."
1.3 Effective Time. On or as soon as practicable after the
Closing Date, the parties hereto shall cause a Certificate of Merger
meeting the requirements of Section 251 of the DGCL (the "Certificate of
Merger") to be properly executed and filed with the Secretary of State of
the State of Delaware in accordance with the DGCL. The Merger shall become
effective at the time of filing of the Certificate of Merger with the
Secretary of State of the State of Delaware in accordance with the DGCL or
at such later time which the parties hereto shall have agreed upon and
designated in such filing as the effective time of the Merger (the
"Effective Time").
1.4 Certificate of Incorporation, Bylaws, Directors and Officers
of the Surviving Corporation; Directors of Parent. Unless otherwise agreed
by the Company and Parent prior to the Closing, at the Effective Time,
without any further action on the part of Parent, Purchaser or the Company:
(a) The Certificate of Incorporation of the Company shall be
amended and restated by virtue of the Merger to read in its entirety in the
form attached hereto as Exhibit A (until further amended as provided by law
and by such Certificate of Incorporation) and, as so amended and restated,
shall be the Certificate of Incorporation of the Surviving Corporation;
(b) The Bylaws of Purchaser as in effect immediately prior to the
Effective Time shall be at and after the Effective Time (until amended as
provided by law, its Certificate of Incorporation and its Bylaws, as
applicable) the Bylaws of the Surviving Corporation;
(c) The officers of the Company immediately prior to the
Effective Time shall continue to serve in their respective offices of the
Surviving Corporation from and after the Effective Time, until their
successors are elected or appointed and qualified or until their
resignation or removal; and
(d) The directors of Purchaser immediately prior to the Effective
Time shall be the directors of the Surviving Corporation from and after the
Effective Time, until their successors are elected or appointed and
qualified or until their resignation or removal.
1.5 Directors of Parent. At the Effective Time, Parent shall take
all actions necessary, including, amending its Bylaws, to cause its Board
of Directors to be expanded by one seat and to cause an individual
designated by the Board of Directors of the Company and reasonably
satisfactory to Parent and who is an Independent Director (as hereinafter
defined) to be nominated and appointed to the class of directors whose term
shall expire in 2004. A director shall be considered an "Independent
Director" if he or she has no relationship to Parent that may interfere
with the exercise of his or her independence from Parent and its
management. Individuals with the following relationships to Parent are not
independent: employment by Parent or any of its affiliates during the
then-current year or any of the past five years; acceptance of compensation
from Parent or any of its affiliates other than compensation for Board
service or benefits under a tax-qualified retirement plan; an immediate
family member of an individual who is, or has been in any of the past five
years, employed by Parent or any of its affiliates as an executive officer;
partnership with or controlling shareholder or executive officer of any
for-profit business organization to which Parent made, or from which Parent
received, payments that are or have been significant to Parent or the
business organization in any of the past five years; and employment as an
executive of another company where any of Parent's executives serve on that
company's compensation committee.
ARTICLE II
Effect of the Merger on Securities
of Purchaser and the Company
2.1 Purchaser Securities. At the Effective Time, each share of
common stock, par value $.01 per share, of Purchaser that is outstanding
immediately prior to the Effective Time shall, by virtue of the Merger and
without any action on the part of the holders thereof, be converted into
and become one validly issued, fully paid and non-assessable share of
common stock, par value $.01 per share, of the Surviving Corporation.
2.2 Company Securities.
(a) Company Common Stock.
(i) At the Effective Time, each Participating Company Share
shall, by virtue of the Merger and without any action on the part
of the holder thereof, be converted into the right to receive the
following (the "Merger Consideration") (capitalized terms used in
this Section 2.2(a) not otherwise defined in this Agreement have
the meanings ascribed to such terms in Section 2.2(a)(iv)):
(A) the number of duly authorized,
validly issued, fully paid and non-assessable
shares of Parent Common Stock, rounded to the
nearest thousandth of a share, equal to the
number (the "Exchange Ratio") determined by
dividing the Per Share Stock Amount by the
Average Parent Trading Price, provided, however,
that (X) if the foregoing would result in an
Exchange Ratio less than the Low-End Ratio, then
the Exchange Ratio shall be the Low-End Ratio,
and (Y) if the foregoing would result in an
Exchange Ratio greater than the High-End Ratio,
then the Exchange Ratio shall be the High-End
Ratio (the "Per Share Stock Consideration"),
provided, however, that the Per Share Stock
Consideration is subject to increase as provided
in Section 2.2(a)(iii);
(B) the lesser of (I) the Per Share
Cash Amount and (II) the number determined by
dividing (X) the Actual Aggregate Cash
Consideration by (Y) the excess of (a) the Total
Outstanding Company Shares over (b) the Total
Parent Owned Company Shares (such lesser amount,
the "Per Share Cash Consideration"), provided,
however, that the Per Share Cash Consideration
is subject to decrease as provided in Section
2.2(a)(ii); and
(C) the Per Share Additional Stock
Consideration, if any.
(ii) If cash is paid in lieu of fractional shares or there
are shares of Dissenting Common Stock, or both, then, (I) the
Actual Aggregate Cash Consideration shall be reduced to equal the
Adjusted Actual Aggregate Cash Consideration and (II) the Per
Share Cash Consideration that the holders of Participating
Company Shares are entitled to receive pursuant to Section
2.2(a)(i)(B) shall be reduced to equal the number determined by
dividing (X) the Adjusted Actual Aggregate Cash Consideration by
(Y) the Participating Company Shares.
(iii) If there are shares of Dissenting Common Stock, then
the Per Share Stock Consideration that the holders of
Participating Company Shares are entitled to receive pursuant to
Section 2.2(a)(i)(A) shall be increased to that number of duly
authorized, validly issued, fully paid and non-assessable shares
of Parent Common Stock, rounded to the nearest thousandth of a
share, equal to the number determined by dividing (I) the Actual
Aggregate Parent Shares by (II) the Participating Company Shares.
(iv) For purposes of this Agreement:
"Actual Aggregate Cash Consideration" shall mean (I) if the
Preliminary Aggregate Cash Consideration is less than or equal to the Cash
Limitation Amount, then, an amount equal to the Preliminary Aggregate Cash
Consideration and (II) if the Preliminary Aggregate Cash Consideration
exceeds the Cash Limitation Amount, then, an amount equal to the Cash
Limitation Amount.
"Actual Aggregate Parent Shares" shall mean the product of (I) the
excess of (X) the Total Outstanding Company Shares over (Y) the Total
Parent Owned Company Shares, if any, and (II) the Per Share Stock
Consideration (determined prior to any increase pursuant to Section
2.2(a)(iii)).
"Adjusted Actual Aggregate Cash Consideration" shall mean the
excess of (I) the Actual Aggregate Cash Consideration over (II) the sum of
(X) the Total Cash In Lieu and (Y) the Total Dissenting Cash.
"Average Parent Trading Price" shall mean the arithmetic average
of the per share 4:00 p.m. Eastern time closing sales price of the Parent
Common Stock on the New York Stock Exchange (the "NYSE") (as reported on
the NYSE Composite Tape) during the Pricing Period.
"Cash Limitation Amount" shall mean the number determined by
dividing (I) the product of (X) the Cash Limitation Percentage and (Y) the
Total Closing Date Stock Consideration Value by (II) the Control
Requirement Percentage.
"Cash Limitation Percentage" shall mean the excess (expressed as a
decimal, without rounding) of (I) one over (II) the Control Requirement
Percentage. For the avoidance of doubt, if the Total Parent Owned Company
Shares shall equal zero, the Cash Limitation Percentage shall equal 0.1950.
"Closing Date Parent Stock Price" shall mean the average of the
high and low trading prices of the Parent Common Stock on the NYSE
Composite Tape on the date on which the Effective Time occurs.
"Controlling Company Shares" shall mean the product of (I) 0.8050
and (II) the Total Outstanding Company Shares.
"Control Requirement Percentage" shall mean the fraction
(expressed as a decimal, without rounding), (I) the numerator of which
shall equal the Controlling Company Shares and (II) the denominator of
which shall equal the excess of (X) the Total Outstanding Company Shares
over (Y) the Total Parent Owned Company Shares. For the avoidance of doubt,
if the Total Parent Owned Company Shares shall equal zero, the Control
Requirement Percentage shall equal 0.8050.
"High-End Ratio" shall mean, subject to adjustment pursuant to
Section 2.4, the number determined by dividing (I) the Per Share Stock
Amount by (II) 17.
"Low-End Ratio" shall mean, subject to adjustment pursuant to
Section 2.4, the number determined by dividing (I) the Per Share Stock
Amount by (II) 20.
"Participating Company Shares" shall mean the excess of (I) the
Total Outstanding Company Shares over (II) the sum of (X) the number of
shares of Dissenting Common Stock, if any, and (Y) the number of shares of
Company Common Stock, if any, cancelled pursuant to Section 2.2(a)(vi).
"Per Share Additional Stock Consideration" shall mean the number
of shares of Parent Common Stock, rounded to the nearest thousandth of a
share, equal to the number determined by dividing (I) the Per Share
Additional Consideration Value by (II) the Closing Date Parent Stock Price.
For purposes of this Section 2.2(a), the Per Share Additional Consideration
Value shall be equal to simple interest on $33 calculated at the 30 day
London Interbank Offered Rate plus 100 basis points, from the date that is
180 days from the date hereof to the date, if later, on which the Effective
Time occurs, provided, however, that if the event described in the first
sentence of Section 5.4(f) does not occur, the Per Share Additional
Consideration Value (and therefore, the Per Share Additional Stock
Consideration) shall be zero. Such amount, if any, shall be determined
using a year of 360 days to calculate the interest-equivalent amount.
"Per Share Cash Amount" shall mean the product of (I) $33 and (II)
the Cash Limitation Percentage.
"Per Share Stock Amount" shall mean the product of (I) $33 and
(II) the Control Requirement Percentage.
"Preliminary Aggregate Cash Consideration" shall mean the product
of (I) the Per Share Cash Amount and (II) the excess of (X) the Total
Outstanding Company Shares over (Y) the Total Parent Owned Company Shares.
"Pricing Period" shall mean the 20 consecutive trading days
immediately preceding the third consecutive trading day prior to the date
of the Stockholders Meeting; provided, however, that if, primarily as a
result of the execution by Parent or any Subsidiary thereof of a Restricted
Acquisition Agreement (as hereinafter defined), the consents, approvals,
permits or authorizations described in Section 5.4 hereof are not obtained
by the date that is 30 days after the date on which the Stockholders
Meeting occurs, the Pricing Period shall be the 20 consecutive trading days
immediately preceding the third consecutive trading day prior to the date
on which the last of the approvals described in Section 5.4 shall have been
obtained and satisfied.
"Total Cash In Lieu" shall mean the product of (I) the total
number of registered holders of Company Common Stock immediately prior to
the Effective Time and (II) the Closing Date Parent Stock Price.
"Total Dissenting Cash" shall mean the product of (I) the number
of shares of Dissenting Common Stock and (II) the greater of (X) $33.00 and
(Y) the sum of (a) the product of the Per Share Stock Consideration
(determined prior to any increase pursuant to Section 2.2(a)(iii)) and the
Closing Date Parent Stock Price and (b) the Per Share Cash Consideration
(determined prior to any decrease pursuant to Section 2.2(a)(ii)).
"Total Parent Owned Company Shares" shall mean the number of
shares of Company Common Stock, if any, owned by Parent (or any Subsidiary
of Parent) at the Effective Time.
"Total Closing Date Stock Consideration Value" shall mean the
product of (I) the number of Actual Aggregate Parent Shares and (II) the
Closing Date Parent Stock Price.
"Total Outstanding Company Shares" shall mean the total number of
issued and outstanding shares of Company Common Stock immediately prior to
the Effective Time.
(v) As a result of the Merger and without any action on the
part of the holders thereof, at the Effective Time, all shares of
Company Common Stock shall cease to be outstanding and shall be
cancelled and retired and shall cease to exist, and each holder
of a share of Company Common Stock (other than the Company or
holders of Total Parent Owned Company Shares) shall thereafter
cease to have any rights with respect to such shares of Company
Common Stock, except the right to receive, without interest, the
Merger Consideration in accordance with Section 2.3 upon the
surrender of a certificate or certificates representing such
shares of Company Common Stock.
(vi) Each share of Company Common Stock included in Total
Parent Owned Company Shares or held in the Company's treasury at
the Effective Time shall, by virtue of the Merger and without any
action on the part of the holder thereof, cease to be outstanding
and shall be cancelled and retired without payment of any
consideration therefor.
(b) Special Voting Preferred Stock.
(i) At the Effective Time, without any action on the part of
the holders thereof, any and all shares of Special Voting
Preferred Stock, par value $.01 per share, of the Company (the
"Special Voting Preferred Stock") then outstanding shall be
redeemed by the Company for an amount in cash equal to $100.00
per share (the "Preferred Redemption Price"), payable by the
Company by certified check to each holder thereof at its address
as set forth on the books of the Company at such time, shall
cease to be outstanding or exist, and each holder of shares of
Special Voting Preferred Stock shall thereafter cease to have any
rights with respect to such shares of Special Voting Preferred
Stock, except the right to receive, without interest, the
Preferred Redemption Price in accordance with Section 2.3(b)(iv)
below upon the surrender of a certificate or certificates
representing such shares of Special Voting Preferred Stock. All
funds necessary to pay the Preferred Redemption Price and any
expenses relating to the redemption of the Special Voting
Preferred Stock shall come solely from the Company. All shares of
Special Voting Preferred Stock so redeemed shall be retired and
shall not thereafter be reissued as part of any series of
Preferred Stock of the Company.
(ii) Each share of Special Voting Preferred Stock issued and
held in the Company's treasury at the Effective Time shall, by
virtue of the Merger, cease to be outstanding and shall be
cancelled and retired without payment of any consideration
therefor.
(iii) Without limiting the generality or effect of Section
1.4(d) and subject thereto, any and all directors elected to the
Company's Board of Directors by holders of Special Voting
Preferred Stock shall, at the Effective Time and the time of the
actions set forth in Section 2.2(b)(i) above, automatically and
without any further action by such directors or such holders be
deemed to have resigned from the Company's Board of Directors.
(iv) At the Effective Time, the Company shall cause to be
mailed to each holder of Special Voting Preferred Stock a notice
of redemption instructing such holder to surrender its
certificate(s) representing Special Voting Preferred Stock in
exchange for the Preferred Redemption Price. Upon surrender of
such certificate(s), the Company shall deliver to such holder the
Preferred Redemption Price and the certificate(s) representing
such shares shall forthwith be cancelled.
(c) Options and SARs; Employee Stock Purchase Plan.
(i) Without limiting the generality or effect of Section
2.2(a) or 2.3, but subject to subsection (v) of this Section
2.2(c), the Company shall take all action necessary (which
includes satisfying the requirements of Rule 16b-3(e) promulgated
under Section 16 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act")) to provide that, immediately prior
to the Effective Time, all options to acquire shares of Company
Common Stock and all stock appreciation rights related to the
price of Company Common Stock (individually, an "Option" and
collectively, the "Options") outstanding immediately prior to the
Effective Time under any Company stock option plan or other
equity incentive plan (the "Company Stock Option Plans"), whether
or not then exercisable, shall (A) cease to represent options to
acquire shares of, or stock appreciation rights related to the
price of, Company Common Stock, (B) be converted into options to
purchase shares of, or stock appreciation rights related to the
price of, Parent Common Stock in an amount and at an exercise
price determined as provided below and (C) with respect to
unvested options or unvested stock appreciation rights that have
an exercise price that is less than the Average Company Trading
Price (as hereinafter defined), become fully vested and
exercisable (and otherwise be subject to the terms of the
applicable option plans and the applicable option agreements
representing grants thereunder) (the "Assumed Options"):
(1) The number of shares of Parent Common Stock to be
subject to each new option or right shall be equal to the
product of the number of shares of Company Common Stock
subject to the original option or right and the Option
Exchange Ratio (as hereinafter defined); provided that any
fractional shares of Parent Common Stock resulting from such
multiplication shall be rounded to the nearest whole share;
and
(2) The exercise price per share of Parent Common Stock
under each new option or right shall be equal to the
exercise price per share of Company Common Stock under the
original option or right divided by the Option Exchange
Ratio; provided that such exercise price shall be rounded to
the nearest whole cent.
The adjustment provided herein with respect to any options that
are intended to be "incentive stock options" (as defined in
Section 422 of the Code) shall be and is intended to be effected
in a manner that is consistent with Section 424(a) of the Code.
The duration and other terms of the new options and rights shall,
except as provided above, be the same as the original options and
rights except that all references to the Company shall be deemed
to be references to Parent. For purposes of this Section 2.2(c),
(A) "Average Company Trading Price" shall mean the arithmetic
average of the per share 4:00 p.m. Eastern time closing sales
price of the Company Common Stock on the NYSE (as reported on the
New York Stock Exchange Composite Tape) for the 20 consecutive
trading days immediately preceding the third trading day prior to
the date of the Stockholders Meeting and (B) "Option Exchange
Ratio" shall mean the quotient derived by dividing $33.00 by the
Average Parent Trading Price per share of Parent Common Stock;
provided that (X) if the foregoing would result in an Option
Exchange Ratio less than 1.65000, the Option Exchange Ratio shall
be deemed to be 1.65000 and (Y) if the foregoing would result in
an Option Exchange Ratio greater than 1.94118, the Option
Exchange Ratio shall be deemed to be 1.94118; provided further,
however, that if the event described in the first sentence of
Section 5.4(e) occurs, the Option Exchange Ratio shall be
appropriately and equitably increased to take into account the
amount of the Per Share Additional Stock Consideration.
(ii) As soon as practicable following the Effective Time,
Parent shall deliver, upon due surrender of the Assumed Options,
to holders of Assumed Options appropriate agreements representing
the right to acquire Parent Common Stock, or stock appreciation
rights related to the price of Parent Common Stock, on the same
terms and conditions as contained in the Assumed Options (except
as otherwise set forth in this Section 2.2(c)). Except as
expressly contemplated herein, Parent shall comply with the terms
of the Company Stock Option Plans as they apply to the Assumed
Options. Parent shall take all corporate action necessary to
reserve for issuance a sufficient number of shares of Parent
Common Stock for delivery upon exercise of the Assumed Options in
accordance with this Section 2.2(c). Parent shall file with the
SEC (as hereinafter defined) a registration statement on Form S-8
(or any successor form) under the Securities Act of 1933, as
amended (the "Securities Act") or on another appropriate form,
effective as of, or reasonably promptly following, the Effective
Time, with respect to Parent Common Stock subject to the Assumed
Options and shall use commercially reasonable efforts to maintain
the effectiveness of such registration statement or registration
statements (and maintain the current status of the prospectus or
prospectuses contained therein) for so long as the Assumed
Options remain outstanding and exercisable. With respect to those
individuals, if any, who, subsequent to the Effective Time, will
be subject to the reporting requirements of Section 16 of the
Exchange Act, Parent shall administer the Company Stock Option
Plans, where applicable, in a manner that complies with Rule
16b-3 promulgated under the Exchange Act.
(iii) Effective at or before the Effective Time, the Company
shall take all actions necessary to cause the termination of the
Galileo International, Inc. Employee Stock Purchase Plan (the
"Company ESPP") and shall take all necessary steps to refund,
without interest, to each Participant (as defined in the Company
ESPP) any amounts withheld from such Participant's compensation
pursuant to a subscription agreement under the Company ESPP to
the extent that such amount has not been used to purchase Company
Common Stock on a Purchase Date (as defined in the Company ESPP)
occurring prior to the effective date of termination of the
Company ESPP.
(iv) After the Effective Time, all options to acquire shares
of common stock, par value $.01 per share ("Quantitude Common
Stock"), of Quantitude, Inc., a Delaware corporation and a wholly
owned subsidiary of the Company ("Quantitude"), and shares of
common stock, par value $.01 per share ("Trip Common Stock"), of
Trip.com, Inc., a Delaware corporation and a wholly owned
subsidiary of the Company ("Trip"), outstanding immediately prior
to the Effective Time under the Quantitude Inc. 2001 Equity
Incentive Plan in the form heretofore provided to Parent (the
"Quantitude Stock Option Plan") and the Trip.com, Inc. 2001
Equity Incentive Plan in the form heretofore provided to Parent
(the "Trip Stock Option Plan," and together with the Quantitude
Stock Option Plan the "Subsidiary Plans"), whether or not
exercisable, shall remain outstanding following the Effective
Time and remain subject to the terms of the applicable Subsidiary
Plan and the applicable option agreements representing grants
thereunder.
(v) The Company and its Subsidiaries shall use its
reasonable best efforts (which include satisfying the
requirements of Rule 16b-3(e) promulgated under Section 16 of the
Exchange Act) to provide that, immediately prior to the Effective
Time, all stock appreciation rights related to Company Stock
(individually, an "SAR" and collectively, the "SARs") outstanding
immediately prior to the Effective Time under any equity
incentive plan of the Company ("Company Equity Incentive Plan"),
whether or not then exercisable, shall be cancelled and each
holder of SAR shall promptly after the Effective Time receive
from the Surviving Corporation, for each SAR, (I) an amount in
cash equal to the difference of the Merger Consideration minus
the per share exercise price of such SAR, without interest, to
the extent such difference is a positive number or (II) to the
extent such difference is a negative number, such other
consideration as is described in subsection (B) below
(hereinafter referred to as the "SAR Consideration"), and that
all SARs will be terminated and thereafter represent only the
right to receive the SAR Consideration; provided, however that
with respect to any Person subject to Section 16(a) of the
Exchange Act, any such amount will be paid as soon as practicable
after the first date payment can be made without liability to
such Person under Section 16(b) of the Exchange Act.
(A) Notwithstanding anything herein stated, no SAR
Consideration will be paid with respect to any SAR unless,
at or prior to the time of such payment (i) such SAR is
cancelled and (ii) to the extent necessary under the terms
of such SAR, the holder of such SAR has executed and
delivered a release of any and all rights the holder had or
may have had in respect of such.
(B) Without limiting the generality or effect of the
foregoing, prior to the Effective Time, the Company will use
reasonable best efforts to obtain all necessary consents or
releases, if any, from holders of SARs under any Company
Equity Incentive Plan and take all such other lawful action
as may be necessary to give effect to the transactions
contemplated by this Section. In the event that any SAR is
not cancelled in accordance with the foregoing, such SAR
shall be converted to a stock appreciation right related to
the price of Parent Common Stock in accordance with Section
2.2(c)(i). The Company or its Subsidiaries may, but shall
not be required to, offer additional consideration for the
purpose of obtaining such consents or releases. Such
additional consideration shall be subject to the advance
approval of Parent, which approval shall not be unreasonably
withheld.
2.3 Exchange of Certificates Representing Company Common Stock.
(a) As of the Effective Time, (i) Parent shall appoint a
commercial bank or trust company, reasonably satisfactory to the Company,
to act as exchange agent (the "Exchange Agent") hereunder for payment of
the Merger Consideration upon surrender of certificates representing any
shares of Company Common Stock cancelled pursuant to Section 2.2(a) (the
"Certificates") and (ii) Parent shall enter into an agreement with the
Exchange Agent reasonably satisfactory to the Company which shall provide
that Parent shall deposit with the Exchange Agent as of the Effective Time,
for the benefit of the holders of shares of Company Common Stock, for
exchange in accordance with this Article II, through the Exchange Agent,
certificates representing the aggregate number of whole shares of Parent
Common Stock (rounded up to the nearest whole share) issuable pursuant to
Section 2.2 in exchange for outstanding shares of Company Common Stock and
an amount of cash equal to the aggregate amount payable to the holders of
outstanding shares of Company Common Stock (such shares of Parent Common
Stock and cash, together with any dividends or distributions with respect
thereto with a record date after the Effective Time being hereinafter
collectively referred to as the "Exchange Fund").
(b) As promptly as possible after the Effective Time, Parent
shall cause the Exchange Agent to mail to each holder of record of shares
of Company Common Stock whose shares were converted into the right to
receive the Merger Consideration pursuant to Section 2.1 (i) a letter of
transmittal which shall specify that delivery shall be effected, and risk
of loss and title to Certificates shall pass, only upon delivery of the
Certificates to the Exchange Agent and which letter shall be in such form
and have such other provisions as are customary for letters of this nature,
and (ii) instructions for effecting the surrender of such Certificates in
exchange for the Merger Consideration. Upon surrender of a Certificate to
the Exchange Agent together with such letter of transmittal, duly executed
and completed in accordance with the instructions thereto, and such other
documents as may be reasonably required by the Exchange Agent, (i) the
holder of such Certificate representing Company Common Stock shall be
entitled to receive in exchange therefor certificates representing that
number of whole shares of Parent Common Stock which such holder has the
right to receive pursuant to the provisions of this Article II, certain
dividends or other distributions in accordance with Section 2.3(c) and a
check in the amount equal to the cash which such holder has the right to
receive pursuant to the provisions of this Article II (including any cash
in lieu of any fractional shares in accordance with Section 2.3(e)), and
(ii) the shares represented by the Certificate so surrendered shall
forthwith be cancelled. No interest will be paid or will accrue on the cash
payable upon surrender of any Certificate. In the event of a transfer of
ownership of Company Common Stock that is not registered in the transfer
records of the Company, exchange and payment may be made with respect to
such Company Common Stock to such a transferee if the Certificate
representing such shares of Company Common Stock is presented to the
Exchange Agent, accompanied by all documents required to evidence and
effect such transfer and to evidence that any applicable stock transfer
taxes have been paid. Until surrendered as contemplated by this Section
2.3, each Certificate shall be deemed at any time after the Effective Time
for all purposes, to represent the right to receive upon surrender the
Merger Consideration with respect to the shares formerly represented
thereby. Notwithstanding the foregoing, Certificates representing Company
Common Stock surrendered for exchange by any person constituting an
"affiliate" of the Company shall not be exchanged until Parent has received
an Affiliate Letter as provided in Exhibit B hereto. From and after the
Effective Time, there shall be no transfers on the stock transfer books of
the Company of the shares of Company Common Stock that were outstanding
immediately prior to the Effective Time. If, after the Effective Time,
Certificates are presented to the Surviving Corporation, they shall be
cancelled and exchanged as provided in this Article II.
(c) No dividends or other distributions with respect to Parent
Common Stock with a record date after the Effective Time shall be paid to
the holder of any unsurrendered Certificate with respect to shares of
Parent Common Stock represented thereby, and no cash which such holder has
the right to receive pursuant to the provisions of this Article II
(including any cash payment in lieu of fractional shares pursuant to
Section 2.3(e)) shall be paid to any such holder, and all such dividends,
other distributions and cash shall be paid by Parent to the Exchange Agent
and shall be included in the Exchange Fund, in each case until the
surrender of such Certificate in accordance with this Article II. Subject
to the effect of applicable escheat or similar laws, following surrender of
any such Certificate there shall be paid to the holder of the certificate
representing whole shares of Parent Common Stock issued in exchange
therefor, without interest, (i) at the time of such surrender, the amount
of dividends or other distributions with a record date after the Effective
Time theretofore paid with respect to such whole shares of Parent Common
Stock and the amount of cash which such holder has the right to receive
pursuant to the provisions of this Article II (including any cash payable
in lieu of a fractional share of Parent Common Stock to which such holder
is entitled pursuant to Section 2.3(e)) and (ii) at the appropriate payment
date, the amount of dividends or other distributions with a record date
after the Effective Time and with a payment date subsequent to such
surrender payable with respect to each whole share of Parent Common Stock.
(d) All shares of Parent Common Stock issued upon the surrender
for exchange of Certificates in accordance with the terms of this Article
II (including any cash paid pursuant to this Article II) shall be deemed to
have been issued (and paid) at the Effective Time in full satisfaction of
all rights pertaining to the shares of Company Common Stock, theretofore
represented by such Certificates, subject, however, to the Surviving
Corporation's obligation to pay any dividends or make any other
distributions with a record date prior to the Effective Time which may have
been declared or made by the Company on such shares of Company Common Stock
in accordance with the terms of the Agreement, which remain unpaid at the
Effective Time.
(e) (i) Notwithstanding anything to the contrary contained
herein, no certificates or scrip representing fractional shares of Parent
Common Stock shall be issued in the Merger upon the surrender for exchange
of Certificates, no dividend or distribution of Parent shall relate to such
fractional share interests and such fractional share interests will not
entitle the owner thereof to vote or to any rights of a stockholder of
Parent. In lieu of the issuance of such fractional shares, the Exchange
Agent shall sell such number of whole shares of Parent Common Stock
(rounded up to the nearest whole share) in the open market in order to pay
each former holder of Company Common Stock an amount in cash equal to the
product obtained by multiplying (A) the fractional share interest to which
such former holder (after taking into account all shares of Company Common
Stock held at the Effective Time by such holder) would otherwise be
entitled by (B) the Average Parent Trading Price.
(ii) As soon as practicable after the determination of the amount
of cash, if any, to be paid to holders of Certificates formerly
representing Company Common Stock with respect to any fractional share
interests, the Exchange Agent shall make available such amounts to such
holders of Certificates formerly representing Company Common Stock subject
to and in accordance with the terms of Section 2.3(b).
(f) Any portion of the Exchange Fund (including the proceeds of
any interest and other income received by the Exchange Agent in respect of
all such funds) that remains unclaimed by the former stockholders of the
Company six months after the Effective Time shall be delivered to Parent.
Any former stockholders of the Company who have not theretofore complied
with this Article II shall thereafter look only to the Surviving
Corporation as general creditors for payment of any Merger Consideration,
without any interest thereon, that may be payable in respect of each share
of Company Common Stock such stockholder holds as determined pursuant to
this Agreement.
(g) None of Parent, the Company, the Surviving Corporation, the
Exchange Agent or any other person shall be liable to any former holder of
shares of Company Common Stock for any amount properly delivered to a
public official pursuant to applicable abandoned property, escheat or
similar laws.
(h) In the event any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the person
claiming such Certificate to be lost, stolen or destroyed and, if required
by the Surviving Corporation, the posting by such person of a bond in such
reasonable amount as the Surviving Corporation may direct as indemnity
against any claim which may be made against it with respect to such
Certificate, the Exchange Agent will issue, in each case, in exchange for
such lost, stolen or destroyed Certificate, the Merger Consideration
payable in respect thereof pursuant to this Agreement.
2.4 Adjustment of Merger Consideration.
(a) If, subsequent to the date of this Agreement but prior to the
Effective Time, the outstanding shares of Company Common Stock or Parent
Common Stock are changed into a different number of shares or a different
class as a result of a stock split, reverse stock split, stock dividend,
subdivision, reclassification, combination, exchange, recapitalization or
other similar transaction, the Exchange Ratio and the Merger Consideration
shall be appropriately and equitably adjusted.
(b) If, subsequent to the date of this Agreement but prior to the
Effective Time, Parent declares, sets aside or pays any dividend or makes
any other distribution or payment (whether in cash, stock, property or any
combination thereof), in each such case with respect to its outstanding
shares of Parent Common Stock, including, without limitation, any of the
foregoing in connection with a spin-off, split-off or split-up, the record
date for which is prior to the Effective Time (a "Section 2.4(b)
Transaction"), then the following adjustments shall be made to the Low-End
Ratio, the High-End Ratio and the Walk-Away Price (as hereinafter defined):
(i) the High-End Ratio shall equal the number determined by
dividing the Per Share Stock Amount by the Adjusted High-End
Price;
(ii) the Low-End Ratio shall equal the number determined by
dividing the Per Share Stock Amount by the Adjusted Low-End
Price; and
(iii) the Walk-Away Price shall equal $14.00 minus the
Adjustment Factor.
(c) As used in this Section 2.4, the following terms shall have
the following meanings:
(i) "Adjusted High-End Price" shall mean an amount equal to
$17.00 minus the Adjustment Factor;
(ii) "Adjusted Low-End Price" shall mean an amount equal to
$20.00 minus the Adjustment Factor; and
(iii) "Adjustment Factor" shall mean the number determined
by dividing the Distribution Value by the aggregate number of
shares of Parent Common Stock outstanding immediately prior to
the Effective Time.
(iv) "Distribution Value" shall mean (I) for Section 2.4(b)
Transactions not involving a Spin-Off (as hereinafter defined)
the aggregate fair market value on the distribution date of the
assets, property, cash, securities, rights, warrants or options
distributed in respect of the Parent Common Stock in the Section
2.4(b) Transaction, as determined in good faith by the Board of
Directors of Parent; or (II) in respect of a dividend or other
distribution of shares of capital stock of any class or series,
or similar equity interests, of or relating to a Subsidiary or
other business unit of Parent, which securities are listed for
and are actually trading on an exchange or the Nasdaq National
Market System (a "Spin-Off"), the product of (x) the arithmetic
average of the per share 4:00 p.m. Eastern time closing sales
price of such securities for the 10 consecutive trading days
commencing on and including the first day of trading of such
securities after the effectiveness of the Spin-Off, and (y) the
aggregate number of such securities outstanding during such
10-day period.
(d) Parent shall not, during the Pricing Period, effect any
Section 2.4(b) Transaction or cause the Parent Common Stock to trade
ex-dividend with respect to any Section 2.4(b) Transaction.
(e) Parent shall not, prior to the Effective Time, effect, or
cause the Parent Common Stock to trade ex-dividend with respect to, any
Section 2.4(b) Transaction other than the previously announced Spin-Off of
Parent's individual membership and loyalty business.
2.5 Dissenting Company Stockholders. Notwithstanding any
provision of this Agreement to the contrary, shares of Company Common Stock
that are issued and outstanding immediately prior to the Effective Time and
which are held by holders of such shares of Company Common Stock who
properly exercise appraisal rights with respect thereto in accordance with
Section 262 of the DGCL (the "Dissenting Common Stock") shall not be
exchangeable for the right to receive the Merger Consideration, and holders
of such shares of Dissenting Common Stock will be entitled only to receive
payment of the appraised value of such shares of Company Common Stock in
accordance with the provisions of such Section 262 unless and until such
holders fail to perfect or effectively withdraw or lose their rights to
appraisal and payment under the DGCL. If, after the Effective Time, any
such holder fails to perfect or effectively withdraws or loses such right,
such shares of Company Common Stock will thereupon be treated as if they
had been converted into and to have become exchangeable for, at the
Effective Time, the right to receive the Merger Consideration, without any
interest thereon. The Company shall give Parent (i) prompt notice of any
demands received by the Company for appraisals of shares of Company Common
Stock and (ii) the opportunity to direct all negotiations and proceedings
with respect to demands for appraisal under the DGCL. The Company shall
not, except with the prior written consent of Parent, make any payment with
respect to any demands for appraisal or offer to settle or settle any such
demands.
ARTICLE III
Representations and Warranties of the Company
The Company hereby represents and warrants to Parent and Purchaser
as follows:
3.1 Existence; Good Standing; Corporate Authority. The Company is
a corporation duly organized, validly existing and in good standing under
the laws of its jurisdiction of incorporation. The Company is duly
qualified to do business as a foreign corporation and is in good standing
under the laws of any other state of the United States in which the
ownership of its properties or the conduct of its business requires such
qualification, except where the failure to be so qualified or in good
standing has not had and would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on the assets,
liabilities, business, results of operations, or financial condition of the
Company and its Subsidiaries, taken as a whole, except any such effect
resulting primarily from (a) this Agreement, the transactions contemplated
by this Agreement or the announcement thereof, (b) Parent's announcement or
other communication of Parent of the plans or intentions of Parent with
respect to the conduct of the business (or any portion thereof) of the
Company or any of its Subsidiaries, (c) changes or conditions (including
changes in economic, financial market, regulatory or political conditions)
affecting generally the air travel industry, the CRS industry, or the
information services industry in which the Company or its Subsidiaries
participates or (d) the Company's or its Subsidiaries' failure to engage in
actions and activities in accordance with Section 5.2(b) in furtherance of
the Company's web hosting business or Quantitude's third party
telecommunications business (a "Company Material Adverse Effect") and would
not prevent or materially delay consummation of the transactions
contemplated hereby. The Company has all requisite corporate power and
authority to own or lease and operate its properties and to carry on its
business as now conducted, except where the failure to have such power and
authority has not had and would not reasonably be expected to have a
Company Material Adverse Effect and would not prevent or materially delay
consummation of the transactions contemplated hereby. Except as set forth
in Schedule 3.1 of the disclosure letter, dated this date, delivered by the
Company to Parent (the "Company Disclosure Letter"), the Company has
heretofore delivered to Parent true and correct copies of the Certificate
of Incorporation and Bylaws (or equivalent organizational documents) as
currently in effect for the Company and each of its Subsidiaries. Except as
set forth in Schedule 3.1 of the Company Disclosure Letter, such
Certificates of Incorporation and Bylaws (or equivalent organizational
documents) are in full force and effect and no other organizational
documents are applicable to or binding upon the Company or its
Subsidiaries. The term "Subsidiaries," when used in this Agreement with
respect to any party, means any corporation or other organization, whether
incorporated or unincorporated, of which such party directly or indirectly
owns or controls more than 50% of the securities or other interests having
by their terms ordinary voting power to elect a majority of the board of
directors or other governing body performing similar functions.
3.2 Authorization, Validity and Effect of Agreements. The
Company's Board of Directors has on or prior to the date of this Agreement
(a) declared the Merger advisable and in the best interest of the Company
and its stockholders and approved this Agreement in accordance with
applicable Law, (b) resolved to recommend the approval of this Agreement by
the Company's stockholders at a meeting thereof duly called and held in
accordance with the Company's Certificate of Incorporation and Bylaws and
the requirements of the DGCL (the "Stockholders Meeting") and (c) directed
that this Agreement be submitted to the Company's stockholders for approval
(collectively, the "Board Recommendation"). The Company has the requisite
corporate power and authority to execute and deliver this Agreement, the
Option Agreement and all other agreements and documents contemplated hereby
(the "Ancillary Documents") to which it is a party and to consummate the
transactions contemplated hereby and thereby. The execution and delivery of
this Agreement, the Option Agreement and the Ancillary Documents to which
it is a party by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby have been duly and validly
authorized by the Company's Board of Directors, and no other corporate
proceedings on the part of the Company are necessary to authorize this
Agreement, the Option Agreement and the Ancillary Documents to which it is
a party or to consummate the transactions contemplated hereby and thereby
other than (i) assuming the accuracy of Parent's and Purchaser's
representation and warranty set forth in Section 4.16, the approval of this
Agreement by the affirmative vote of the holders of a majority of the
outstanding shares of Company Common Stock (voting as one class with each
share of Company Common Stock having one vote) (the "Company Stockholder
Approval") and (ii) the filing and recordation of the Certificate of Merger
in accordance with the DGCL. This Agreement and the Option Agreement have
been, and any Ancillary Document to which the Company is a party at the
time of execution shall have been, duly and validly executed and delivered
by the Company, and (assuming this Agreement and such Ancillary Documents
each constitutes a valid and binding obligation of any other parties
thereto) constitutes and will constitute the valid and binding obligations
of the Company, enforceable in accordance with their respective terms,
subject, as to enforceability, to applicable bankruptcy, insolvency,
moratorium or other similar laws, now or hereafter in effect, relating to
creditors' rights and general principles of equity.
3.3 Compliance with Laws. Except as set forth in Schedule 3.3 of
the Company Disclosure Letter, the Company and each of its Subsidiaries are
in compliance with and are not in default under or in violation of (a)
their respective Certificates of Incorporation and Bylaws (or equivalent
organizational documents), (b) any order of any foreign, federal, state or
local judicial, legislative, executive, administrative or regulatory body
or authority or any arbitration board or tribunal ("Governmental Entity")
or (c) any foreign, federal, state or local law, statute, ordinance, rule,
regulation, order, judgment or decree ("Laws") applicable to the Company or
such Subsidiaries or any of their respective properties or assets, except,
in the case of clauses (b) and (c) above, where such non-compliance,
default or violation, individually or in the aggregate, has not had and
would not reasonably be expected to have a Company Material Adverse Effect,
would not prevent or materially delay consummation of the transactions
contemplated hereby and would not impose a risk of criminal liability,
criminal fines, imprisonment or confinement, in each case, upon any
officer, employee or director of the Company, Parent or any of their
respective Subsidiaries. Schedule 3.3 of the Company Disclosure Letter sets
forth any material order of any Governmental Entity binding on the Company
or such Subsidiaries.
3.4 Capitalization. The authorized capital stock of the Company
consists of (a) 250,000,000 shares of Company Common Stock, (b) 7 shares of
Special Voting Preferred Stock of which (i) 1 share has been designated
Series A Special Voting Preferred Stock (the "Series A Special Voting
Preferred Stock"), (ii) 1 share has been designated Series B Special Voting
Preferred Stock (the "Series B Special Voting Preferred Stock"), (iii) 1
share has been designated Series C Special Voting Preferred Stock (the
"Series C Special Voting Preferred Stock"), (iv) 1 share has been
designated Series D Special Voting Preferred Stock (the "Series D Special
Voting Preferred Stock"), (v) 1 share has been designated Series E Special
Voting Preferred Stock (the "Series E Special Voting Preferred Stock"),
(vi) 1 share has been designated Series F Special Voting Preferred Stock
(the "Series F Special Voting Preferred Stock"), and (vii) 1 share has been
designated Series G Special Voting Preferred Stock (the "Series G Special
Voting Preferred Stock"), and (c) 25,000,000 shares of ordinary preferred
stock, par value $.01 per share (the "Ordinary Preferred Stock," and,
collectively with the Special Voting Preferred Stock, the "Preferred
Stock"). 2,500,000 shares of Ordinary Preferred Stock have been designated
as Series H Junior Participating Preferred Stock ("Series H Preferred
Stock") in connection with the Rights issued pursuant to the Rights
Agreement. As of May 31, 2001, (A) 87,390,109 shares of Company Common
Stock were issued and outstanding, (B) (1) 1 share each of Series A, B and
E of Special Voting Preferred Stock were issued and outstanding, (2) no
shares of Ordinary Preferred Stock were issued and outstanding, (3) no
shares of Series H Preferred Stock were issued or outstanding, and (4) no
other shares of capital stock of the Company were issued and outstanding,
(C) 4,047,545 shares of Company Common Stock were reserved for issuance
upon the exercise of outstanding stock options, and (D) 18,021,476 shares
of Company Common Stock were held by the Company in its treasury. Except
for the Rights and the aforementioned stock options, and except as set
forth in Schedule 3.4 of the Company Disclosure Letter and the Option
Agreement, the Company has no outstanding bonds, debentures, notes or other
obligations entitling the holders thereof to vote (or which are convertible
into or exercisable for securities having the right to vote) with the
stockholders of the Company on any matter. All issued and outstanding
shares of capital stock of the Company are duly authorized, validly issued,
fully paid, nonassessable and free of preemptive rights. Except for the
Rights, the Option Agreement and the aforementioned stock options and other
than pursuant to the Company Benefit Plans (as defined in Section 3.11) or
as set forth in Schedule 3.4 of the Company Disclosure Letter, there are no
existing options, warrants, calls, subscriptions, convertible securities,
or other rights, agreements or commitments (Y) to which the Company or any
of its Subsidiaries is a party of any character relating to the issued or
unissued capital stock or other equity interests of the Company or any of
its Subsidiaries, or (Z) obligating the Company or any Subsidiary of the
Company to (1) issue, transfer or sell any shares of capital stock or other
equity interests of the Company or any Subsidiary of the Company or
securities convertible into or exchangeable for such shares or equity
interests, (2) grant, extend or enter into any such subscription, option,
warrant, call, convertible securities or other similar right, agreement,
arrangement or commitment, (3) redeem or otherwise acquire any such shares
of capital stock or other equity interests or (4) make any investment (in
the form of a loan, capital contribution or otherwise) in any person in an
amount in excess of $1,000,000, individually or in the aggregate. Except as
set forth under the heading "Certain Relationships and Related
Transactions" in the Company's definitive proxy statement for its annual
meeting of stockholders held on May 17, 2001 (the "2001 Proxy Statement"),
or in Schedule 3.4 of the Company Disclosure Letter, there are no voting
trusts, voting agreements or other agreements or understandings to which
the Company or any of its Subsidiaries is a party with respect to the
voting of the capital stock or other equity interest of the Company or any
of its Subsidiaries.
3.5 Subsidiaries. Schedule 3.5 of the Company Disclosure Letter
lists all of the Subsidiaries of the Company. Except as set forth in
Schedule 3.5 of the Company Disclosure Letter, each of the Company's
Subsidiaries is a corporation, partnership, limited liability company or
similar form of entity duly organized, validly existing and in good
standing under the laws of its jurisdiction of incorporation or
organization and has the corporate, partnership or similar power and
authority to own or lease and operate its properties and carry on its
business as now conducted. Except as set forth in Schedule 3.5 of the
Company Disclosure Letter, each of the Company's Subsidiaries is duly
qualified to do business as a foreign corporation and is in good standing
in each jurisdiction in which the ownership of its property or the conduct
of its business requires such qualification, except where the failure to be
so qualified or in good standing, individually or in the aggregate, has not
had and would not reasonably be expected to have a Company Material Adverse
Effect and would not prevent or materially delay consummation of the
transactions contemplated hereby. The Company owns, directly or indirectly,
all of the outstanding shares of capital stock (or other ownership
interests having by their terms ordinary voting power to elect a majority
of directors or others performing similar functions with respect to such
Subsidiaries) of each of the Company's Subsidiaries, free and clear of all
liens, pledges, security interests, claims or other encumbrances
(collectively, "Liens"). Except as set forth in Schedule 3.5 of the Company
Disclosure Letter, neither the Company or any of its Subsidiaries nor any
of their respective officers, employees or directors have issued, granted
or sold, or promised, committed or proposed to issue, grant or sell, to any
person any options, warrants, shares or other equity interests in any
Subsidiary of the Company, including Quantitude and Trip. No Subsidiary of
the Company owns any capital stock or has any equity interest in the
Company. Each of the outstanding shares of capital stock (or such other
ownership interests) of each of the Company's Subsidiaries is duly
authorized, validly issued, fully paid and nonassessable. Schedule 3.5 of
the Company Disclosure Letter sets forth the following information for each
Subsidiary of the Company: (a) its name and jurisdiction of incorporation
or organization, (b) its authorized capital stock or share capital, (c) the
number of issued and outstanding shares of capital stock, share capital or
other equity interests, and (d) any debt securities issued by it. Except
for the Company's interests in the Subsidiaries as set forth in Schedule
3.5 of the Company Disclosure Letter or as otherwise set forth in such
Schedule, neither the Company nor the Subsidiaries own, directly or
indirectly, any stock, interest or investment (whether equity or debt) in
any corporation, partnership, limited liability company, joint venture,
business, trust or other form of entity.
3.6 No Violation; Consents. Except as set forth in Schedule 3.6
of the Company Disclosure Letter, neither the execution and delivery by the
Company of this Agreement, the Option Agreement or any of the Ancillary
Documents to which it is a party nor the consummation by the Company of the
transactions contemplated hereby or thereby will: (a) violate, conflict
with or result in a breach of the respective Certificates of Incorporation
or Bylaws (or equivalent organizational documents) of the Company or any
Subsidiary of the Company; (b) violate, conflict with, result in a breach
of, constitute (with or without due notice or lapse of time or both) a
default under, result in the termination or in a right of termination of,
accelerate the performance required by or benefit obtainable under, result
in the triggering of any payment or other obligations pursuant to, result
in the creation of any Lien upon any of the properties of the Company or
its Subsidiaries under, or result in there being declared void, voidable,
or without further binding effect, any of the terms, conditions or
provisions of any loan or credit agreement, note, bond, mortgage,
indenture, deed of trust or any license, franchise, permit, lease,
sublease, contract, agreement or other instrument, commitment or obligation
(each, a "Contract" and, collectively, "Contracts") to which the Company or
any of its Subsidiaries is a party, or by which the Company or any of its
Subsidiaries or any of their respective properties or assets is bound,
except for any of the foregoing matters which, individually or in the
aggregate, has not had and would not reasonably be expected to have a
Company Material Adverse Effect; (c) provided that the authorizations,
filings and registrations described in clause (d) of this Section 3.6 have
been obtained and made, violate any Laws applicable to the Company, any
Subsidiary of the Company or any of their respective properties or assets
except for any such violations which, individually or in the aggregate, has
not had and would not reasonably be expected to have a Company Material
Adverse Effect; or (d) require any consent, approval or authorization of,
or filing or registration with, any Governmental Entity, except (i) for (A)
applicable requirements of the Securities Act and the Exchange Act, (B) the
applicable pre-merger notification requirements of the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended and the rules and
regulations thereunder (the "HSR Act"), any required filings with or
approvals under the EC Merger Regulation (as hereinafter defined) and the
Australian Approval (as hereinafter defined), (C) such other required
filings with or approvals of foreign competition Law authorities, (D) the
applicable requirements of the Communications Act of 1934, as amended (the
"FCC Act"), and (E) the filing and recordation of a Certificate of Merger
pursuant to the DGCL, or (ii) where the failure to obtain any such consent,
approval or authorization, or to make any such filing or registration would
not, individually or in the aggregate, have or reasonably be expected to
have a Company Material Adverse Effect and would not prevent or materially
delay consummation of the transactions contemplated hereby.
3.7 Company Reports; Financial Statements. (a) The Company filed
all forms, reports, schedules, statements and other documents required to
be filed by it with the Securities and Exchange Commission (the "SEC")
since December 31, 1998 (collectively, including all exhibits and
information incorporated by reference therein, the "Company Reports"). As
of their respective dates (and if amended or supplemented by a filing prior
to the date of this Agreement, then as of the date of such filing), the
Company Reports (i) complied in all material respects with the
then-applicable requirements of the Securities Act, the Exchange Act, and
the rules and regulations promulgated thereunder and (ii) did not contain
any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements made
therein, in the light of the circumstances under which they were made, not
misleading. No Subsidiary of the Company is required to file any forms,
reports or other documents with the SEC.
(b) Except as set forth in Schedule 3.7 of the Company Disclosure
Letter, each of the consolidated balance sheets (including all related
notes) included in the Company Reports fairly presents the consolidated
financial position of the Company and its Subsidiaries as of its date, and
each of the consolidated statements of income (including all related
notes), retained earnings and cash flows of the Company included in the
Company Reports fairly presents the results of operations, retained
earnings or cash flows of the Company and its Subsidiaries for the periods
set forth therein (subject, in the case of unaudited statements, to normal,
recurring year-end audit adjustments, none of which are material in kind or
amount), in each case, in accordance with United States generally accepted
accounting principles consistently applied ("GAAP") during the periods
involved, except as may be noted therein.
3.8 Litigation. Except as set forth in Schedule 3.8 of the
Company Disclosure Letter or under the heading "Legal Proceedings" in the
Company's Annual Report on Form 10-K for the fiscal year ended December 31,
2000 (the "2000 Annual Report"), there are no actions, suits, proceedings,
inquiries or, to the knowledge of the Company, investigations
("Litigation") pending, publicly announced or, to the knowledge of the
Company, threatened in writing against or affecting the Company or any of
its Subsidiaries, at law or in equity, and there are no orders of any
Governmental Entity outstanding against the Company or any of its
Subsidiaries that, individually or in the aggregate, (a) have had or would
reasonably be expected to have a Company Material Adverse Effect, (b) would
prevent or materially delay consummation of the transactions contemplated
hereby or (c) as of the date hereof, question or challenge the validity of
this Agreement.
3.9 Absence of Certain Changes. Except as set forth in Schedule
3.9 of the Company Disclosure Letter, since March 31, 2001, the Company and
its Subsidiaries have conducted their respective businesses only in the
ordinary course, consistent with past practice, and there has not been or
occurred (a) any event, condition, circumstance or state of facts that,
individually or in the aggregate, has had or would reasonably be expected
to have a Company Material Adverse Effect or (b) any action taken by the
Company that, if taken after the date of this Agreement without the prior
written consent of Parent, would be a violation of Section 5.2 hereof.
3.10 Taxes. (a) Except as set forth in Schedule 3.10 of the
Company Disclosure Letter and except as, individually or in the aggregate,
has not had and would not reasonably be expected to have a Company Material
Adverse Effect, each of the Company and its Subsidiaries (i) have timely
filed all Tax Returns (as defined below) required to be filed by each of
the Company and its Subsidiaries, and all such Tax Returns are complete and
correct and (ii) except for those Taxes (as defined below) being contested
in good faith and for which adequate reserves have been established in the
financial statements included in the Company Reports in accordance with
GAAP, each of the Company and its Subsidiaries have paid (or the Company
has paid on its behalf) all Taxes required to be paid by each of the
Company and its Subsidiaries. Except as set forth in Schedule 3.10 of the
Company Disclosure Letter, the financial statements included in the Company
Reports reflect an adequate reserve in accordance with GAAP for all Taxes
payable by the Company and each of its Subsidiaries for all taxable periods
and portions thereof accrued through the date of such financial statements.
Except as set forth in Schedule 3.10 of the Company Disclosure Letter,
there is no action, suit, claim or assessment pending with respect to Taxes
that is not adequately reserved for or which, if upheld, individually or in
the aggregate, has not had and would not reasonably be expected to have a
Company Material Adverse Effect. Except as set forth in Schedule 3.10 of
the Company Disclosure Letter, each of the Company and its Subsidiaries
have complied with all applicable rules and regulations relating to the
withholding of Taxes and have withheld and paid over to the relevant taxing
authority all Taxes required to have been withheld and paid, including,
without limitation, withholding in connection with payments to employees,
independent contractors, creditors, stockholders or other third parties,
except for Taxes which, individually or in the aggregate, have not had and
would not reasonably be expected to have a Company Material Adverse Effect.
Except as set forth in Schedule 3.10 of the Company Disclosure Letter,
there is no agreement, contract, plan or arrangement involving the Company
or any of its Subsidiaries and covering any person that individually or
collectively could give rise to the payment of any amount that would not be
deductible by Parent, Purchaser, the Company or any of their respective
Subsidiaries by reason of Section 280G of the Code. For purposes of this
Agreement, (A) "Tax" (and, with correlative meaning, "Taxes") means any (x)
federal, state, local or foreign income, gross receipts, property, sales,
use, license, excise, franchise, employment, payroll, premium, withholding,
alternative or added minimum, ad valorem, transfer or excise tax, or any
other tax, custom, duty, governmental fee or other like assessment or
charge of any kind whatsoever, together with any interest or penalty,
imposed by any Governmental Entity, (y) liability for the payment of any
amounts described in clause (x) above as a result of being a member of an
affiliated, consolidated, combined, unitary or similar group or as a result
of transferor or successor liability and (z) liability for the payment of
any amounts as a result of being a party to any tax sharing agreement or as
a result of any agreement to indemnify any other person with respect to the
payment of any amounts of the type described in clause (x) or (y) above,
and (B) "Tax Return" means any return, report or similar statement required
to be filed with respect to any Tax (including any attached schedules),
including, without limitation, any information return, claim for refund,
amended return or declaration of estimated Tax.
(b) None of the Company nor any of its affiliates has taken or
agreed to take any action, has failed to take any action, or knows of any
fact, agreement, plan or other circumstance that is reasonably likely to
prevent the Merger from qualifying as a reorganization within the meaning
of Section 368(a) of the Code.
3.11 Employee Benefit Plans. (a) All employee benefit plans,
compensation arrangements and other benefit arrangements, whether or not
"employee benefit plans" (within the meaning of Section 3(3) of ERISA (as
hereinafter defined), whether or not subject to ERISA), providing cash-or
equity-based incentives, health, medical, dental, disability, accident or
life insurance benefits or severance, retirement, pension or savings
benefits, which are subject to U.S. Law and cover employees, directors,
former employees and former directors of the Company or its Subsidiaries
(the "Company Benefit Plans") and all employee agreements (excluding (i)
offer letters establishing the terms of at-will employment and (ii)
non-U.S. employment or consulting agreements, which in each case are
required or imposed by the Law of the jurisdiction) providing compensation,
severance or other benefits to any officer, employee or former employee of
the Company or its Subsidiaries are set forth in Schedule 3.11 of the
Company Disclosure Letter. Except as set forth in Schedule 3.11 of the
Company Disclosure Letter, any Company Benefit Plan intended to be
qualified under Section 401(a) or 401(k) of the Code has received a
determination letter from the Internal Revenue Service and, to the
knowledge of the Company, continues to satisfy the requirements for such
qualification, except for where the failure to so qualify, individually or
in the aggregate, has not had and would not reasonably be expected to have
a Company Material Adverse Effect. Except as set forth in Schedule 3.11 of
the Company Disclosure Letter, neither the Company nor any ERISA Affiliate
of the Company maintains, contributes to, or has since January 1, 1996,
maintained or contributed to, any benefit plan which is covered by Title IV
of ERISA or Section 412 of the Code. Except as set forth in Schedule 3.11
of the Company Disclosure Letter, no Company Benefit Plan and neither the
Company nor its Subsidiaries has incurred any liability or penalty under
Section 4975 of the Code or Section 502(i) of ERISA which, individually or
in the aggregate, has not had and would reasonably be expected to result in
a Company Material Adverse Effect or has engaged in any transaction which
is reasonably likely to result in any such liability or penalty. Except as
set forth in Schedule 3.11 of the Company Disclosure Letter, each Company
Benefit Plan has been maintained and administered in compliance with its
terms and with ERISA and the Code to the extent applicable thereto, except
for such non-compliance which, individually or in the aggregate, has not
had and would not reasonably be expected to have a Company Material Adverse
Effect. Except as set forth in Schedule 3.8 or Schedule 3.11 of the Company
Disclosure Letter, there is no pending or, to the knowledge of the Company,
threatened Litigation against or otherwise involving any of the Company
Benefit Plans and no Litigation (excluding routine claims for benefits
incurred in the ordinary course of Company Benefit Plan activities) has
been brought against or with respect to any such Company Benefit Plan,
except for any of the foregoing which, individually or in the aggregate,
has not had and would not reasonably be expected to have a Company Material
Adverse Effect. Except as required by Law or as set forth in Schedule 3.11
of the Company Disclosure Letter, neither the Company nor its Subsidiaries
maintains or contributes to any plan or arrangement which, and no Company
Benefit Plan, provides, or has any liability to provide, life insurance or
medical or other employee welfare benefits to any employee or former
employee upon his retirement or termination of employment. Except as set
forth in Schedule 3.11 of the Company Disclosure Letter, all contributions
required to be made with respect to any Company Benefit Plan on or prior to
the Closing Date have been timely made or are reflected on the balance
sheet of the Company dated March 31, 2001, except for such failures to
contribute as, individually or in the aggregate, has not had and would not
reasonably be expected to have a Company Material Adverse Effect. Except as
would not be reasonably expected to result in a Material Adverse Effect,
and except as set forth in Schedule 3.11 of the Company Disclosure Letter,
there has been no formal amendment by the Company to any Company Benefit
Plan that would increase materially the expense of maintaining such Plan
above the level or expense incurred in respect thereof for the year ended
December 31, 2000. Except as set forth in Schedule 3.11 of the Company
Disclosure Letter, the consummation of the transactions contemplated by
this Agreement will not, either alone or in combination with another event,
(A) entitle any current or former employee or officer of the Company or any
ERISA Affiliate to severance pay, unemployment compensation or any other
payment, except as expressly provided in this Agreement, or (B) accelerate
the time of payment or vesting, or increase the amount of compensation due
any such employee or officer except as expressly provided in this
Agreement, and no amounts payable under the Company Benefit Plans will fail
to be deductible for federal income tax purposes by virtue of Section 280G
of the Code. Except as set forth in Schedule 3.11 of the Company Disclosure
Letter, no liability under Title IV of ERISA has been incurred by the
Company, any of its Subsidiaries or any of its ERISA Affiliates since the
effective date of ERISA that has not been satisfied in full and that,
individually or in the aggregate, has had or would reasonably be expected
to have a Company Material Adverse Effect. Except as set forth in Schedule
3.11 of the Company Disclosure Letter, with respect to each Company Benefit
Plan that is subject to Title IV of ERISA, the present value of projected
benefit obligations under such Company Benefit Plan, as determined by the
Company Benefit Plan's actuary based upon the actuarial assumptions used
for funding purposes in the most recent actuarial report prepared by the
Company Benefit Plan's actuary with respect to such Company Benefit Plan,
did not, as of its latest valuation date, exceed the then current value of
the assets of such Company Benefit Plan allocable to such projected benefit
obligations. Except as set forth in Schedule 3.11 of the Company Disclosure
Letter, no Company Benefit Plan is a "multiemployer plan," as such term is
defined in Section 3(37) of ERISA, or a "multiple employer plan" as such
term is defined in Section 413 of the Code. Each Company Benefit Plan that
is intended to satisfy the requirements of Section 501(c)(9) of the Code
satisfies the requirements of Section 501(c)(9) of the Code, except where
non-compliance would not be reasonably expected to have a Material Adverse
Effect. Except as set forth in Schedule 3.11 of the Company Disclosure
Letter, with respect to each Company Benefit Plan that is not subject to
United States Law (a "Foreign Benefit Plan"): (i) all employer and employee
contributions to each Foreign Benefit Plan required by Law or by the terms
of such Foreign Benefit Plan have been made, or if applicable, accrued in
accordance with normal accounting practices except for such contributions
or accruals, the failure of which to make or accrue, individually or in the
aggregate, has not had and would not reasonably be expected to have a
Company Material Adverse Effect; (ii) the fair market value of the assets
of each funded Foreign Benefit Plan, the liability of each insurer for any
Foreign Benefit Plan funded through insurance or the book reserve
established for any Foreign Benefit Plan, together with any accrued
contributions, is sufficient to procure or provide for the accrued benefit
obligations, as of the Closing Date, with respect to all current and former
participants in such plan according to the actuarial assumptions and
valuations most recently used to determine employer contributions to such
Foreign Benefit Plan and no transaction contemplated by this Agreement
shall cause such assets or insurance obligations to be less than such
benefit obligations, except in each case, for insufficiencies or
transactions which, individually or in the aggregate, has not had and would
not reasonably be expected to have a Company Material Adverse Effect; and
(iii) each Foreign Benefit Plan required to be registered has been
registered and has been maintained in good standing with applicable
regulatory authorities except for such failures to register or maintain as,
individually or in the aggregate, has not had and would not reasonably be
expected to have a Company Material Adverse Effect.
(b) For purposes of this Agreement, "ERISA Affiliate" means any
business or entity which is a member of the same "controlled group of
corporations," under "common control" or an "affiliated service group" with
an entity within the meanings of Sections 414(b), (c) or (m) of the Code,
or required to be aggregated with the entity under Section 414(o) of the
Code, or is under "common control" with the entity, within the meaning of
Section 400l(a)(14) of ERISA, or any regulations promulgated or proposed
under any of the foregoing Sections.
3.12 Labor and Employment Matters. Except as set forth in
Schedule 3.12 of the Company Disclosure Letter or to the extent imposed or
implied by applicable foreign Law, neither the Company nor any of its
Subsidiaries is a party to, or bound by, any collective bargaining
agreement with employees or other Contracts or understandings with a labor
union or labor organization. Except as set forth in Schedule 3.12 of the
Company Disclosure Letter, there are no strikes or lockouts with respect to
any employee of the Company or any Subsidiary, and to the knowledge of the
Company, there is no union organizing effort pending or threatened against
the Company or any Subsidiary. Except for such matters which, individually
or in the aggregate, have not had and would not reasonably be expected to
have a Company Material Adverse Effect or except as set forth in Schedule
3.12 of the Company Disclosure Letter, (a) there is no unfair labor
practice, labor dispute (other than routine individual grievances) or labor
arbitration proceeding pending or, to the knowledge of the Company,
threatened against the Company or its Subsidiaries relating to their
business; (b) there is no slowdown, work stoppage or threat thereof by or
with respect to such employees; and (c) the Company and its Subsidiaries
are in compliance with all applicable Laws respecting (A) employment and
employment practices, (B) terms and conditions of employment and wages and
hours, and (C) unfair labor practices. Except as set forth in Schedule 3.8
or Schedule 3.12 of the Company Disclosure Letter, there is no Litigation
pending or, to the knowledge of the Company, threatened in writing against
the Company or any of its Subsidiaries, at law or in equity, alleging a
violation of applicable Laws, rules or regulations respecting employment
and employment practices, terms and conditions of employment and wages and
hours, or unfair labor practice that, individually or in the aggregate, has
had or would reasonably by expected to have a Company Material Adverse
Effect. Except as set forth in Schedule 3.12 of the Company Disclosure
Letter, neither the Company nor any of its Subsidiaries has any liabilities
under the Worker Adjustment and Retraining Notification Act (the "WARN
Act") as a result of any action taken by the Company (other than at the
written direction of Parent) and that, individually or in the aggregate,
has had or would reasonably be expected to have a Company Material Adverse
Effect.
3.13 Intellectual Property Rights.
(a) Schedule 3.13 of the Company Disclosure Letter set forth a
complete and accurate list of all U.S. and foreign patents, patent
applications, trademarks, trademark applications, trademark registrations,
Internet domain name registrations, service marks, service mark
applications, service mark registrations, logos, copyrights, copyright
registrations and copyright applications, and such Schedule sets forth a
complete and accurate list of all technical know-how and other proprietary
intellectual property rights and software programs and systems
(collectively, "Intellectual Property Rights") that are material to the
conduct of the business of (i) the Company and its Subsidiaries taken as a
whole, (ii) Trip or (iii) Quantitude, in each case, as currently or planned
to be conducted, and identifying the owner or licensor of such material
Intellectual Property Rights. Each of the Company and its Subsidiaries
owns, or is validly licensed or otherwise has the right to use all the
Intellectual Property Rights that are material to the conduct of the
business of the Company and its Subsidiaries taken as a whole ("Material
Intellectual Property Rights") used by it in connection with its businesses
as currently conducted or planned to be conducted, in each case, free and
clear of all Liens, except for where the failure to own, be validly
licensed or have the right to use such Material Intellectual Property
Rights or where the presence of Liens on such Material Intellectual
Property Rights would not reasonably be expected to result in a Company
Material Adverse Effect.
(b) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, no claims are pending or, to the knowledge of the
Company, threatened in writing that the Company or any of its Subsidiaries
are infringing, misappropriating or otherwise violating or interfering with
the rights of any person with regard to any Intellectual Property Rights.
Except as set forth in Schedule 3.13 of the Company Disclosure Letter, as
of the date of this Agreement, to the knowledge of the Company, no person
or persons are infringing, misappropriating or otherwise violating or
interfering with the rights of the Company or of any of its Subsidiaries
with respect to any Intellectual Property Rights.
(c) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, no claims are pending or, to the knowledge of the
Company, threatened in writing with regard to ownership or enforceability
by the Company or any of its Subsidiaries of any of their respective
Intellectual Property Rights.
(d) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, the Material Intellectual Property Rights owned by the
Company and its Subsidiaries are in full force and effect, and have not
expired or been cancelled or abandoned, and, to the knowledge of the
Company, are valid and enforceable, except where such cancellation,
expiration or abandonment, individually or in the aggregate, has not had
and would not reasonably be expected to have a Company Material Adverse
Effect. Except as set forth in Schedule 3.13 of the Company Disclosure
Letter, all material patents, trademarks and applications and registrations
therefor owned by the Company or any of its Subsidiaries have been duly
registered, filed with or issued by each appropriate Governmental Entity in
the jurisdiction indicated on Schedule 3.13 of the Company Disclosure
Letter, all necessary affidavits of continuing use have been filed and all
necessary maintenance and other applicable fees have been timely paid to
continue all such rights in effect, except failures to register, file or
pay that, individually or in the aggregate, have not had and would not
reasonably be expected to have a Company Material Adverse Effect. Except as
set forth in Schedule 3.13 of the Company Disclosure Letter, none of the
material patents and patent applications listed on Schedule 3.13 of the
Company Disclosure Letter has been declared invalid or unenforceable, in
whole or in part, by any Governmental Entity. Except as set forth in
Schedule 3.13 of the Company Disclosure Letter, each inventor named on the
patents and patent applications identified as being owned by the Company or
any of its Subsidiaries on Schedule 3.13 of the Company Disclosure Letter
has executed an agreement assigning his, her or its entire right, title and
interest in and to such patent or patent application, and the inventions
embodied and claimed therein, to the Company or a Subsidiary of the
Company, except to the extent that any failures to assign would not
reasonably be expected to have a Company Material Adverse Effect.
(e) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, the Company uses, and has used, reasonable best efforts
to maintain the confidentiality of its trade secrets and other confidential
proprietary information.
(f) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, all of the Material Intellectual Property Rights that
are owned by the Company or one of its Subsidiaries were either developed
(i) by employees of the Company or any Subsidiary (or a predecessor entity
thereof) within the scope of their employment or (ii) by independent
contractors who have assigned their rights to the Company or any Subsidiary
pursuant to written agreements.
(g) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, neither the Company nor any Subsidiary has licensed its
rights in any Intellectual Property Rights owned by it except pursuant to
written agreement, except as have not had and would not reasonably be
expected to have a Company Material Adverse Effect.
(h) Except as set forth in Schedule 3.13 of the Company
Disclosure Letter, no royalties, honoraria or other fees are payable by the
Company or any Subsidiary to any third parties (other than Governmental
Entities) for the use of or right to use any Intellectual Property Rights
except (i) pursuant to written agreements or (ii) as have not had and would
not reasonably be expected to have a Company Material Adverse Effect.
3.14 Permits. Except as set forth in Schedule 3.14 of the Company
Disclosure Letter, the Company and its Subsidiaries are in possession of
all franchises, grants, authorizations, licenses, permits, easements,
variances, exceptions, consents, certificates, approvals and orders of any
Governmental Entity necessary for the Company and its Subsidiaries to own,
lease and operate their properties and assets or to carry on their
businesses as they are now being conducted (the "Company Permits"), except
where the failure to have any of the Company Permits, individually or in
the aggregate, has not had and would not reasonably be expected to have a
Company Material Adverse Effect and would not prevent or materially delay
consummation of the transactions contemplated hereby. Except as set forth
in Schedule 3.14 of the Company Disclosure Letter, all Company Permits are
in full force and effect, except where the failure to be in full force and
effect has not had and would not reasonably be expected to have a Company
Material Adverse Effect and would not prevent or materially delay
consummation of the transactions contemplated hereby.
3.15 Environmental Compliance. Except for any non-compliance
which, individually or in the aggregate, has not had and would not
reasonably be expected to have a Company Material Adverse Effect or as set
forth in Schedule 3.15 of the Company Disclosure Letter, (a) the Company
and its Subsidiaries are in compliance with all applicable Laws relating to
Environmental Matters (as hereinafter defined); (b) the Company and its
Subsidiaries have obtained, and are in compliance with, all permits,
licenses, authorizations, registrations and other governmental consents
required by applicable Laws for the use, storage, treatment,
transportation, release, emission and disposal of raw materials,
by-products, wastes and other substances used or produced by or otherwise
relating to the operations of the Company or its Subsidiaries; and (c) to
the Company's knowledge, there are no past or present events, conditions,
or activities by the Company or its Subsidiaries that would prevent
compliance or continued compliance with any Law or give rise to any
Environmental Liability (as hereinafter defined).
As used in this Agreement, the term "Environmental Matters" means
any matter arising out of or relating to pollution or protection of the
environment, human safety or health, or sanitation, including matters
relating to emissions, discharges, releases or threatened releases of
pollutants, contaminants, or hazardous or toxic materials or wastes into
ambient air, surface water, ground water, or land, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of pollutants, contaminants or hazardous or
toxic materials or wastes. "Environmental Liability" means any liability or
obligation arising from or relating to any Environmental Matter or arising
under any Law or under any current theory of law or equity (including,
without limitation, any liability for personal injury, property damage or
remediation) that results from, or is based upon or related to, the
manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling, or the emission, discharge, release or threatened
release into the environment, of any pollutant, contaminant, chemical, or
industrial, toxic or hazardous substance or waste.
3.16 Material Contracts.
(a) Except as set forth in Schedule 3.16(a) of the Company
Disclosure Letter, neither the Company nor any of its Subsidiaries is a
party to or is bound by any of the following Contracts (collectively, the
"Material Contracts"):
(i) Contracts with any current or former director or officer
of the Company other than (A) Contracts with former directors or
officers that are no longer in effect, (B) Contracts pursuant to
any Company Benefit Plan or similar arrangement listed in Section
3.11 or in Schedule 3.11 of the Company Disclosure Letter, and
(C) Contracts entered into in the ordinary course of business
consistent with past practice;
(ii) Contracts involving amounts in excess of $3,000,000 and
which cannot be cancelled by the Company or a Subsidiary of the
Company within 90 days following notice thereof without the
payment of a material penalty (A) for the sale of any of the
assets of the Company or any of its Subsidiaries, other than
contracts entered into in the ordinary course of business,
consistent with past practice, or (B) for the grant to any person
of any preferential rights to purchase any of its assets;
(iii) Any non-competition agreements or other Contracts
which restrict the Company or any of its Subsidiaries from
competing in any line of business or with any person in any
geographical area in any material manner; or otherwise limit in
any material respect the manner in which or localities in which
the Company and its Subsidiaries conduct their businesses
("Non-Competition Contracts");
(iv) Any Contract that requires the Company to conduct
business exclusively with one or more Persons in any particular
geographic area or with respect to any particular product or
service and that cannot be canceled by the Company within 90 days
following notice thereof without the payment of a material
penalty ("Exclusivity Contracts");
(v) Indentures, credit agreements, security agreements,
mortgages, guarantees and promissory notes, and other Contracts
relating to the borrowing of money or the lending of money by the
Company or any of its Subsidiaries involving amounts in excess of
$3,000,000 ("Loan Contracts");
(vi) Contracts between the Company or any of its
Subsidiaries, on the one hand, and any holder of more than 5% of
the Company's equity securities, on the other hand, including
United and SAir Group Ltd. ("SAirGroup") or any affiliate
thereof;
(vii) Agreements involving the provision of services by the
Company involving annual amounts in excess of $3,000,000 and that
cannot be canceled by the Company within 90 days following notice
thereof without the payment of a material penalty;
(viii) Partnership, joint venture and similar agreements
("Partnership Contracts");
(ix) Bonds or agreements of guarantee or indemnification in
which the Company or any Subsidiary of the Company acts as
surety, guarantor or indemnitor with respect to any obligation
(fixed or contingent) in excess of $3,000,000 and that cannot be
terminated by the Company or such Subsidiary of the Company
within 90 days following notice thereof without the payment of a
material penalty, other than any of the foregoing relating to
obligations of the Company or any Subsidiary of the Company
("Guarantees");
(x) Any Contract (other than (A) Contracts pursuant to any
Company Benefit Plan or similar arrangement listed in Section
3.11 or in Schedule 3.11 of the Company Disclosure Letter or (B)
Contracts with former directors, officers or employees of the
Company or any of its Subsidiaries that are no longer in effect)
providing for future payments in excess of $3,000,000 that are
conditioned, in whole or in part, on a change in control of the
Company or any of its Subsidiaries ("Change in Control
Contracts");
(xi) Any nondisclosure, confidentiality or standstill
agreements with any Person (excluding nondisclosure agreements
with any Person entered into in the ordinary course of business
consistent with past practice) ("Confidentiality Contracts");
provided, however, that any such agreement that was entered into
in connection with the strategic evaluation process that led to
the execution of this Agreement shall be provided in form only,
with a schedule of material changes or modifications to such form
agreed to by the Company;
(xii) Any Contracts having a value in excess of $3,000,000
and (A) that grant or obtain any right to use or practice any
Material Intellectual Property Rights or (B) restricting the
Company's or any of its Subsidiaries' right to use any Material
Intellectual Property Rights;
(xiii) Any lease or sublease pursuant to which the Company
and its Subsidiaries leases or subleases material facilities
("Leases"); and
(xiv) Any Contract that cannot be cancelled by the Company
within 90 days following notice thereof without the payment of a
material penalty and that obligates the Company to make any
annual payments to any person, including for the purchase of
goods or services, in excess of $3,000,000 ("Miscellaneous
Contracts").
(b) Except as set forth in Schedule 3.16 (b) of the Company
Disclosure Letter, all of the Material Contracts are in full force and
effect and are the legal, valid and binding obligations of the Company
and/or its Subsidiaries, enforceable against them in accordance with their
respective terms, subject, as to enforceability, to applicable bankruptcy,
insolvency, reorganization, moratorium and similar Laws, now or hereafter
in effect, affecting creditors' rights and remedies generally and to
general principles of equity (regardless of whether enforcement is sought
in proceeding at law or in equity). Except as set forth in Schedule 3.16
(b) of the Company Disclosure Letter, neither the Company nor any of its
Subsidiaries is in breach of or default under any Material Contract nor, to
the knowledge of the Company, is any other party to any Material Contract
in breach thereof or default thereunder, except, in each case, for such
breaches or defaults that, individually or in the aggregate, have not had
and would not reasonably be expected to have a Company Material Adverse
Effect.
(c) Except as set forth on Schedule 3.16(c), the Company has not
received written notice from any of the persons listed on Schedule 3.16(c)
under the heading "Section 3.16(c) Persons" of the Company Disclosure
Letter terminating, or threatening to terminate any of its Material
Contracts listed in Schedule 3.16(a) of the Company Disclosure Letter or
the business relationship arising therefrom.
3.17 Title to Property. Except as set forth in Schedule 3.16 or
Schedule 3.17 of the Company Disclosure Letter, each of the Company and its
Subsidiaries (a) has good and marketable title to all real property owned
by it and (b) has good and marketable title to, or valid leasehold
interests in, or the right to use, all its material properties and assets
necessary for the conduct of their respective businesses, except, in each
case, for defects in title, easements, restrictions, restrictive covenants
and encumbrances that, individually or in the aggregate, have not had and
would not reasonably be expected to have a Company Material Adverse Effect.
3.18 Brokers. Except for J.P. Morgan Securities, Inc. (the
"Financial Advisor"), no broker, finder or financial advisor is entitled to
any brokerage, finder's or other fee or commission in connection with the
transactions contemplated by this Agreement that is based upon any
arrangement made by or on behalf of the Company or any of its Subsidiaries.
True and correct copies of the engagement letter between the Company and
the Financial Advisor have been made available to Parent.
3.19 Opinion of Financial Advisor. The Company has received the
written opinion of the Financial Advisor to the effect that, as of the date
hereof, the Merger Consideration is fair, from a financial point of view,
to the stockholders of the Company.
3.20 Rights Agreement. The Company has caused the Rights
Agreement to be amended to be inapplicable to the approval, execution and
delivery of (a) this Agreement, (b) the Option Agreement and (c) the
Transaction Support Agreement, and the consummation of the transactions
contemplated hereby or thereby.
3.21 State Takeover Statutes. Prior to the date hereof, the
Company's Board of Directors has approved the Merger, this Agreement, the
Transaction Support Agreement, the Option Agreement and the transactions
contemplated hereby and thereby and, assuming the accuracy of Parent's and
Purchaser's representation and warranty set forth in Section 4.16, such
approval is sufficient to render inapplicable to the Merger, this
Agreement, the Option Agreement, the Transaction Support Agreement and the
transactions contemplated hereby and thereby, the limitations on business
combinations contained in Section 203 of the DGCL. To the knowledge of the
Company and, assuming the accuracy of Parent's and Purchaser's
representations and warranties set forth in Section 4.16, no other state
takeover statute or similar statute or regulation applies to the
transactions contemplated hereby and by the Ancillary Documents and no such
statute or regulation, and no similar provision of the Certificate of
Incorporation or Bylaws of the Company or any of its Subsidiaries would,
directly or indirectly, restrict or impair the ability of Parent to vote,
or otherwise to exercise the rights of a stockholder with respect to,
shares of Company Common Stock that may be acquired or controlled by
Parent.
3.22 No Undisclosed Liabilities. Except (i) as disclosed in
Schedule 3.22 of the Company Disclosure Letter, (ii) as reflected or
reserved against in the Company's consolidated balance sheets (or the notes
thereto) included in the 2000 Annual Report or in the Company's Quarterly
Report on Form 10-Q for the fiscal quarter ended March 31, 2001 (the "2001
Quarterly Report"), (iii) for liabilities incurred in connection with this
Agreement or the transactions contemplated hereby, and (iv) for liabilities
and obligations incurred in the ordinary course of business, consistent
with past practice, since March 31, 2001, neither the Company nor any
Subsidiary of the Company has any liabilities or obligations of any nature,
whether or not accrued, contingent or otherwise, that would be required by
GAAP to be reflected on a consolidated balance sheet of the Company and its
Subsidiaries (or in the notes thereto).
3.23 Vote Required. Assuming the accuracy of Parent's and
Purchaser's representation and warranty set forth in Section 4.16, the
Company Stockholder Approval is the only vote of holders of any class or
series of the Company's capital stock required to approve the Merger and
adopt this Agreement and the Ancillary Agreements to which the Company is a
party under the DGCL, the Company's Certificate of Incorporation and the
Company's Bylaws.
3.24 Form S-4; Proxy Statement. None of the information supplied
in writing by the Company for inclusion in, and none of the information
regarding the Company incorporated by reference in (a) the registration
statement on Form S-4 to be filed with the SEC by Parent in connection with
the issuance of shares of Parent Common Stock in connection with the
Merger, or any of the amendments or supplements thereto (collectively, the
"Form S-4") will, at the time the Form S-4 is filed with the SEC, at any
time it is amended or supplemented, at the time it becomes effective under
the Securities Act and at the time of the Stockholders Meeting, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein
not misleading, and (b) the proxy statement for use relating to the
adoption by the stockholders of the Company of this Agreement or any of the
amendments or supplements thereto (collectively, the "Proxy Statement"),
will, at the date it is first mailed to the Company's stockholders and at
the time of the Stockholders Meeting contain any untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in the light
of the circumstances under which they are made, not misleading. The Proxy
Statement will comply as to form in all material respects with the
requirements of the Exchange Act and the rules and regulations thereunder,
except that no representation is made by the Company with respect to
statements made or incorporated by reference therein based on information
supplied by Parent or Purchaser specifically for inclusion or incorporation
by reference in the Proxy Statement.
ARTICLE IV
Representations and Warranties of Parent and Purchaser
Parent and Purchaser hereby represent and warrant to the Company
as follows:
4.1 Existence; Good Standing; Corporate Authority. Each of Parent
and Purchaser is a corporation duly organized, validly existing and in good
standing under the laws of its jurisdiction of incorporation. Each of
Parent and Purchaser is duly qualified to do business as a foreign
corporation and is in good standing under the laws of any other state of
the United States in which the ownership of its properties or the conduct
of its business requires such qualification, except where the failure to be
so qualified or in good standing has not had and would not reasonably be
expected to have, individually or in the aggregate, a material adverse
effect on the assets, liabilities, business, results of operations, or
financial condition of Parent and its Subsidiaries, taken as a whole,
except any such effect resulting primarily from (a) this Agreement and
would not materially and adversely impair Parent's and Purchaser's ability
to consummate the Merger, the transactions contemplated by this Agreement
or the announcement thereof, in and of themselves, (b) Parent's
announcement or other communication of Parent of the plans or intentions of
Parent with respect to the conduct of the business (or any portion thereof)
of the Company or any of its Subsidiaries; or (c) changes or conditions
(including changes in economic, financial market, regulatory or political
conditions) affecting generally the industries in which Parent operates its
business (a "Parent Material Adverse Effect") and would not prevent or
materially delay consummation of the transactions contemplated hereby.
Parent has all requisite corporate power and authority to own or lease and
operate its properties and to carry on its business as now conducted,
except where the failure to have such power and authority has not had and
would not reasonably be expected to have a Parent Material Adverse Effect
and would not prevent or materially delay consummation of the transactions
contemplated hereby. Parent has heretofore delivered to the Company true
and correct copies of the Certificate of Incorporation and Bylaws (or
equivalent organizational documents) as currently in effect for Parent and
Purchaser. Such Certificates of Incorporation and Bylaws (or equivalent
organizational documents) are in full force and effect and no other
organizational documents are applicable to or binding upon Parent or
Purchaser.
4.2 Authorization, Validity and Effect of Agreements. The
respective Boards of Directors of Parent and Purchaser have, on or prior to
the date of this Agreement, approved this Agreement in accordance with
applicable Law. Each of Parent and Purchaser has the requisite corporate
power and authority to execute and deliver this Agreement, the Option
Agreement, the Transaction Support Agreement and the Ancillary Documents to
which it is a party and to consummate the transactions contemplated hereby
and thereby. The execution and delivery of this Agreement, the Option
Agreement, the Transaction Support Agreement and the Ancillary Documents to
which it is a party and the consummation by Parent and Purchaser of the
transactions contemplated hereby and thereby have been duly and validly
authorized by the respective Boards of Directors of Parent and Purchaser
and by Parent as the sole stockholder of Purchaser and no other corporate
proceedings on the part of Parent or Purchaser are necessary to authorize
this Agreement, the Option Agreement, the Transaction Support Agreement and
the Ancillary Documents to which it is a party or to consummate the
transactions contemplated hereby and thereby (other than the filing and
recordation of the Certificate of Merger in accordance with the DGCL). This
Agreement, the Option Agreement and the Transaction Support Agreement each
have been, and any Ancillary Document to which it is a party at the time of
execution shall have been, duly and validly executed and delivered by
Parent and/or Purchaser, as applicable, and (assuming this Agreement, the
Option Agreement, the Transaction Support Agreement and such Ancillary
Documents each constitutes a valid and binding obligation of any other
parties thereto) constitutes and will constitute the valid and binding
obligations of each of Parent and Purchaser, enforceable in accordance with
their respective terms, subject, as to enforceability, to applicable
bankruptcy, insolvency, moratorium or other similar laws, now or hereafter
in effect, relating to creditors' rights and general principles of equity.
4.3 Compliance with Laws. Parent and Purchaser and each of their
respective Subsidiaries are in compliance with and are not in default under
or in violation of (a) their respective Certificates of Incorporation and
Bylaws (or equivalent organizational documents), (b) any order of any
Governmental Entity, or (c) any Laws applicable to Parent, Purchaser or
such Subsidiaries or any of their respective properties or assets, except,
in the case of clauses (b) and (c) above, where such non-compliance,
default or violation, individually or in the aggregate, has not had and
would not reasonably be expected to have a Parent Material Adverse Effect,
would not prevent or materially delay consummation of the transactions
contemplated hereby and would not impose a risk of criminal liability,
criminal fines or imprisonment or confinement, in each case upon any
officer, employee or director of the Company, Parent or any of their
Subsidiaries. Schedule 4.3 of the Parent Disclosure Letter sets forth any
material order of any Governmental Entity binding Parent, Purchaser or such
Subsidiaries.
4.4 Capitalization. The authorized capital stock of Parent
consists of (a) 2,500,000,000 shares of common stock, par value $0.01 per
share, of which (i) 2,000,000,000 shares are designated as Parent Common
Stock and (ii) 500,000,000 shares are designated as Move.com common stock
("Move.com Common Stock") and (b) 10,000,000 shares of preferred stock, par
value $.01 per share, of Parent ("Parent Authorized Preferred Stock"). As
of May 31, 2001, (A) 854,257,638 shares of Parent Common Stock and
1,861,995 shares of Move.com Common Stock were issued and outstanding; (B)
no shares of Parent Authorized Preferred Stock and no other shares of
capital stock of Parent were issued and outstanding; (C) 283,363,275 shares
of Parent Common Stock and no shares of Move.com Common Stock were reserved
for issuance pursuant to the stock-based plans identified in Schedule 4.4
of the Parent Disclosure Letter (such plans, collectively, the "Parent
Stock Plans"), of which approximately 227,320,729 shares of Parent Common
Stock and no shares of Move.com Common Stock are subject to outstanding
employee stock options or other rights to purchase or receive Parent Common
Stock granted under the Parent Stock Plans (collectively, "Parent Employee
Stock Options"); (D) 1,563,214 shares of Parent Common Stock and no shares
of Move.com Common Stock are subject to warrants (collectively, "Parent
Warrants"); and (E) 176,564,752 shares of Parent Common Stock were held by
Parent in its treasury. Except as set forth in this Section 4.4, Parent has
no outstanding bonds, debentures, notes or other obligations entitling the
holders thereof to vote (or which are convertible into or exercisable for
securities having the right to vote) with the stockholders of Parent on any
matter. All issued and outstanding shares of capital stock of Parent are
duly authorized, validly issued, fully paid, nonassessable and free of
preemptive rights. Except (1) as set forth in this Section 4.4, (2) for the
3% Convertible Subordinated Notes, (3) for the Zero Coupon Senior
Convertible Contingent Debt Securities (CODESSM), (4) the Zero Coupon
Convertible Debentures, (5) for changes since May 31, 2001 resulting from
the issuance of shares of Parent Common Stock pursuant to the Parent Stock
Plans or Parent Employee Stock Options or Parent Warrants and other rights
referred to in this Section 4.4, and (6) as set forth in Schedule 4.4 of
the disclosure letter, dated this date, delivered by Parent to the Company
(the "Parent Disclosure Letter"), there are no existing options, warrants,
calls, subscriptions, convertible securities, or other rights, agreements
or commitments (x) to which Parent or any of its Subsidiaries is a party of
any character relating to the issued or unissued capital stock or other
equity interests of Parent or any of its Subsidiaries, or (y) obligating
Parent or any Subsidiary of Parent to (1) issue, transfer or sell any
shares of capital stock or other equity interests of Parent or any
Subsidiary of Parent or securities convertible into or exchangeable for
such shares or equity interests, (2) grant, extend or enter into any such
subscription, option, warrant, call, convertible securities or other
similar right, agreement, arrangement or commitment, (3) redeem or
otherwise acquire any such shares of capital stock or other equity
interests or (4) make any investment (in the form of a loan, capital
contribution or otherwise) in any person in an amount over $1,000,000,
individually or in the aggregate. Except as set forth in Schedule 4.4 of
the Parent Disclosure Letter, there are no voting trusts, voting agreements
or other agreements or understandings to which Parent or any of its
Subsidiaries is a party with respect to the voting of the capital stock or
other equity interest of Parent or any of its Subsidiaries.
4.5 No Violation; Consents. Neither the execution and delivery by
Parent and Purchaser of this Agreement, the Option Agreement, the
Transaction Support Agreement or any of the Ancillary Documents to which it
is a party, nor the consummation by them of the transactions contemplated
hereby or thereby, will: (a) violate, conflict with or result in a breach
of the respective Certificates of Incorporation or Bylaws (or equivalent
organizational documents) of Parent or Purchaser; (b) violate, conflict
with or result in a breach of, constitute (with or without due notice or
lapse of time or both) a default under, result in the termination or in a
right of termination of, accelerate the performance required by or benefit
obtainable under, result in the triggering of any payment or other
obligations pursuant to, result in the creation of any Lien upon any of the
properties of Parent or Purchaser under, or result in there being declared
void, voidable, or without further binding effect, any of the terms,
conditions or provisions of any Contract to which Parent or Purchaser is a
party, or by which Parent or Purchaser, or any of their respective
properties or assets is subject, except for any of the foregoing matters
which, individually or in the aggregate, has not had and would not
reasonably be expected to have a Parent Material Adverse Effect; (c)
provided that the authorizations, filings and registrations described in
clause (d) of this Section 4.5 have been obtained and made, violate any
Laws applicable to Parent or Purchaser or any of their respective
properties or assets, except for any such violations which, individually or
in the aggregate, have not had and would not reasonably be expected to have
a Parent Material Adverse Effect; or (d) require any consent, approval or
authorization of, or filing or registration with, any Governmental Entity,
except (i) for (A) applicable requirements of the Securities Act and the
Exchange Act, (B) the applicable pre-merger notification requirements of
the HSR Act, any required filings with or approvals under the EC Merger
Regulation and the Australian Approval, (C) such other required filings
with or approvals of foreign Governmental Entities, including foreign
investment, exchange control, telecommunications and competition Law
authorities, (D) the applicable requirements of the FCC Act, and (E) the
filing of a Certificate of Merger pursuant to the DGCL, or (ii) where the
failure to obtain any such consent, approval or authorization, or to make
any such filing or registration would not, individually or in the
aggregate, have or reasonably be expected to have a Parent Material Adverse
Effect and would not prevent or materially delay consummation of the
transactions contemplated hereby.
4.6 Parent Reports. (a) Parent filed all forms, reports,
schedules, statements and other documents required to be filed by it with
the SEC since December 31, 1998 (collectively, including all exhibits and
information incorporated by reference therein, the "Parent Reports"). As of
their respective dates (and if amended or supplemented by a filing prior to
the date of this Agreement, then as of the date of such filing), the Parent
Reports (i) complied in all material respects with the then-applicable
requirements of the Securities Act, the Exchange Act, and the rules and
regulations promulgated thereunder and (ii) did not contain any untrue
statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements made therein, in the
light of the circumstances under which they were made, not misleading. No
Subsidiary of Parent is required to file any forms, reports or other
documents with the SEC.
(b) Each of the consolidated balance sheets (including all
related notes) included in the Parent Reports fairly presents the
consolidated financial position of Parent and its Subsidiaries as of its
date, and each of the consolidated statements of income (including all
related notes), retained earnings and cash flows of Parent included in the
Parent Reports fairly presents the results of operations, retained earnings
or cash flows of Parent and its Subsidiaries for the periods set forth
therein (subject, in the case of unaudited statements, to normal, recurring
year-end audit adjustments, none of which are material in kind or amount),
in each case, in accordance with GAAP during the periods involved, except
as may be noted therein.
4.7 Litigation. Except as set forth in Schedule 4.7 of the Parent
Disclosure Letter or under the heading "Legal Proceedings" in Parent's
Annual Report on Form 10-K for the fiscal year ended December 31, 2000 (the
"Parent 2000 Annual Report"), there is no Litigation pending, publicly
announced or, to the knowledge of Parent, threatened in writing against or
affecting Parent or any of its Subsidiaries, at law or in equity, and there
are no orders of any Governmental Entity outstanding against Parent or any
of its Subsidiaries that, individually or in the aggregate, (a) have had or
would reasonably be expected to have a Parent Material Adverse Effect, (b)
would prevent or materially delay consummation of the transactions
contemplated hereby or (c) as of the date hereof, question or challenge the
validity of this Agreement.
4.8 Absence of Certain Changes. Except as set forth in Schedule
4.8 of the Parent Disclosure Letter, from March 31, 2001 through the date
hereof, Parent, Purchaser and their respective Subsidiaries have conducted
their respective businesses only in the ordinary course, consistent with
past practice, and there has not been or occurred any event, condition,
circumstance or state of facts that, individually or in the aggregate, has
had or would reasonably be expected to have a Parent Material Adverse
Effect.
4.9 Interim Operations of Purchaser. Purchaser was formed solely
for the purpose of engaging in the transactions contemplated hereby, has
engaged in no other business activities and has conducted its operations as
contemplated hereby.
4.10 Form S-4; Proxy Statement. None of the information supplied
in writing by Parent or Purchaser for inclusion in and none of the
information regarding Parent incorporated by reference in (a) the Form S-4
will, at the time the Form S-4 is filed with the SEC, at any time it is
amended or supplemented, at the time it becomes effective under the
Securities Act and at the time of the Stockholders Meeting, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein
not misleading, and (b) the Proxy Statement will, at the date it is first
mailed to the Company's stockholders and at the time of the Stockholders
Meeting, contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which
they are made, not misleading. The Form S-4 will comply as to form in all
material respects with the requirements of the Securities Act and the rules
and regulations thereunder, except that no representation is made by Parent
or Purchaser with respect to statements made or incorporated by reference
therein based on information supplied by the Company specifically for
inclusion or incorporation by reference in the Form S-4.
4.11 Tax Matters. None of Parent nor any of its affiliates has
taken or agreed to take any action, has failed to take any action, or knows
of any fact, agreement, plan or other circumstance that is reasonably
likely to prevent the Merger from qualifying as a reorganization within the
meaning of Section 368(a) of the Code.
4.12 State Takeover Statutes. Prior to the date hereof, Parent's
Board of Directors has approved the Merger, this Agreement, the Option
Agreement, the Transaction Support Agreement and the transactions
contemplated hereby and thereby. To the knowledge of Parent, no state
takeover statute or similar statute or regulation applies to the
transactions contemplated hereby and by the Ancillary Documents and no such
statute or regulation and no similar provision of the Certificate of
Incorporation or Bylaws of Parent would, directly or indirectly, restrict
or impair the ability of Parent to consummate the transactions contemplated
hereby.
4.13 No Undisclosed Liabilities. Except (a) as reflected or
reserved against in Parent's consolidated balance sheets (or the notes
thereto) included in the Parent 2000 Annual Report or in Parent's Quarterly
Report on Form 10-Q for the fiscal quarter ended March 31, 2001, (b) for
liabilities incurred in connection with this Agreement or the transactions
contemplated hereby and (c) for liabilities incurred in the ordinary course
of business, consistent with past practice since March 31, 2001, neither
Parent nor any Subsidiary of Parent has any liabilities or obligations of
any nature, whether or not accrued, contingent or otherwise, that would be
required by GAAP to be reflected on a consolidated balance sheet of Parent
and its Subsidiaries (or in the notes thereto).
4.14 Parent Shareholder Approval. This Agreement and the
transactions contemplated hereby, including the issuance of shares of
Parent Common Stock pursuant to Article II hereof, do not require the
approval of the holders of any shares of capital stock of Parent.
4.15 Parent Common Stock. All shares of Parent Common Stock which
may be issued pursuant to this Agreement or pursuant to the Assumed Options
shall be, when issued in accordance with this Agreement, duly authorized,
validly issued, fully paid and nonassessable shares of Parent Common Stock,
and shall not be subject to preemptive rights.
4.16 Ownership of Company Common Stock. To Parent's knowledge,
neither Parent, Purchaser nor any of their respective affiliates, (i)
beneficially owns (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, or (ii) is an owner or owns (as defined in Section
203(c)(9) of the DGCL), in each case, shares of capital stock of the
Company, except, in each such case, as may result from the execution or
performance of the Option Agreement and the Transaction Support Agreement.
ARTICLE V
Covenants
5.1 Alternative Proposals.
(a) Except as set forth below, from and after the date hereof and
prior to the Effective Time, the Company agrees that neither it nor any
Subsidiary or affiliate of it, nor any officer, director, employee,
investment banker, agent or other representative of it or its Subsidiaries
shall, directly or indirectly, (i) encourage, invite, initiate or solicit
any inquiries relating to or the submission or making of a proposal by any
person with respect to a Third-Party Acquisition (as defined below) or (ii)
participate in or encourage, invite, initiate or solicit negotiations or
discussions with, or furnish or cause to be furnished any information to,
any person relating to a Third-Party Acquisition. Upon the execution of
this Agreement, the Company shall immediately (A) cease, or cause to be
ceased, any discussions or negotiations with any person, entity or group in
connection with any proposed or potential Third-Party Acquisition and shall
request the prompt return to the Company, or destruction of, any
confidential information provided in connection with any such discussions
or negotiations and (B) take all actions necessary to terminate, effective
as of the business day immediately following the date hereof, the Company's
stock repurchase program authorized by the Company's Board of Directors on
April 21, 2000 (the "Stock Repurchase Program"). Except as otherwise
provided in Sections 5.1(d) and 5.3, the Company's Board of Directors shall
not (1) make a Change in the Company Recommendation (as defined in Section
5.3(b)), or (2) cause the Company to enter into any memorandum of
understanding, agreement in principle, letter of intent, contract or
agreement (whether written or oral) (each, a "Company Acquisition
Agreement") related to any Third-Party Acquisition.
(b) Prior to the Stockholders Meeting, if the Company, without
being in violation of the terms of this Section 5.1, receives an
unsolicited bona fide written proposal from any person or group with
respect to a Third-Party Acquisition which the Company's Board of Directors
(after consideration of advice it shall have obtained from its legal and
financial advisors) reasonably expects will result in a Superior Proposal
(as hereinafter defined), then the Company may, directly or indirectly,
furnish information and access to such person or group pursuant to an
appropriate confidentiality agreement and may participate in discussions
and negotiations with such person or group; provided, however, that the
terms of such confidentiality agreement shall not be less restrictive than
the terms set forth in the confidentiality agreement between the Company
and Parent, dated as of March 9, 2001 (the "Confidentiality Agreement").
(c) The Company shall notify Parent in writing of the receipt of
any proposal, written or oral, as soon as possible, but, in any event,
within twenty-four (24) hours of the receipt of any such proposal, relating
to a Third-Party Acquisition or any request for non-public information
relating to the Company or any of its Subsidiaries in connection with any
pending, proposed or contemplated Third-Party Acquisition or for access to
the properties, books or records of the Company or any Subsidiary by any
person that, to the knowledge of the Company, is considering making, or has
made, a proposal relating to a Third-Party Acquisition. Such notice shall
identify the person submitting the proposal, attach a copy of any written
correspondence or other written materials relating to such proposal, and
summarize any significant terms of such proposal not reflected in any such
attached materials, and, to the extent then known by the Company, state
whether the Company is providing or intends to provide the person or group
making such proposal with access to information concerning the Company or
any of its Subsidiaries, in accordance with this Section 5.1, including any
expectation by the Company's Board of Directors, if then known, that such
Third-Party Acquisition proposal will result in a Superior Proposal or, if
not then known, then the Company shall thereafter give prompt notice to
Parent of any subsequent determination as to the provision to the person or
group making such proposal of access to such information, and any such
expectation. The Company shall keep Parent informed of the status of any
such negotiations and shall further update, to the extent of any
significant developments, the information required to be provided in each
notice upon the request of Parent.
(d) Notwithstanding anything in this Agreement to the contrary,
(i) the Company or its Board of Directors shall be permitted, to the extent
applicable, to comply with Rule 14e-2(a) of the Exchange Act or to make any
required disclosure to the stockholders of the Company if, in the good
faith judgment of the Board of Directors of the Company (after
consideration of advice it shall have obtained from its outside counsel)
failure to so disclose would constitute a violation of applicable law and
(ii) in the event that the Company's Board of Directors determines in good
faith, after consideration of advice it shall have obtained from its
outside counsel, that failure to take such action would create a
substantial probability of violating the Company's Board of Directors'
fiduciary duties to the Company's stockholders under applicable Law, the
Company's Board of Directors may make a Change in the Company
Recommendation and disclose to the Company's stockholders the position of
the Company's Board of Directors with respect to the transactions
contemplated hereby or otherwise make disclosure to them, with respect to
the matters to be considered at the Stockholders Meeting. Notwithstanding
the foregoing, the obligation of the Company to duly call, give notice of,
convene and hold the Stockholders Meeting in accordance with Section 5.3
hereof shall not be affected by the commencement, proposal, public
disclosure or communication to the Company of a Third-Party Acquisition or
a Superior Proposal or by the taking of any action by the Company's Board
of Directors in accordance with this Section 5.1.
(e) As used in this Agreement, the term "Third-Party Acquisition"
shall mean any of the following events other than, in each case, the
transactions contemplated by this Agreement: (i) the merger,
reorganization, share exchange, consolidation, business combination,
recapitalization, liquidation, dissolution or similar transaction involving
the Company, or any purchase or sale of the consolidated assets (including
without limitation stock of Subsidiaries) of the Company and its
Subsidiaries, taken as a whole having an aggregate value of 20% or more of
the total assets of the Company, or any purchase or sale of, or tender or
exchange offer for 20% or more of the equity securities of the Company, or
a "merger of equals" with, any person which includes any officer or
director of the Company or any of its affiliates or any affiliate of such
officer or director) other than a Subsidiary of Parent (a "Third Party");
(ii) the acquisition by a Third Party of twenty percent (20%) or more of
the outstanding shares of Company Common Stock; (iii) the acquisition by a
Third Party of Quantitude or Trip; (iv) the adoption by the Company of a
plan of liquidation or the declaration or payment of an extraordinary
dividend; or (v) the repurchase by the Company or any of its Subsidiaries
of more than twenty percent (20%) of the outstanding shares of Company
Common Stock.
(f) As used in this Agreement, "Superior Proposal" means any bona
fide written proposal to acquire, directly or indirectly, for consideration
consisting of cash and/or securities, all of the shares of Company Common
Stock then outstanding or all or substantially all of the assets of the
Company, that (i) is not subject to any financing conditions or
contingencies, (ii) provides holders of Company Common Stock with per share
consideration that the Company's Board of Directors determines in good
faith (after consideration of advice that it shall have obtained from its
financial advisor) to be more favorable to the stockholders of the Company
from a financial point of view than the Merger Consideration (taking into
account all the terms and conditions of such proposal and this Agreement
(including any changes to the financial or other terms of this Agreement
proposed by Parent in response to such offer or otherwise), (iii) is
determined by the Company's Board of Directors in its good faith judgment
(after consideration of advice that it shall have obtained from its legal
or financial advisor) to be reasonably capable of being completed (taking
into account all legal, financial, regulatory and other aspects of the
proposal, the person making the proposal and the expected timing to
complete the proposal) and (iv) does not, in the definitive Company
Acquisition Agreement, contain any "due diligence" conditions.
5.2 Interim Operations.
(a) From the date of this Agreement until the Effective Time,
except as set forth in Schedule 5.2 of the Company Disclosure Letter, or
unless Parent has consented in writing thereto, which consent shall not be
unreasonably withheld, the Company shall, and shall cause its Subsidiaries
to, (i) conduct its operations only in, and not take any actions except in,
the ordinary course of business, consistent with past practice; (ii) use
its reasonable best efforts to preserve intact its business organizations
and goodwill, keep available the services of its officers and employees,
and maintain satisfactory relationships with those persons having business
relationships with them; and (iii) upon the discovery thereof, promptly
notify Parent of the existence of any breach of any representation or
warranty contained herein (or, in the case of any representation or
warranty that makes no reference to Company Material Adverse Effect other
than the representations and warranties in Section 3.4 or Section 3.7(b),
any breach of such representation or warranty that would reasonably be
expected to result in costs to the Company in excess of $3,000,000 ("Excess
Costs")) or the occurrence of any event that would cause any representation
or warranty contained herein no longer to be true and correct (or, in the
case of any representation or warranty that makes no reference to Company
Material Adverse Effect other than the representations and warranties in
Section 3.4 or Section 3.7(b), where the effect of no longer being true and
correct would reasonably be expected to result in Excess Costs).
(b) Without limiting the generality of Section 5.2(a), from and
after the date of this Agreement until the Effective Time, except for
actions required to be taken by the Company or any of its Subsidiaries in
the performance of their respective obligations under the Contracts listed
in Schedule 3.16 of the Company Disclosure Letter, or as set forth in
Schedule 5.2 of the Company Disclosure Letter, unless Parent has consented
in writing thereto or except as otherwise expressly contemplated by this
Agreement, the Company shall not, and shall not permit its Subsidiaries to:
(i) amend their respective organizational documents;
(ii) issue, sell, pledge, dispose of or encumber, or
authorize the issuance, sale, pledge, disposition or encumbrance
of, any shares of its capital stock or other ownership interest
in the Company or any Subsidiaries or any securities convertible
into or exchangeable for any such shares or ownership interest,
or any rights, warrants or options to acquire or with respect to
any such shares of capital stock, ownership interest, or
convertible or exchangeable securities (other than (A) issuances
of Company Common Stock in respect of any exercise of stock
options outstanding on the date hereof and disclosed in Schedule
5.2 of the Company Disclosure Letter and (B) as set forth in
Section 5.2(b)(iv);
(iii) split, combine or reclassify its capital stock, or
otherwise change its capitalization as it exists on the date
hereof, or propose the issuance of any other securities in
respect of, in lieu of or in substitution for, shares of its
capital stock or any other equity interest;
(iv) grant, confer or award any option, warrant, convertible
security or other right to acquire any shares of its capital
stock or take any action to cause to be exercisable any otherwise
unexercisable option under any existing stock option plan (except
(A) as otherwise required by the express terms of any
unexercisable options outstanding on the date hereof or (B) in
connection with grants of options to purchase Company Common
Stock to newly hired employees of the Company or any of its
Subsidiaries in the ordinary course of business, consistent with
past practice);
(v) declare, set aside or pay any dividend or make any other
distribution or payment (whether in cash, stock or property or
any combination thereof) with respect to any shares of its
capital stock or other ownership interests, including any
constructive or deemed distributions, or make any other payments
to stockholders in their capacity as such (other than any such
payments by any Subsidiary to the Company);
(vi) from and after the date set forth in Section 5.1(a)(B),
directly or indirectly redeem, purchase or otherwise acquire any
shares of its capital stock or capital stock of the Subsidiaries
(including repurchases of Company Common Stock pursuant to the
Stock Repurchase Program);
(vii) transfer, license, mortgage, encumber, sell, lease or
otherwise dispose of any of its material assets (including
capital stock of the Subsidiaries);
(viii) acquire by merger, purchase or any other manner, any
business, entity or division, or make any capital expenditures or
otherwise acquire any material property or assets, except for (A)
purchases of supplies or capital equipment in the ordinary course
of business, consistent with past practice or (B) capital
expenditures or purchases of property and assets in accordance
with the Company's Capital Plan attached to Schedule 5.2 of the
Company Disclosure Letter (the "Capital Plan"); provided,
however, that capital expenditures (X) for which the Company has
no binding commitment to third parties on the date hereof and (Y)
are primarily for the purpose of supporting Quantitude's
third-party telecommunications or the Company's web-hosting
business shall not be made without the prior written consent of
Parent.
(ix) incur, assume, guarantee or otherwise become liable for
any indebtedness for borrowed money except for in the ordinary
course of business, consistent with past practice, (A) under the
Company's existing credit agreements or (B) to trade creditors of
the Company or its Subsidiaries;
(x) make or forgive any loans, advances or capital
contributions (which shall expressly be deemed not to include
marketing incentive payments or up-front financial assistance
payments, however structured) to, or investments in, any other
person in an amount in excess of $3,000,000 individually, or
$10,000,000 the aggregate, (other than advances in respect of
business expenses and loans and advances in respect of relocation
arrangements, in each case made to officers or employees in the
ordinary course of business, consistent with past practice);
(xi) grant any stock-related or stock-based awards other
than as described in subsections (b)(ii) or (b)(iv) of this
Section 5.2;
(xii) modify, amend, terminate or waive any rights under any
Confidentiality Contract entered into in connection with any
Third-Party Acquisition Proposal;
(xiii) other than (A) in accordance with the Company's
Capital Plan, or (B) Material Contracts not involving costs,
individually or in the aggregate, in excess of Excess Costs,
enter into any Material Contract;
(xiv) modify, amend, terminate or waive any rights under any
Material Contract in any manner that would reasonably be expected
to (A) have a Company Material Adverse Effect, or (B) result in
Excess Costs;
(xv) (A) increase the compensation, severance or, except
pursuant to plan amendments permitted under clause (C) below,
other benefits payable or to become payable to its directors,
officers or employees, other than (I) annual increases for
officers or employees of the Company or its Subsidiaries in the
ordinary course of business consistent with past practice
(including in connection with annual compensation reviews), (II)
salary increases for officers and employees of Southern Cross
Distribution Systems Pty Limited in an amount not in excess of 6%
of aggregate compensation, (B) grant any severance or termination
pay (except payments required to be made under employee benefit
plans or other obligations existing on the date hereof in
accordance with the terms of such obligations) to, or enter into
any employment, consulting, salary continuation or severance
agreement with, any officer or director of the Company or any of
its Subsidiaries (other than any of the foregoing arising by
operation of Law), or (C) establish, adopt, enter into, amend or
modify in any material respect or in any manner that would result
in Excess Costs any collective bargaining agreement, employee
benefit plan, trust, fund, policy or arrangement for the benefit
of any current or former directors, officers or employees or any
of their beneficiaries, except, in each case, as may be required
by Law;
(xvi) take any action to change accounting policies,
procedures or practices, except as required by a change in GAAP,
SEC position or applicable Law after the date hereof ("Reporting
Requirements");
(xvii) subject to Section 5.3, approve or authorize any
action to be submitted to the stockholders of the Company for
approval other than pursuant to this Agreement, other than, if
the transactions contemplated hereby have not been consummated by
January 1, 2002, the election of directors and ratification of
auditors at an annual meeting of stockholders to be held after
June 1, 2002;
(xviii) materially change any method of reporting income,
deductions or other material items for income Tax purposes, make
or change any material election with respect to Taxes, agree to
or settle any material claim or assessment in respect of Taxes,
or agree to an extension or waiver of the limitation period to
any material claim or assessment in respect of Taxes, other than
in the ordinary course of business consistent with past practice
or as required by Reporting Requirements;
(xix) settle or compromise any pending or threatened suit,
action or claim not covered by insurance in an aggregate amount
in excess of $3,000,000;
(xx) amend in any material respect any Material Contract so
as to include any "change of control" provision which would be
triggered upon the Merger or any sale of the Company or any of
its Subsidiaries;
(xxi) enter into, amend in any material respect or renew any
Contract with any customer or supplier set forth in Schedule
3.16(c) of the Company Disclosure Letter;
(xxii) enter into, amend or renew any Contract set forth on
Schedule 5.2(b)(xxii) of the Company Disclosure Letter;
(xxiii) amend, extend, renew or otherwise modify any
material Lease in any manner that would reasonably be expected to
have a Material Adverse Effect or result in Excess Costs; or
(xxiv) enter into any Contract to provide web-hosting
services or third party telecommunications services; or
(xxv) agree in writing or otherwise to take any of the
foregoing actions.
(c) Parent shall respond to any request from the Company for any
consents sought pursuant to this Section 5.2 as promptly as practicable,
with due regard and consideration to the relevant business needs of the
Company in seeking and obtaining such consent.
5.3 Preparation of the Form S-4 and the Proxy Statement; Company
Stockholder Approval.
(a) Promptly following the date of this Agreement, the Company
shall, with the assistance and approval of Parent (which approval shall not
be unreasonably withheld or delayed), prepare and file with the SEC the
Proxy Statement, and Parent shall, with the assistance and approval of the
Company (which approval shall not be unreasonably withheld or delayed),
prepare and file with the SEC the Form S-4, in which the Proxy Statement
will be included as a prospectus (the "Proxy Statement/Prospectus"). Each
of the Company and Parent shall use its reasonable best efforts to have the
Form S-4 declared effective under the Securities Act as promptly as
practicable after such filing. The Company will use its reasonable best
efforts to cause the Proxy Statement to be mailed to its stockholders as
promptly as practicable after the Form S-4 is declared effective under the
Securities Act and, subject to Section 5.1, solicit from holders of shares
of Company Common Stock proxies in favor of the adoption of this Agreement
and take all other action reasonably necessary or advisable to secure, at
the Stockholders Meeting, the Company Stockholder Approval. Parent also
shall take any action (other than qualifying to do business in any
jurisdiction in which it is not now so qualified) required to be taken
under any applicable state securities law in connection with the issuance
of Parent Common Stock in connection with the Merger, and the Company shall
furnish all information concerning the Company and the holders of the
Company Common Stock and rights to acquire Company Common Stock pursuant to
the Company Stock Option Plans as may be reasonably required in connection
with any such action. No filing of, or amendment or supplement to, the Form
S-4 or the Proxy Statement will be made by Parent or the Company,
respectively, without providing the other party the opportunity to review
and comment thereon; provided, that with respect to documents filed by a
party which are incorporated by reference in the Form S-4 or Proxy
Statement/Prospectus, this right of approval shall apply only with respect
to information relating to the other party or its business, financial
condition or results of operations; and provided, further, that the
Company, in connection with a Change in the Company Recommendation, may
amend or supplement the Proxy Statement/Prospectus (including by
incorporation by reference) pursuant to a Qualifying Amendment (as defined
below) to effect a Change in the Company Recommendation, and in such event,
this right of review and comment shall be satisfied if the Company files
the Qualifying Amendment no earlier than 24 hours after providing Parent
with notice and a copy thereof. A "Qualifying Amendment" means an amendment
or supplement to the Proxy Statement/Prospectus or Form S-4 (including by
incorporation by reference) to the extent it contains (i) a Change in the
Company Recommendation, (ii) a statement of the reasons of the Company's
Board of Directors for making such Change in the Company Recommendation and
(iii) additional information reasonably related to the foregoing. Parent
will advise the Company, promptly after it receives notice thereof, of the
time when the Form S-4 has become effective or any supplement or amendment
has been filed, the issuance of any stop order, the suspension of the
qualification of the Parent Common Stock issuable in connection with the
Merger for offering or sale in any jurisdiction, or any request by the SEC
for amendment of the Form S-4 or comments thereon and responses thereto or
requests by the SEC for additional information. The Company will inform
Parent, promptly after it receives notice thereof, of any request by the
SEC for the amendment of the Proxy Statement and responses thereto or
requests by the SEC for additional information. Each of Parent, Purchaser
and the Company shall furnish all information concerning itself to the
other as may be reasonably requested in connection with any such action and
the preparation, filing and distribution of the Form S-4 and the
preparation, filing and distribution of the Proxy Statement. The Company,
Parent and Purchaser each agree to correct any information provided by it
for use in the Form S-4 or the Proxy Statement which shall have become
false or misleading. If, at any time prior to the Effective Time, any
information relating to Parent or the Company, or any of their respective
affiliates, officers or directors, should be discovered by Parent or
Company which should be but is not set forth in an amendment or supplement
to any of the Form S-4 or the Proxy Statement, so that any of such
documents would not include any misstatement of a material fact or omit to
state any material fact necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading, the party
which discovers such information shall promptly notify the other parties
hereto and an appropriate amendment or supplement describing such
information shall be promptly filed with the SEC and, to the extent
required by Law, disseminated to the stockholders of the Company.
(b) The Company, acting through the Company's Board of Directors,
shall in accordance with applicable Law (i) duly call, give notice of,
convene and hold, as promptly as practicable following the date upon which
the Form S-4 becomes effective, the Stockholders Meeting and (ii) use its
reasonable best efforts to solicit from holders of shares of Company Common
Stock proxies in favor of the adoption of this Agreement and take all other
action necessary or advisable to secure, at the Stockholders Meeting, the
Company Stockholder Approval, by the vote described in Section 3.2 of this
Agreement, and the Company's Board of Directors shall recommend adoption of
this Agreement by the stockholders of the Company to the effect set forth
in Section 3.2 of this Agreement (the "Company Recommendation"), and shall
not, in response to any proposal for a Third-Party Acquisition, a Superior
Proposal or otherwise (1) withdraw, revoke or change the Company
Recommendation, or (2) approve or recommend, or propose publicly to approve
or recommend, any Third-Party Acquisition (collectively, a "Change in the
Company Recommendation"); provided, the foregoing shall not prohibit
accurate disclosure (and such disclosure shall not be deemed to be a Change
in the Company Recommendation) of factual information regarding the
business, financial condition or results of operations of Parent or the
Company or the fact that a proposal for a Third-Party Acquisition has been
made, the identity of the party making such proposal or the material terms
of such proposal in the Form S-4 or the Proxy Statement/Prospectus or
otherwise, to the extent such information, facts, identity or terms is
required to be disclosed under applicable Law; provided that the Company
affirmatively states that it recommends that its stockholders vote in favor
of the Merger and, provided further, that, without limitation of the
foregoing, the Company's Board of Directors may make a Change in the
Company Recommendation pursuant to Section 5.1 hereof.
(c) If there is a Change in the Company Recommendation in
accordance with Section 5.1 hereof and this Agreement has not been
terminated pursuant to Article VII hereof, then, without limiting the
Company's ability to take the action otherwise permitted by Sections 5.1
and 5.3:
(i) from and after the date of such Change in the Company
Recommendation, in performing its obligations under this Section
5.3, the Company shall not be obligated to solicit from holders
of shares of Company Common Stock proxies in favor of the
adoption of this Agreement or to take all action necessary or
advisable to secure, at the Stockholders Meeting, the Company
Stockholder Approval, but instead shall be obligated to solicit
impartially from holders of shares of Company Common Stock
proxies to be voted at the Stockholders Meeting (making no
instructions to vote in favor or against, but merely to return a
completed proxy card or cards) and to take all action necessary
or advisable to maximize, at the Stockholders Meeting, the number
of proxies submitted by holders of Company Common Stock;
(ii) the Company shall be obligated to vote all unspecified
but executed proxies submitted by holders of shares of Company
Common Stock after the Change in the Company Recommendation
proportionately in accordance with the manner in which all
specified proxies shall have been voted;
(iii) Parent and its affiliates and agents shall have the
right, as a participant in the Company's solicitation of proxies,
to communicate with and solicit from holders of shares of Company
Common Stock the submission of Company proxies in favor of the
adoption of this Agreement and to take all actions necessary or
advisable to secure, at the Stockholders Meeting, the Company
Stockholders Approval and otherwise to act as a participant in
the Company's solicitation, all in accordance with applicable
Law; and
(iv) The parties shall cooperate with each other in
connection with any actions taken in connection with the
Stockholders Meeting and make any filings under federal
securities Laws required in connection herewith.
5.4 Filings; Other Action. (a) Subject to the terms and
conditions herein provided, each of the Company, Parent and Purchaser
shall: (i) use reasonable best efforts to cooperate with one another in (A)
determining which filings are required or advisable to be made prior to the
Effective Time with, and which consents, approvals, permits or
authorizations are required or advisable to be obtained prior to the
Effective Time from, Governmental Entities or other third parties in
connection with the execution and delivery of this Agreement, the Option
Agreement, the Transaction Support Agreement and any other Ancillary
Documents to which it is a party and the consummation of the transactions
contemplated hereby and thereby and (B) timely making all such filings and
timely seeking all such consents, approvals, permits, authorizations and
waivers; and (ii) use reasonable best efforts to take, or cause to be
taken, all other action and do, or cause to be done, all other things
necessary, proper or appropriate to consummate and make effective the
transactions contemplated by this Agreement, the Option Agreement, the
Transaction Support Agreement and the Ancillary Documents to which it is a
party. If, at any time after the Effective Time, any further action is
necessary or desirable to carry out the purpose of this Agreement, the
proper officers and directors of Parent and the Surviving Corporation shall
take all such necessary action.
(b) In furtherance and not in limitation of the foregoing, each
party hereto agrees to make an appropriate filing of a Notification and
Report Form pursuant to the HSR Act and any other Regulatory Law (as
hereinafter defined) with respect to the transactions contemplated hereby
as promptly as practicable after the date hereof and to supply as promptly
as practicable any additional information and documentary material that may
be requested pursuant to the HSR Act and any other Regulatory Law and to
take all other actions necessary to cause the expiration or termination of
the applicable waiting periods under the HSR Act and any Regulatory Law as
soon as practicable. Nothing in this Agreement shall require any of Parent
and its Subsidiaries or the Company and its Subsidiaries to sell, hold
separate or otherwise dispose of or conduct their business in a specified
manner, or agree to sell, hold separate or otherwise dispose of or conduct
their business in a specified manner, or permit the sale, holding separate
or other disposition of, any assets of Parent, the Company or their
respective Subsidiaries or the conduct of their business in a specified
manner, whether as a condition to obtaining any approval from a
Governmental Entity or any other person or for any other reason
("Regulatory Restrictions").
(c) Each of Parent and the Company shall, in connection with the
efforts referenced in Section 5.4(a) obtain all requisite material
approvals and authorizations for the transactions contemplated by this
Agreement under the HSR Act or any other Regulatory Law, use its reasonable
best efforts to (i) cooperate in all respects with each other in connection
with any filing or submission and in connection with any investigation or
other inquiry, including any proceeding initiated by a private party, (ii)
promptly inform the other party of any communication received by such party
from, or given by such party to, the Antitrust Division of the Department
of Justice (the "DOJ"), the Federal Trade Commission (the "FTC") or any
other Governmental Entity and of any material communication received or
given in connection with any proceeding by a private party, in each case
regarding any of the transactions contemplated hereby, and (iii) permit the
other party to review any communication given by it to, and consult with
each other in advance of any meeting or conference with, the DOJ, the FTC
or any such other Governmental Entity or, in connection with any proceeding
by a private party, with any other person, and to the extent appropriate or
permitted by the DOJ, the FTC or such other applicable Governmental Entity
or other person, give the other party the opportunity to attend and
participate in such meetings and conferences. For purposes of this
Agreement, "Regulatory Law" means the Sherman Act, as amended, Council
Regulation No. 4064/89 of the European Community, as amended (the "EC
Merger Regulation") the Clayton Act, as amended, the HSR Act, the Federal
Trade Commission Act, as amended, the Foreign Acquisition and Takeovers Act
1975(th) of the Commonwealth of Australia, as amended, and all other
federal, state and foreign, if any, statutes, rules, regulations, orders,
decrees, administrative and judicial doctrines and other laws that are
designed or intended to prohibit, restrict or regulate (A) foreign
investment, (B) antitrust or competition law or (C) telecommunications.
(d) Subject to the terms and conditions of this Agreement, in
furtherance and not in limitation of the covenants of the parties contained
in Section 5.4(a) and 5.4(b), if any administrative or judicial action or
proceeding, including any proceeding by a private party, is instituted (or
threatened to be instituted) challenging any transaction contemplated by
this Agreement as violative of any Regulatory Law (a "Regulatory
Challenge"), each of Parent and the Company shall cooperate in all respects
with each other and use its respective reasonable best efforts in order to
contest and resist any such Regulatory Challenge and to have vacated,
lifted, reversed or overturned any decree, judgment, injunction or other
order whether temporary, preliminary or permanent, that is in effect and
that prohibits, prevents or restricts consummation of the transactions
contemplated by this Agreement.
(e) If any objections are asserted with respect to the
transactions contemplated hereby under any Regulatory Law or if any suit is
instituted by any Governmental Entity or any private party challenging any
of the transactions contemplated hereby as violative of any Regulatory Law,
each of Parent and the Company shall use its reasonable best efforts and
cause its respective Subsidiaries to use their reasonable best efforts to
resolve any such objections or challenge as such Governmental Entity or
private party may have to such transactions under such Regulatory Law so as
to permit consummation of the transactions contemplated by this Agreement.
(f) If, primarily as a result of the execution by Parent or any
Subsidiary thereof of a Restricted Acquisition Agreement, the consents,
approvals, permits or authorizations described in this Section 5.4 hereof
are not obtained by (i) the date that is 180 days from the date hereof,
then (A) the Merger Consideration shall be increased by an amount
calculated in accordance with Section 2.2(a) hereof, and (B) from and after
such 180th day, Parent and Purchaser shall be deemed to have waived (I) the
condition set forth in Section 6.2(a) relating to the failure of any
representation or warranty set forth in Section 3.8, Section 3.9, the third
sentence of Section 3.10(a), the sixth sentence of Section 3.11(a), Section
3.12 (other than clause (c) thereto), Sections 3.13(b) and (c), Section
3.16(c) or Section 3.22, to be true and correct as of the Effective Time
where such failure to be true and correct would reasonably be expected to
result in a Company Material Adverse Effect, and (II) the condition set
forth in Section 6.2(e) hereof, in either of clause (I) or (II) to the
extent such condition otherwise would fail to be satisfied primarily as a
result of any event, change, development or circumstance occurring after
such 180th day or (ii) March 31, 2002, then Parent shall, or shall cause
any applicable Subsidiary to, promptly terminate the Restricted Acquisition
Agreement. In this regard, Parent shall not, and shall not permit any of
its Subsidiaries to, enter into any Restricted Acquisition Agreement unless
such Restricted Acquisition Agreement permits Parent or such Subsidiary to
terminate such Restricted Acquisition Agreement under the circumstances
described above in clause (ii) of this Section 5.4(f). As used herein, (x)
"Restricted Acquisition" shall mean (A) a merger, reorganization, share
exchange, consolidation, or similar transaction involving Parent or any of
its Subsidiaries and any Restricted Person (as defined below), (B) any
purchase of all or a substantial portion of the assets of a Restricted
Person or any division or unit thereof by Parent or any of its
Subsidiaries, (C) any purchase of, or tender or exchange offer for, more
than 20% of the outstanding equity securities of any Restricted Person by
Parent or any of its Subsidiaries, or (D) any other transaction similar in
nature to the foregoing with a Restricted Person that would otherwise be
subject to any Regulatory Law, (y) "Restricted Acquisition Agreement" shall
mean any memorandum of understanding, agreement in principle, letter of
intent, contract or agreement (whether written or oral) related to a
Restricted Acquisition and (z) "Restricted Person" shall mean any person
described in Schedule 5.4(f) hereof.
5.5 Access to Information. (a) From the date of this Agreement
until the Closing, the Company shall, and shall cause its Subsidiaries to,
(i) give Parent, its officers and a reasonable number of its employees and
its authorized representatives, reasonable access at all reasonable times
during normal business hours to the Contracts, books, records, analysis,
projections, plans, systems, personnel, commitments, offices and other
facilities and properties of the Company and its Subsidiaries and their
accountants and accountants' work papers and (ii) furnish Parent on a
timely basis with such financial and operating data and other information
with respect to the business and properties of the Company and its
Subsidiaries as Parent may from time to time reasonably request and use
reasonable best efforts to make available at all reasonable times during
normal business hours to the officers, employees, accountants, counsel,
financing sources and other representatives of the Parent the appropriate
individuals (including management personnel, attorneys, accountants and
other professionals) for discussion of the Company's business, properties,
prospects and personnel as Parent may reasonably request.
(b) From the date of this Agreement until the Closing, Parent
shall, and shall cause its Subsidiaries to, (i) give the Company, its
officers and a reasonable number of its employees and its authorized
representatives, reasonable access at all reasonable times during normal
business hours to the contracts, books, records, analysis, projections,
plans, systems, personnel, commitments, offices and other facilities and
properties of Parent and its Subsidiaries and their accountants and
accountants' work papers and (ii) furnish the Company on a timely basis
with such financial and operating data and other information with respect
to the business and properties of Parent and its Subsidiaries as the
Company may from time to time reasonably request and use reasonable best
efforts to make available at all reasonable times during normal business
hours to the officers, employees, accountants, counsel, financing sources
and other representatives of the Company the appropriate individuals
(including management personnel, attorneys, accountants and other
professionals) for discussion of Parent's business, properties, prospects
and personnel as the Company may reasonably request.
(c) As soon as practicable after the execution of this Agreement,
the Company shall permit Parent to electronically link the Company's
financial reporting system to Parent's financial reporting system
("Hyperion"). Access to Hyperion will be provided by Parent's financial
reporting staff and the tasks necessary to complete the link to Hyperion
will be led by Parent's accounting staff, with the necessary assistance
from the Company's accounting staff and other technical staff, if
necessary, at no cost to the Company and provided that neither such
installment nor the operation or use by Parent of Hyperion shall interfere
with or disrupt the normal operation of the Company's business or its
financial reporting system or violate any applicable software licenses.
Parent will provide the necessary Hyperion software to be installed on a
computer in the Company's accounting department; provided, however, that
the information retrieved from the Company's financial reporting system
will not be made available to persons who are directly involved in pricing
or any other competitive activity at Parent or any Subsidiary of Parent;
provided, further, that Parent shall not use such information other than
for purposes of assessing the financial condition of the Company for
purposes of the transactions contemplated by this Agreement, and shall not
share, provide or sell the information to any third party or use the
information in any manner that could reasonably be considered a restraint
on competition or result in a violation of any applicable Laws. Any
information provided under this Section 5.5(c) shall be subject to the
terms of the Confidentiality Agreement.
(d) All such information provided to or obtained by Parent under
this Section 5.5 shall be subject to the terms and conditions of the
Confidentiality Agreement.
5.6 Publicity. The initial press release relating to this
Agreement shall be issued jointly by the Company and Parent in a form
previously agreed upon by the Company and Parent. Thereafter, Parent,
Purchaser and the Company shall consult with each other, and use reasonable
efforts to agree upon the text of any press release, before issuing any
press release or making any public statement with respect to this
Agreement, the Merger or the other transactions contemplated hereby and
shall not issue any such press release or make any such public statement
without the prior consent of the other parties, which shall not be
unreasonably withheld; provided, however, that any party may, without the
prior consent of the others, issue such press release or make such public
statement as may, upon the advice of counsel, be required by law or the
rules and regulations of the SEC or the NYSE, in advance of obtaining such
prior consent, in which case, the parties shall cooperate to reach mutual
agreement as to the language of any such report, statement or press
release.
5.7 Further Action. Upon the terms and subject to the conditions
set forth in this Agreement, but without limiting the rights of the parties
hereunder, each of the parties agrees to use its reasonable best efforts to
take, or cause to be taken, all actions, and to do, or cause to be done,
and to assist and cooperate with the other parties in doing, all things
necessary, proper or advisable to consummate and make effective, in the
most expeditious manner practicable, the Merger and the other transactions
contemplated by this Agreement, the Option Agreement and the Transaction
Support Agreement, including using its reasonable best efforts to
accomplish the following:
(a) the taking of all acts reasonably necessary to cause the
Closing to be satisfied as promptly as practicable;
(b) subject to Section 5.4, the obtaining of all necessary
actions or nonactions, waivers, consents and approvals from Governmental
Entities and the making of all necessary registrations and filings
(including filings with Governmental Entities), including, without
limitation, filings pursuant to the FCC Act and any other required filings
or approvals under the telecommunications regulatory laws of any
jurisdiction where the Company or any of its Subsidiaries holds Company
Permits, and the taking of all steps as may be necessary to obtain an
approval or waiver from, or to avoid an action or proceeding by, a
Governmental Entity;
(c) the obtaining of all necessary consents, approvals or waivers
from third parties;
(d) the defending of any lawsuits or other legal proceedings,
whether judicial or administrative, challenging this Agreement, the Option
Agreement, the Transaction Support Agreement or the consummation of the
transactions contemplated hereby and thereby;
(e) taking all necessary actions to prevent the entry of
Restraints (as hereinafter defined) and to appeal as promptly as possible
any such Restraints that may be entered; and
(f) the execution and delivery of any additional instruments
reasonably necessary to consummate the transactions contemplated by, and to
fully carry out the purposes of, this Agreement, the Option Agreement and
the Transaction Support Agreement.
5.8 Insurance; Indemnity.
(a) Parent will cause the Surviving Corporation to maintain in
effect for not less than six years after the Effective Time, the Company's
current directors' and officers' insurance policies, if such insurance is
obtainable (or policies equivalent in all material respects to those
maintained by or on behalf of the Company and its Subsidiaries on the date
hereof, and having at least the same coverage and containing terms and
conditions no less advantageous to the current and all former directors and
officers of the Company) with respect to acts or failures to act prior to
the Effective Time; provided, however, that in order to maintain or procure
such coverage, Parent and the Surviving Corporation shall not be required
to maintain or obtain policies providing such coverage except to the extent
such coverage can be provided at an annual cost of no greater than two
times the most recent annual premium paid by the Company prior to the date
hereof (the "Cap"); and provided, further, that if equivalent coverage
cannot be obtained, or can be obtained only by paying an annual premium in
excess of the Cap, Parent or the Surviving Corporation shall be required to
only obtain as much coverage as can be obtained by paying an annual premium
equal to the Cap.
(b) From and after the Effective Time, Parent and the Surviving
Corporation shall indemnify and hold harmless to the fullest extent
permitted under applicable law, each person who is, or has been at any time
prior to the date hereof or who becomes prior to the Effective Time, an
officer or director of the Company or any of its Subsidiaries (each, an
"Indemnified Party") against all losses, claims, damages, liabilities,
costs or expenses (including attorneys fees), judgments, fines, penalties
and amounts paid in settlement in connection with any claim, action, suit,
proceeding or investigation arising out of or pertaining to acts or
omissions, or alleged acts or omissions, by them in their capacities as
such, which acts or omissions occurred prior to the Effective Time, whether
asserted or claimed prior to, at or after the Effective Time. In the event
of any such claim, action, suit, proceeding or investigation (an "Action"),
the Surviving Corporation shall control the defense of such Action with
counsel selected by the Surviving Corporation, which counsel shall be
reasonably acceptable to the Indemnified Party; provided, however, that the
Indemnified Party shall be permitted to participate in the defense of such
Action through counsel selected by the Indemnified Party, which counsel
shall be reasonably acceptable to the Surviving Corporation, at the
Indemnified Party's expense. Notwithstanding the foregoing, if there is any
conflict between the Surviving Corporation and any Indemnified Parties or
there are additional defenses available to any Indemnified Parties, the
Indemnified Parties shall be permitted to participate in the defense of
such Action with counsel selected by the Indemnified Parties, which counsel
shall be reasonably acceptable to the Surviving Corporation, and Parent
shall cause the Surviving Corporation to pay the reasonable fees and
expenses of such counsel, as accrued and in advance of the final
disposition of such Action to the full extent permitted by applicable law;
provided, however, that the Surviving Corporation shall not be obligated to
pay the reasonable fees and expenses of more than one counsel for all
Indemnified Parties in any single Action except to the extent that the
Surviving Corporation and any Indemnified Party have conflicting interests
in the outcome of such Action.
(c) Parent shall cause the Surviving Corporation to keep in
effect for a period of not less than six years from the Effective Time (or,
in the case of matters occurring prior to the Effective Time which have not
been resolved prior to the sixth anniversary of the Effective Time, until
such matters are finally resolved) all provisions in the Surviving
Corporation's Certificate of Incorporation and Bylaws that provide for
exculpation of director and officer liability and indemnification (and
advancement of expenses related thereto) of the past and present officers
and directors of the Company to the fullest extent permitted by the DGCL,
and such provisions shall not be amended except as either required by
applicable Law or to make changes permitted by Law that would enhance the
rights of past or present officers and directors to indemnification or
advancement of expenses.
(d) If Parent or the Surviving Corporation or any of their
respective successors or assigns (i) shall consolidate with or merge into
any other corporation or other entity and shall not be the continuing or
surviving corporation or entity of the consolidation or merger or (ii)
shall transfer all or substantially all of its properties and assets to any
individual, corporation or other entity, then and in each such case, proper
provisions shall be made so that the successors and assigns of Parent or
the Surviving Corporation shall assume all of the obligations set forth in
this Section 5.8.
(e) The provisions of this Section 5.8 are intended to be for the
benefit of, and shall be enforceable by, each of the Indemnified Parties,
their heirs and their representatives.
5.9 Employee Benefit Plans. (a) For a period of one year
following the Effective Time, Parent shall cause the Surviving Corporation
to continue to provide employees of the Company and its Subsidiaries (each,
a "Company Employee") as of the Effective Time and former employees who, as
of the Effective Time, have satisfied the requirements for benefits under
any Company Benefit Plan (and their eligible dependents) employee benefits
on terms substantially identical to those provided by the Company and its
Subsidiaries as of the date hereof, and such employee benefits shall be
provided by means of plans, policies and arrangements that are
substantially identical to the Company Benefit Plans. Notwithstanding the
foregoing, (i) except as otherwise provided in Section 5.9(d), the terms of
the plans, policies or arrangements (including, without limitation,
eligibility policies) by which Parent provides equity-based incentives to
employees of the Surviving Corporation for such one-year period shall not
be required to be substantially similar to any Company Stock Option Plan or
the Subsidiary Plans (including, without limitation, eligibility policies);
provided that Company Employees shall participate or not participate in
Parent equity-based plans, policies and arrangements on the same basis as
similarly situated employees of Parent and its Subsidiaries, and (ii)
Parent shall cause the Surviving Corporation to maintain the Galileo
International L.L.C. Severance Plan and the severance plan of any
Subsidiary listed in Schedule 5.9(a) (each a "Severance Plan"), as in
effect as of the date hereof, with respect to any eligible Company Employee
who is employed by the Company or any of its Subsidiaries as of the
Effective Time and whose employment is terminated (A) during the one-year
period commencing at the Effective Time (the "Measurement Period") for any
reason other than cause as determined under such Plan, or (B) from and
after the end of the Measurement Period, as a result of (I) the Merger or
any of the transactions contemplated by this Agreement, including, without
limitation, on account of any combination, restructuring or reorganization
of operations or facilities, or reduction in force, provided that, during
the Measurement Period, the Parent provides written notification of such
termination to the Company Employee, or (II) any combination, restructuring
or reorganization of operations or facilities, or reduction in force not
related to the Merger and set forth in Disclosure Schedule 5.9(a).
(b) From and after the Effective Time, Parent will cause the
Surviving Corporation and its Subsidiaries to honor, pay and perform all of
their respective covenants and obligations (i) with respect to the
Strategic Alternative Bonus Payments as set forth in paragraph 5 of
Disclosure Schedule 5.2, (ii) under all employment, stock plan, severance,
termination protection, consulting and other employee agreements between
the Company or its Subsidiaries and any officer, director or employee of
the Company or any of its Subsidiaries, in accordance with the terms
thereof as in effect immediately prior to the date hereof, and (iii) the
Company Benefit Plans, in each case, to the extent disclosed on the Company
Disclosure Letter.
(c) For purposes of determining eligibility and vesting (but not
for benefit accrual) under any Parent benefit plans, each Company Employee
shall be credited with their years of service with the Company or its
Subsidiaries (except to the extent necessary to avoid the duplication of
benefits). To the extent that any Parent benefit plan in which a Company
Employee participates after the Effective Time provides medical, dental,
vision or other welfare benefits, Parent shall cause (i) all pre-existing
condition exclusions and actively at work requirements of such plan to be
waived for such Company Employee and his or her covered dependents, and
(ii) any eligible expenses incurred by such Company Employee on or before
the Effective Time to be taken into account under such plan for purposes of
satisfying all deductible, coinsurance and maximum out-of-pocket
requirements applicable to such Company Employee and his or her covered
dependents for the applicable plan year.
(d) (i) Effective immediately following the Effective Time,
Parent shall cause to be granted to each employee or officer of the
Surviving Corporation who was, as of the Effective Time, (i) a Company
Employee or an officer of the Company or any of its Subsidiaries and (ii)
eligible for an award under a Company Stock Option Plan (an "Option
Eligible Employee"), options to purchase Parent Common Stock under Parent's
stock option plans ("Parent Option Plan"), as in effect at the Effective
Time, at fair market value (as defined in such plan) on the date of grant
on such terms as apply as of the date hereof, to similarly situated
employees of Parent, where applicable (or with respect to Non-Management
Employees and Managers, on terms at least as favorable as those terms
applicable to participants in Parent's stock option plans in the closest
salary grade to such Company Employees immediately prior to the Effective
Time), except that, notwithstanding the foregoing, the number of such
options shall be determined as set forth in Section 5.9(d)(ii) and shall
become vested in accordance with the following vesting schedule:
- ----------------------------------------------------------------------------
Vesting Date Cumulative Vested Percentage
- ----------------------------------------------------------------------------
First anniversary of date of grant 25%
- ----------------------------------------------------------------------------
Second anniversary of date of grant 50%
- ----------------------------------------------------------------------------
Third anniversary of date of grant 100%
- ----------------------------------------------------------------------------
(ii) In connection with the option award described in
Section 5.9(d)(i), prior to the Effective Time, the Company's
Compensation Committee shall designate with respect to each
Option Eligible Employee a number of options to purchase Company
Common Stock ("Designated Number"), based on the following ("2001
Option Awards"): (A) in the category of Non-Management Employee
or Manager, the target number of options set forth in Schedule
5.9(d) applicable to such Option Eligible Employee, or (B) with
respect to the categories of Chief Executive Officer, Executive
and Senior Vice President, Director and Vice President of Galileo
International, L.L.C., the number of options derived under the
formulaic target listed in Schedule 5.9(d); provided that, with
respect to clause (B), in each individual case, such award may
exceed such target, but in no event shall the aggregate awards
with respect to all such Option Eligible Employees exceed 105% of
the aggregate targets otherwise applicable to all such employees.
In lieu of any 2001 Option Awards, Parent shall grant the number
of options to purchase Parent Stock to be awarded to each such
Option Eligible Employee pursuant to this Section 5.9(d)(ii) by
multiplying the Designated Number by the Option Exchange Ratio in
accordance with Section 2.2(c)(i), assuming for purposes of
Section 2.2(c)(i)(2)(A) and (B), such options had been granted
prior to the Effective Time.
(iii) Notwithstanding the foregoing, in the event that the
Effective Time occurs after December 31, 2001, in lieu of the
awards described in Section 5.9(d)(i) and (ii), the Company shall
be entitled to grant, prior to the Effective Time, the 2001
Option Awards on the same terms and conditions as in effect with
respect to such Option Eligible Employees as of the date hereof
(and further providing, with respect to Vice Presidents and
director level employees who are Option Eligible Employees, for
the immediate vesting of such options in the event that such
employee's employment with the Company or its Subsidiaries is
terminated other than for Cause, as defined in the Form of Stock
Option Agreement applicable as of the date hereof to Executive
Vice Presidents of Galileo International L.L.C., within two years
after the Effective Time), except that in no event shall the
Company award any 2001 Option Awards to any person, including the
Chief Executive Officer or any Executive Vice President or Senior
Vice President, to the extent that such grant or any accelerated
vesting of such options as a result of the Merger would, either
alone or in conjunction with another event, result in an "excess
parachute payment" within the meaning of Code Section 280G(b)(2)
("280G Persons"), provided, however, that all 280G Persons shall
be included in the option grant described in Sections 5.9(d)(i)
and (ii). Notwithstanding Section 2.2(c)(i), the 2001 Options
awarded by the Company pursuant to this Section 5.9(d)(iii) shall
not become vested at or prior to the Effective Time; provided
that Parent reserves the right to cause such awards to become
vested immediately prior to the Effective Time.
5.10 Conveyance Taxes. The Company and Parent shall cooperate in
the preparation, execution and filing of all returns, questionnaires,
applications or other documents regarding any real property transfer or
gains, sales, use, transfer, value added, stock transfer and stamp taxes,
any transfer, recording, registration and other fees and any similar Taxes
which become payable in connection with the transactions contemplated by
this Agreement that are required or permitted to be filed on or before the
Effective Time. Each of Parent and the Company shall pay, without deduction
from any amount payable to holders of Company Common Stock and without
reimbursement from the other party, any such Taxes or fees imposed on it by
any Governmental Entity (and/or for which its shareholders are primarily
liable), which becomes payable in connection with the transactions
contemplated by this Agreement.
5.11 Certain Tax Matters. (a) During the period from the date
hereof to the Effective Time, the Company shall and shall cause each of its
Subsidiaries to: (i) timely file all Tax Returns ("Post Signing Returns")
required to be filed by it and, subject to Section 5.2(b)(xviii), such Post
Signing Returns shall be prepared in a manner consistent with past
practice, (ii) timely pay all Taxes due and payable in respect of such Post
Signing Returns that are so filed, (iii) accrue a reserve in its books and
records and financial statements, in accordance with past practice, for all
Taxes payable by it for which no Post Signing Return is due prior to the
Effective Time, and (iv) promptly notify Parent of any federal or state
income or franchise, or other material tax, suit, claim, action,
investigation, proceeding or audit pending against or with respect to the
Company or any of its Subsidiaries in respect of any Tax matters (or any
significant developments with respect to any ongoing Tax matters),
including material Tax liabilities and material refund claims.
(b) Neither the Company nor Parent nor their respective
affiliates shall directly or indirectly (without the consent of the other)
take any action or fail to take any action, that would reasonably be
expected to adversely affect the qualification of the Merger as a
reorganization under Section 368(a) of the Code.
(c) Officers of Parent, Purchaser and the Company shall execute
and deliver to Skadden, Arps, Slate, Meagher & Flom LLP ("Skadden Arps"),
tax counsel to Parent, and Jones Day, tax counsel to the Company,
certificates substantially in the form agreed to by the parties and such
law firms at such time or times as may be reasonably requested by such law
firms, including contemporaneously with the execution of this Agreement, at
the time the Form S-4 and Proxy Statement is declared effective by the SEC
and at the Effective Time, in connection with such tax counsel's respective
delivery of opinions, pursuant to Sections 6.2(e) and 6.3(d) hereof, with
respect to the tax treatment of the Merger.
(d) None of Parent, Purchaser or the Company shall take or cause
to be taken any action which would cause to be untrue (or fail to take or
cause not to be taken any action which would cause to be untrue) any of the
certifications and representations included in the certificates described
in Section 5.11(b).
5.12 Section 16 Matters. The Company and Parent shall take all
such steps as may be required to cause any dispositions of Company Common
Stock (including derivative securities with respect to the Company Common
Stock) and the acquisition of Parent Common Stock, as the case may be,
resulting from the transactions contemplated by this Agreement by each
officer or director of the Company who is subject to the reporting
requirements of Section 16(a) of the Exchange Act with respect to the
Company to be exempt under Rule 16b-3 promulgated under the Exchange Act,
such steps to be taken in accordance with the No-Action Letter, dated
January 12, 1999, issued by the SEC to Skadden Arps.
5.13 Stock Options and SARs. By adopting or approving this
Agreement the Board of Directors of each of the Company and Parent shall be
deemed to have approved and authorized, and the stockholders of the Company
shall be deemed to have approved and ratified, each and every amendment to
(and such other actions in respect of ) the Company Stock Option Plans, the
Company ESPP, and the agreements evidencing awards under the Company Stock
Option Plans and the Company ESPP as the officers of the Company and Parent
may deem necessary or appropriate to give effect to the provisions of
Section 2.2(c).
5.14 Stock Exchange Listing. Parent shall use its reasonable best
efforts to have approved for listing on the NYSE prior to the Effective
Time, subject to official notice of issuance, the Parent Common Stock to be
issued in the Merger and any and all shares of Parent Common Stock to be
reserved for issuance upon exercise of the Assumed Options.
5.15 Amendments to the Rights Agreement; Section 203.
(a) The Company agrees that it will not amend, modify or waive
any provision of the Rights Agreement, take any action to redeem the
Rights, or render the Rights inapplicable to any Third-Party Proposal.
(b) The Company agrees that it will not take any action to render
Section 203 of the DGCL or any other state takeover statute or similar
statute or regulation inapplicable to any person in respect of any
Third-Party Proposal.
5.16 Affiliates. As soon as practicable after the date hereof,
the Company shall deliver to Parent a letter identifying all persons who
may be deemed, at the time this Agreement is submitted for adoption by the
stockholders of the Company, "affiliates" of the Company for purposes of
Rule 145 under the Securities Act. The Company shall use its reasonable
best efforts to cause each such person to deliver to Parent at least 30
days prior to the Closing Date a written agreement substantially in the
form attached as Exhibit B hereto.
ARTICLE VI
Conditions
6.1 Conditions to Each Party's Obligation to Effect the Merger.
The respective obligation of each party to effect the Merger shall be
subject to the satisfaction or waiver, where permissible, prior to the
Effective Time, of the following conditions:
(a) The Company Stockholder Approval shall have been obtained at
or prior to the Effective Time in accordance with the DGCL.
(b) No temporary restraining order, preliminary or permanent
injunction or other judgment or order issued by any court of competent
jurisdiction or other statute, law, rule, legal restraint or prohibition
(collectively, "Restraints") shall be in effect preventing the consummation
of the Merger.
(c) No action, suit or proceeding shall have been instituted, or
shall be pending or threatened, by a Governmental Entity (i) seeking to
restrain in any material respect to prohibit the consummation of the
Merger, (ii) seeking to obtain from the Company, Parent or Purchaser any
damages that, individually or in the aggregate, would be reasonably likely
to result in a Company Material Adverse Effect or a Parent Material Adverse
Effect, or (iii) seeking to impose the Restraints referred to in subsection
(b) above.
(d) The Form S-4 and any required post-effective amendment
thereto shall have become effective under the Securities Act and shall not
be the subject of any stop order or proceedings seeking a stop order.
(e) The shares of Parent Common Stock issuable to the holders of
Company Common Stock and issuable upon exercise to holders of Assumed
Options pursuant to this Agreement have been approved for listing on the
NYSE, subject to official notice of issuance.
(f) (I) Any waiting period (and any extension thereof) applicable
to the Merger under the HSR Act shall have been terminated or expired, (II)
the European Commission shall have issued a decision under Article 6(1)(b)
or 8(2) of the EC Merger Regulation (or shall be deemed to have done so
under Article 10(6) of the EC Merger Regulation) declaring the Merger
compatible with the EC Common Market, (III) the governmental approval and
consent of the Treasurer of the Commonwealth of Australia under the Foreign
Acquisition and Takeovers Act 1975(th) (the "Australian Approval") shall
have been obtained and (IV) any applicable waiting periods under Section
123 of the Canadian Competition Act shall have expired or been earlier
terminated or waived, and the Commission of Competition thereunder shall
have issued an advance ruling certificate in respect of the Merger to the
effect that he does not intend to take any action with the Competition
Tribunal in respect of the Merger.
(g) All consents, approvals and actions of, and filings with and
notices to any Governmental Entity required of the Company, Parent,
Purchaser or any of their respective Subsidiaries under any Regulatory Law
(other than the filings set forth in Section 6.1(f)) to consummate the
Merger and the other transactions contemplated by this Agreement, the
failure of which to be obtained or made would (I) impose a risk of criminal
liability, criminal fines, imprisonment or confinement, in each case, upon
any officer, employee or director of the Company, Parent or any of their
respective Subsidiaries, (II) reasonably be expected to have a Company
Material Adverse Effect or a Parent Material Adverse Effect, or (III)
impose operating or other Regulatory Restrictions in jurisdictions from
which more than 10% of the consolidated revenues of the Company and its
Subsidiaries are generated, shall have been obtained or made.
6.2 Conditions to Obligation of Parent and Purchaser to Effect
the Merger. The obligation of Parent and Purchaser to effect the Merger
shall be subject to the fulfillment or waiver (to the extent permitted by
applicable Law) at or prior to the Effective Time of the following
conditions:
(a) (I) The representations and warranties of the Company set
forth in this Agreement (other than the representations and warranties set
forth in Section 3.2 and Section 3.4 and in Section 3.7(b) shall be true
and correct both when made and as of the Effective Time (except to the
extent expressly made as of a specified date, in which case as of such
date), except where the failure of such representations and warranties to
be so true and correct (without giving effect to any limitation as to
"materiality" or "Company Material Adverse Effect" set forth therein) would
not, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.
(II) The representations and warranties of the Company set forth
in Section 3.2 and Section 3.4 and in Section 3.7(b) shall be true and
correct in all material respects both when made and as of the Effective
Time (except to the extent expressly made as of a specified date, in which
case as of such date).
(b) The Company shall have performed and complied in all material
respects with all obligations, agreements and covenants required by this
Agreement to be performed or complied with by it prior to the Effective
Time.
(c) Parent shall have received a certificate signed by the chief
financial officer of the Company, dated as of the Closing Date, to the
effect that, to the best of such officer's knowledge, the conditions set
forth in Section 6.2(a) and Section 6.2(b) have been satisfied.
(d) There shall have been no event, change, development or
circumstance (regardless of whether such event, change, development or
circumstance arose before or after the date of this Agreement or was
disclosed on the Company Disclosure Letter) that would reasonably be
expected to have a Company Material Adverse Effect after the date of this
Agreement.
(e) Parent shall have received the opinion of Skadden Arps, in
form and substance reasonably satisfactory to Parent, dated as of the
Closing Date, on the basis of the facts, certifications, representations
and assumptions set forth in such opinion, all of which are consistent with
the state of facts existing as of the Effective Time, to the effect that
the Merger will qualify as a reorganization within the meaning of Section
368(a) of the Code. In rendering such opinion, Skadden Arps shall have
received and may rely upon the certifications and representations set forth
in the certificates referred to in Section 5.11(c).
(f) A Change in the Company Recommendation shall not have
occurred; or
(g) Parent shall have received from each person named in the
letter referred to in Section 5.16 an executed copy of the letter set forth
as Exhibit B hereto.
6.3 Conditions to Obligations of the Company to Effect the
Merger. The obligation of the Company to effect the Merger shall be subject
to the fulfillment or waiver (to the extent permitted by applicable Law) at
or prior to the Effective Time of the following conditions:
(a) (I) The representations and warranties of Parent and
Purchaser set forth in this Agreement (other than the representations and
warranties set forth in Section 4.2, Section 4.4, Section 4.6(b), Section
4.8, Section 4.13 and Section 4.16) shall be true and correct both when
made and as of the Effective Time (except to the extent expressly made as
of an earlier date, in which case as of such date) except where the failure
of such representations and warranties to be so true and correct, without
giving effect to any limitation as to "materiality" or "Parent Material
Adverse Effect" set forth therein, would not, individually or in the
aggregate, be reasonably expected to have a Parent Material Adverse Effect.
(II) The representations and warranties of Parent and Purchaser
set forth in Section 4.2, Section 4.4, Section 4.6(b) and Section 4.16
shall be true and correct in all material respects both when made and at
and as of the Effective Time (except to the extent expressly made as of an
earlier date, in which case as of such date).
(b) Parent and Purchaser shall have performed and complied in all
material respects with all obligations, agreements and covenants required
by this Agreement to be performed and complied with by it prior to the
Effective Time.
(c) The Company shall have received a certificate signed by the
chief financial officer of Parent, dated as of the Closing Date, to the
effect that, to the best of such officer's knowledge, the conditions set
forth in Section 6.3(a) and Section 6.3(b) have been satisfied.
(d) The Company shall have received the opinion of Jones Day, in
form and substance reasonably satisfactory to the Company, dated as of the
Closing Date, on the basis of the facts, certifications, representations
and assumptions set forth in such opinion, all of which are consistent with
the state of facts existing as of the Effective Time, to the effect that
the Merger will qualify as a reorganization within the meaning of Section
368(a) of the Code. In rendering such opinion, Jones Day shall have
received and may rely upon the certifications and representations set forth
in the certificates referred to in Section 5.11(b).
ARTICLE VII
Termination
7.1 Termination by Mutual Consent. This Agreement may be
terminated at any time prior to the Effective Time, whether or not the
Company Stockholder Approval has been obtained, by the mutual consent of
Parent and the Company.
7.2 Termination by Either Parent or Company. This Agreement may
be terminated by action of the Board of Directors of either Parent or the
Company, whether or not the Company Stockholder Approval has been obtained,
as follows:
(a) if the Effective Time shall not have occurred on or prior to
July 1, 2002; provided, however, that the right to terminate this Agreement
under this Section 7.2(a) shall not be available to any party whose failure
to fulfill any obligation under this Agreement has been the cause of, or
resulted in, the failure of the Merger to be consummated on or prior to
such date; or
(b) if a Governmental Entity shall have issued a nonappealable
final order, decree or ruling or taken any other nonappealable final action
having the effect of permanently restraining, enjoining or otherwise
prohibiting the Merger (which order, decree, ruling or other action the
party seeking to terminate this Agreement shall have used their reasonable
best efforts to lift); or
(c) if the Stockholders Meeting has been held and the Company
Stockholder Approval shall not have been obtained.
7.3 Termination by the Company. This Agreement may be terminated
at any time prior to the Effective Time by action of the Company's Board of
Directors, whether or not the Company Stockholder Approval has been
obtained, as follows:
(a) upon a material breach of any covenant or agreement set forth
in this Agreement (a "Terminating Breach") on the part of Parent or
Purchaser; provided that, if such Terminating Breach is curable on or prior
to the earlier of (i) forty-five days following notice of such Terminating
Breach and (ii) July 1, 2002 by Parent or Purchaser through the exercise of
its reasonable best efforts and for so long as Parent and Purchaser
continue to exercise such reasonable best efforts, the Company may not
terminate this Agreement under this Section 7.3(a) until the earlier of (i)
forty-five days following notice of such Terminating Breach and (ii) July
1, 2002;
(b) if Parent or Purchaser shall have breached any representation
and warranty set forth in this Agreement in any material respect; provided
that, (i) if such breach is curable prior to the earlier of (A) forty-five
days following notice of such breach and (B) July 1, 2002 by Parent or
Purchaser, as the case may be, through the exercise of its reasonable best
efforts and for so long as Parent or Purchaser, as the case may be,
continues to exercise such reasonable best efforts, the Company may not
terminate this Agreement under this Section 7.3(b) until the earlier of (A)
forty-five days following notice of such breach and (B) July 1, 2002, and
(ii) such breach would give rise to the failure of a condition set forth in
Section 6.3(a); or
(c) if the Average Parent Trading Price is less than or equal to
the Walk Away Price.
7.4 Termination by Parent. This Agreement may be terminated at
any time prior to the Effective Time, by action of the Board of Directors
of Parent, on behalf of Parent and Purchaser, whether or not the Company
Stockholder Approval has been obtained, as follows:
(a) upon a Terminating Breach on the part of the Company;
provided that, if such Terminating Breach is curable on or prior to the
earlier of (i) forty-five days following notice of such Terminating Breach
and (ii) July 1, 2002 by the Company through the exercise of its reasonable
best efforts and for so long as the Company continues to exercise such
reasonable best efforts, Parent may not terminate this Agreement under this
Section 7.4(a) until the earlier of (i) forty-five days following notice of
such Terminating Breach and (ii) July 1, 2002;
(b) if a Change in the Company Recommendation shall have
occurred; or
(c) if the Company shall have breached any representation and
warranty set forth in this Agreement in any material respect; provided
that, (i) if such breach is curable on or prior to the earlier of (A)
forty-five days following notice of such breach and (B) July 1, 2002 by the
Company through the exercise of its reasonable best efforts and for so long
as the Company continues to exercise such reasonable best efforts, Parent
may not terminate this Agreement under this Section 7.4(c) until the
earlier of (A) forty-five days following notice of such breach and (B) July
1, 2002, and (ii) such breach would give rise to the failure of a condition
set forth in Section 6.2(a).
7.5 Effect of Termination and Abandonment; Termination Fee. In
the event of the termination of this Agreement pursuant to Article VII,
written notice thereof shall forthwith be given to the other party or
parties specifying the provision hereof pursuant to which such termination
is made, and this Agreement shall forthwith become void and there shall be
no liability on the part of any party hereto or any of its affiliates,
directors, officers, stockholders, representatives or agents, except for
any obligation of the Company or Parent set forth in Article VII hereof, if
any. Notwithstanding the foregoing, or any other provision of this
Agreement (including Section 7.6), nothing herein shall relieve the
Company, Parent or Purchaser from liability for any prior material breach
hereof; provided, however, that in the event of termination of this
Agreement pursuant to Article VII as a result of which Parent is entitled
to the Fee and Parent Expenses under Section 7.6(a) of this Agreement, the
Company shall have no liability for any breach of this Agreement other than
for any prior willful breach hereof by the Company; provided, further
however, that if Parent has initiated any claim, proceeding or litigation
asserting any breach of this Agreement by the Company prior to any payment
of the Fee, or any determination of whether Parent is entitled to such a
Fee ("Fee Determination"), final resolution of such claim, proceeding or
litigation shall be deferred without prejudice to Parent, pending
resolution of a Fee Determination.
7.6 Fees and Expenses.
(a) The Company shall pay, or cause to be paid, to Parent, the
Parent Expenses (as hereinafter defined) actually incurred and a fee of
$100 million (the "Fee") upon the first to occur of any of the following
events:
(i) the termination of this Agreement by Parent or the
Company pursuant to Section 7.2(a), or the termination of this
Agreement by Parent pursuant to Section 7.4(a) or (c); provided,
that, prior to such termination, the Company becomes aware that
any person has made or intends to make a proposal relating to a
Third-Party Acquisition and, within twelve months following the
date of such termination, a Third-Party Acquisition is
consummated or a definitive agreement with respect to a
Third-Party Acquisition is executed by the Company;
(ii) the termination of this Agreement by Parent pursuant to
Section 7.4(b); or
(iii) the termination of this Agreement by Parent or the
Company pursuant to Section 7.2(c); provided, that (I) (A) Parent
had the right to terminate under Section 7.4(b) or (B) a
Third-Party Acquisition shall be publicly announced or otherwise
made known to the public at or prior to the Stockholders Meeting
and, within twelve months following the date of such termination,
a Third-Party Acquisition is consummated or a definitive
agreement with respect to a Third-Party Acquisition is executed
by the Company.
(b) "Parent Expenses" means all out-of-pocket expenses and fees
(including fees and expenses payable to all banks, investment banking
agents and counsel for arranging, committing to provide or providing any
financing for the transactions contemplated hereby or structuring the
transactions contemplated hereby and all fees of counsel, accountants,
experts and consultants to Parent and Purchaser and all printing and
advertising expenses) actually incurred or accrued by either of them or on
their behalf in connection with the transactions contemplated hereby,
including the financing thereof, and actually incurred by banks, investment
banking firms, other financial institutions and other persons and incurred
by Parent and Purchaser in connection with the negotiation, preparation,
execution and performance of this Agreement, the structuring and financing
of the Transactions and any financing commitments or agreements relating
thereto; provided, however, that the Parent Expenses shall not exceed
$10,000,000 in the aggregate.
(c) The Fee and Parent Expenses shall be paid by wire transfer of
same day funds to an account designated by Parent within two business days
after a demand for payment following the first to occur of any of the
events described in Section 7.6(a).
(d) In the event of a termination of this Agreement pursuant to
Section 7.2(c) in circumstances where Section 7.6(a)(iii) is not
applicable, the Company shall pay, or cause to be paid, to Parent the
Parent Expenses actually incurred. The Parent Expenses shall be paid by
wire transfer of same day funds to an account designated by Parent within
two business days after Parent shall have provided to the Company's
independent public accountants documentation supporting the calculation of
the Parent Expenses in reasonable detail.
(e) Notwithstanding anything in Section 7.6(a) or the Option
Agreement to the contrary, in no event will the sum of (i) the Fee paid to
Parent pursuant to this Agreement and (ii) the aggregate amounts actually
paid to or realized by Parent pursuant to Sections 11(b)(i), (ii) and (iii)
of the Option Agreement, exceed $100 million.
(f) The agreements contained in this Section 7.6 are an integral
part of the transactions contemplated hereby and do not constitute a
penalty. In the event of any dispute between the Company and Parent as to
whether the Fee and Parent Expenses under this Section 7.6 is due and
payable, the prevailing party shall be entitled to receive from the other
party the reasonable costs and expenses (including reasonable legal fees
and expenses) in connection with any action, including the filing of any
lawsuit or other legal action, relating to such dispute. Interest shall be
paid on the amount of any unpaid Fee or Parent Expenses at the publicly
announced prime rate of Citibank, N.A. from the date such Fee and Parent
Expenses was required to be paid.
7.7 Extension; Waiver. At any time prior to the Effective Time,
any party hereto, by action taken by its Board of Directors, may, to the
extent legally allowed, (a) extend the time for the performance of any of
the obligations or other acts of the other parties hereto, (b) waive any
inaccuracies in the representations and warranties made to such party
contained herein or in any document delivered pursuant hereto and (c) waive
compliance with any of the agreements or conditions for the benefit of such
party contained herein; provided, that, any agreement on the part of a
party hereto to any such extension or waiver shall be valid only if set
forth in an instrument in writing signed on behalf of such party.
ARTICLE VIII
General Provisions
8.1 Nonsurvival of Representations and Warranties. None of the
representations and warranties in this Agreement, or in any instrument
delivered pursuant to this Agreement, shall survive the Effective Time.
8.2 Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly
given or made as of the date of receipt and shall be delivered personally
or mailed by registered or certified mail (postage prepaid, return receipt
requested), sent by overnight courier or sent by facsimile, to the
applicable party at the following addresses or facsimile numbers (or at
such other address or telecopy number for a party as shall be specified by
like notice):
If to Parent or Purchaser:
Cendant Corporation
9 West 57th Street
New York, New York 10019
Attn: General Counsel
Facsimile: 212-413-1922
With a copy to:
Skadden, Arps, Slate, Meagher & Flom LLP
One Rodney Square
Wilmington, Delaware 19801
Attn: Patricia Moran, Esq.
Facsimile: 302-651-3001
If to the Company:
Galileo International, Inc.
9700 West Higgins Road, Suite 400
Rosemont, Illinois 60018
Attn: General Counsel
Facsimile: 847-518-4915
With a copy to:
Jones, Day, Reavis & Pogue
77 West Wacker Drive
Chicago, Illinois 60601-1692
Attn: Elizabeth C. Kitslaar, Esq.
Facsimile: 312-782-8585
or to such other address as any party shall specify by written notice so
given, and such notice shall be deemed to have been delivered as of the
date so telecommunicated, personally delivered or mailed. Any party to this
Agreement may notify any other party of any changes to the address or any
of the other details specified in this paragraph; provided that such
notification shall only be effective on the date specified in such notice
or five business days after the notice is given, whichever is later.
Rejection or other refusal to accept or the inability to deliver because of
changed address of which no notice was given shall be deemed to be receipt
of the notice as of the date of such rejection, refusal or inability to
deliver.
8.3 Assignment; Binding Effect; No Third-Party Beneficiaries.
Neither this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by any of the parties hereto (whether by
operation of law or otherwise) without the prior written consent of the
other parties; provided, however, that either Parent or Purchaser (or both)
may assign its rights hereunder to a wholly owned subsidiary of Parent;
and, further provided, that nothing shall relieve the assignor from its
obligations hereunder. Subject to the preceding sentence, this Agreement
shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and assigns. Notwithstanding anything
contained in this Agreement to the contrary, except for the provisions of
Section 5.8, nothing in this Agreement, expressed or implied, is intended
to confer on any person other than the parties hereto, or their respective
heirs, successors, executors, administrators and assigns, any rights,
remedies, obligations or liabilities under or by reason of this Agreement.
8.4 Entire Agreement. This Agreement, the Option Agreement, the
Transaction Support Agreement, the Confidentiality Agreement, the
Disclosure Letters, the Exhibits, the Ancillary Documents and any other
documents delivered by the parties in connection herewith constitute the
entire agreement among the parties with respect to the subject matter
hereof and supersede all prior representations, warranties, agreements and
understandings among the parties, both written and oral, with respect
thereto; provided, that if there is any conflict between the
Confidentiality Agreement and this Agreement, this Agreement shall prevail;
provided, further, that notwithstanding anything to the contrary contained
in the Confidentiality Agreement, following the receipt of any notice from
the Company pursuant to Section 5.1(c) hereof of a proposal relating to a
Third-Party Acquisition and prior to termination of this Agreement, Parent
may respond to any such proposal, including responding by making a proposal
to revise the transactions contemplated hereby.
8.5 Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware without
regard to its rules of conflict of laws. Each of the Company, Parent and
Purchaser hereby irrevocably and unconditionally consents to submit to the
exclusive jurisdiction of the courts of the State of Delaware and of the
United States of America located in the State of Delaware (the "Delaware
Courts") for any litigation arising out of or relating to this Agreement
and the transactions contemplated hereby (and agrees not to commence any
litigation relating thereto except in such courts), waives any objection to
the laying of venue of any such litigation in the Delaware Courts and
agrees not to plead or claim in any Delaware Court that such litigation
brought therein has been brought in an inconvenient forum.
8.6 Fee and Expenses. Whether or not the Merger is consummated,
except as otherwise provided by Section 7.6, all costs and expenses
incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the party incurring such costs and
expenses; provided, that all liability for transfer taxes, if any, incurred
by the Company or holders of Company Common Stock in connection with the
transactions contemplated hereby shall be paid by the Company out of the
Company's funds and will not be paid, directly or indirectly, by Parent.
8.7 Certain Definitions. For purposes of this Agreement, the
following terms shall have the following meanings:
(i) "affiliate" of a Person means a Person that directly or
indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, the first
mentioned Person.
(ii) "business day" means any day other than a Saturday,
Sunday or day on which banks in Chicago, Illinois or New York,
New York are authorized or required by Law to close.
(iii) "ERISA" means the Employee Retirement Income Security
Act of 1974, as amended.
(iv) "knowledge" of any party hereto shall mean the actual
knowledge, after reasonable inquiry, of any of the executive
officers of that party named in such party's most recent report
on Form 10-K filed with the SEC.
(v) "person" means an individual, corporation, partnership,
limited liability company, association, trust, unincorporated
organization, entity or group (as defined in the Exchange Act).
8.8 Headings. Headings of the Articles and Sections of this
Agreement are for the convenience of the parties only, and shall be given
no substantive or interpretive effect whatsoever. The table of contents
contained in this Agreement is for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement.
8.9 Interpretation. In this Agreement, unless the context
otherwise requires, words describing the singular number shall include the
plural and vice versa, and words denoting any gender shall include all
genders and words denoting natural persons shall include corporations and
partnerships and vice versa. Whenever the words "include," "includes" or
"including" are used in this Agreement, they shall be understood to be
followed by the words "without limitation." The words "hereof," "herein"
and "hereunder" and words of similar import when used in this Agreement
will refer to this Agreement as a whole and not to any particular provision
of this Agreement. All terms used herein with initial capital letters have
the meanings ascribed to them herein and all terms defined in this
Agreement will have such defined meanings when used in any certificate or
other document made or delivered pursuant hereto unless otherwise defined
therein. The definitions contained in this Agreement are applicable to the
singular as well as the plural forms of such terms and to the masculine as
well as to the feminine and neuter genders of such term. Any agreement,
instrument or statute defined or referred to herein or in any agreement or
instrument that is referred to herein means such agreement, instrument or
statute as from time to time amended, modified or supplemented, including
(in the case of agreements or instruments) by waiver or consent and (in the
case of statutes) by succession of comparable successor statutes and
references to all attachments thereto and instruments incorporated therein.
References to a person are also to its permitted successors and assigns.
Each of the parties has participated in the drafting and negotiation of
this Agreement. If an ambiguity or question of intent or interpretation
arises, this Agreement must be construed as if it is drafted by all the
parties and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of authorship of any of the provisions of
this Agreement.
8.10 Waivers. Except as otherwise provided herein, no action
taken pursuant to this Agreement, including, without limitation, any
investigation by or on behalf of any party, shall be deemed to constitute a
waiver by the party taking such action of compliance with any
representations, warranties, covenants or agreements contained in this
Agreement or in any of the Ancillary Documents. Any term, covenant or
condition of this Agreement may be waived at any time by the party which is
entitled to the benefit thereof, but only by a written notice signed by
such party expressly waiving such term or condition. The waiver by any
party hereto of a breach of any provision hereunder shall not operate or be
construed as a waiver of any prior or subsequent breach of the same or any
other provision hereunder.
8.11 Severability. Any term or provision of this Agreement that
is invalid or unenforceable in any jurisdiction shall, as to that
jurisdiction, be ineffective to the extent of such invalidity or
unenforceability without rendering invalid or unenforceable the remaining
terms and provisions of this Agreement or affecting the validity or
enforceability of any of the terms or provisions of this Agreement in any
other jurisdiction. If any provision of this Agreement is so broad as to be
unenforceable, the provision shall be interpreted to be only so broad as is
enforceable. Upon such determination that any term or other provision is
invalid, illegal or incapable of being enforced, the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the
original intent of the parties as closely as possible in an acceptable
manner in order that the transactions contemplated hereby are consummated
as originally contemplated to the greatest extent possible.
8.12 Parent Actions. The Company hereby acknowledges that from
and after the date of this Agreement, Parent or any of its Subsidiaries may
take actions involving (i) a merger, reorganization, share exchange,
spin-off, consolidation, recapitalization, liquidation, dissolution or
similar transaction involving Parent or any of its Subsidiaries, (ii) any
purchase or sale of the consolidated assets of a person or any division or
unit thereof by Parent or any of its Subsidiaries, (iii) any purchase or
sale of, or tender or exchange offer for, equity securities of any person
by Parent or any of its Subsidiaries, (iv) the acquisition of twenty
percent (20%) or more of the outstanding equity securities of any person by
Parent or any of its Subsidiaries or (v) any financings by the Company or
any of its Subsidiaries; provided, however, that this Section 8.12 shall
not modify, abrogate or diminish the Company's rights or Parent's
obligations under this Agreement.
8.13 Enforcement of Agreement. The parties hereto agree that
irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with its specific terms or
was otherwise breached. It is accordingly agreed that the parties shall be
entitled to an injunction or injunctions to prevent breaches of this
Agreement and to enforce specifically the terms and provisions hereof in
any Delaware Court, this being in addition to any other remedy to which
they are entitled at law or in equity.
8.14 Amendment. Subject to applicable law, this Agreement may be
amended by the parties hereto, by action taken by their respective boards
of directors, at any time before or after the Company Stockholder Approval,
but after any such Company Stockholder Approval, no amendment shall be made
which by law requires the further approval of stockholders without
obtaining such further approval. This Agreement may not be amended except
by an instrument in writing signed on behalf of each of the parties.
8.15 Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT WAIVES,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF
OR RELATING TO THIS AGREEMENT.
8.16 Execution. This Agreement may be executed by facsimile
signatures by any party and such signature shall be deemed binding for all
purposes hereof, without delivery of an original signature being thereafter
required.
8.17 Date for Any Action. In the event that any date on which any
action is required to be taken hereunder by any of the parties hereto is
not a business day, such action shall be required to be taken on the next
succeeding day which is a business day.
8.18 Counterparts. This Agreement may be executed by the parties
hereto in separate counterparts, each of which, when so executed and
delivered, shall be an original. All such counterparts shall together
constitute one and the same instrument. Each counterpart may consist of a
number of copies hereof, each signed by less than all, but together signed
by all, of the parties hereto.
IN WITNESS WHEREOF, the parties have executed this Agreement and
caused the same to be duly delivered on their behalf on the day and year
first written above.
GALILEO INTERNATIONAL, INC.
By: James E. Barlett
-------------------------------------
Its: Chairman, President and Chief Executive
Officer
CENDANT CORPORATION
By: Samuel L. Katz
------------------------------------
Its: Senior Executive Vice President,
Strategic & Business Development
GALAXY ACQUISITION CORP.
By: Samuel L. Katz
------------------------------------
Its: Executive Vice President
[GALILEO LETTERHEAD]
June ___, 2001
Cendant Corporation
9 West 57th Street
New York, New York 10019
Attn: General Counsel
Ladies and Gentlemen:
Pursuant to the terms of the Agreement and Plan of Merger, dated
as of the date hereof (the "Agreement") among Galileo International, Inc.
(the "Company"), Galaxy Acquisition Corp. (the "Purchaser") and Cendant
Corporation (the "Parent"), the Company hereby discloses to Purchaser and
Parent the following information and exceptions to the representations and
warranties contained in the Agreement. Capitalized terms used herein have
the respective meanings assigned to them in the Agreement unless otherwise
defined herein. Section references used herein refer to the respective
sections of the Agreement.
The purpose of this letter and the schedules attached hereto
(collectively, the "Company Disclosure Letter") is to disclose matters
which may be relevant to the representations and warranties of the Company
in the Agreement (the "Representations"). Each Representation that
specifically refers to the Company Disclosure Letter is qualified by the
disclosures contained in the corresponding Section of this Company
Disclosure Letter. Where a document includes an expression of opinion, no
representation or warranty is given as to its accuracy except to the extent
that such opinion is expressly required by the Agreement.
Matters reflected in this Company Disclosure Letter are not
necessarily limited to matters required by the Agreement to be included in
the Company Disclosure Letter. These additional matters are set forth for
informational purposes and do not necessarily include other matters of a
similar nature and shall not be deemed to constitute additional
representations and warranties of the Company or be an admission that any
such matter is material.
Very truly yours,
GALILEO INTERNATIONAL, INC.
By:
-----------------------
Its
----------------------
EXHIBIT A
TO THE MERGER AGREEMENT
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
GALILEO INTERNATIONAL, INC.
FIRST: The name of the Corporation is Galileo International, Inc.
(hereinafter the "Corporation").
SECOND: The address of the registered office of the Corporation
in the State of Delaware is 1209 Orange Street, in the City of Wilmington,
County of New Castle. The name of its registered agent at that address is
The Corporation Trust Company.
THIRD: The purpose of the Corporation is to engage in any lawful
act or activity for which a corporation may be organized under the General
Corporation Law of the State of Delaware as set forth in Title 8 of the
Delaware Code (the "DGCL").
FOURTH: The total number of shares of stock which the Corporation
shall have authority to issue is one thousand (1,000) shares of Common
Stock, each having a par value of $.01.
FIFTH: The following provisions are inserted for the management
of the business and the conduct of the affairs of the Corporation, and for
further definition, limitation and regulation of the powers of the
Corporation and of its directors and stockholders:
(1) The business and affairs of the Corporation shall be managed
by or under the direction of the Board of Directors.
(2) The directors shall have concurrent power with the
stockholders to make, alter, amend, change, add to or repeal the
By-Laws of the Corporation.
(3) The number of directors of the Corporation shall be as from
time to time fixed by, or in the manner provided in, the By-Laws of
the Corporation. Election of directors need not be by written ballot
unless the By-Laws so provide.
(4) In addition to the powers and authority hereinbefore or by
statute expressly conferred upon them, the directors are hereby
empowered to exercise all such powers and do all such acts and things
as may be exercised or done by the Corporation, subject, nevertheless,
to the provisions of the DGCL, this Certificate of Incorporation, and
any By-Laws adopted by the stockholders; provided, however, that no
By-Laws hereafter adopted by the stockholders shall invalidate any
prior act of the directors which would have been valid if such By-Laws
had not been adopted.
SIXTH: Meetings of stockholders may be held within or without the
State of Delaware, as the By-Laws may provide. The books of the Corporation
may be kept (subject to any provision contained in the DGCL) outside the
State of Delaware at such place or places as may be designated from time to
time by the Board of Directors or in the By-Laws of the Corporation.
SEVENTH: (a) The Corporation (i) shall indemnify any person who
was or is a party or is threatened to be made a party to, or is involved in
any manner in, any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative by
reason of the fact that he or she is or was a director or an officer of the
Corporation, or is or was serving at the request of the Corporation as a
director or an officer of another corporation, partnership, joint venture,
trust or other enterprise; and (ii) may indemnify, if the Board of
Directors determines such indemnification is appropriate, any person who
was or is a party or is threatened to be made a party to, or is involved in
any manner in, any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative by
reason of the fact that he or she is or was an employee or agent of the
Corporation, or is or was serving at the request of the Corporation as an
employee or agent of another corporation, partnership, joint venture, trust
or other enterprise, in each case, to the fullest extent authorized or
permitted by law, as now or hereafter in effect.
(b) Notwithstanding anything to the contrary contained in
subsection (a) of this Article SEVENTH, except for proceedings to enforce
rights to indemnification, the Corporation shall not be obligated to
indemnify any person in connection with a proceeding (or part thereof)
initiated by such person unless such proceeding (or part thereof) was
authorized in advance, or unanimously consented to, by the Board of
Directors.
(c) The rights to indemnification conferred in this Article
SEVENTH also include, to the fullest extent permitted by applicable law,
the right to be paid the expenses (including attorneys' fees) incurred in
connection with any such civil, criminal, administrative or investigative
action, suit or proceeding in advance of its final disposition.
(d) The Corporation may purchase and maintain insurance on behalf
of any person who is or was a director, officer, employee or agent of the
Corporation, or is or was serving at the request of the Corporation as a
director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, against any liability asserted
against him or her and incurred by him or her in any such capacity, or
arising out of his or her status as such, whether or not the Corporation
would have the power to indemnify him or her against such liability under
the provisions of applicable law.
(e) Any repeal or modification of this Article SEVENTH by the
stockholders of the Corporation shall not adversely affect any rights to
indemnification and to advancement of expenses that any person may have at
the time of such repeal or modification with respect to any acts or
omissions occurring prior to such repeal or modification.
EIGHTH: (a) A director of the Corporation shall not be personally
liable to the Corporation or its stockholders for monetary damages for
breach of fiduciary duty as a director, except for liability (i) for any
breach of the director's duty of loyalty to the Corporation or its
stockholders, (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) under Section
174 of the DGCL, or (iv) for any transaction from which the director
derived any improper personal benefit.
(b) If the DGCL is amended hereafter to authorize the further
elimination or limitation of the liability of directors, then the liability
of a director of the Corporation shall be eliminated or limited to the
fullest extent authorized by the DGCL, as so amended, without further
action by either the Board of Directors or the stockholders of the
Corporation.
(c) Any repeal or modification of this Article EIGHTH shall not
adversely affect any right or protection of a director of the Corporation
existing hereunder with respect to any act or omission occurring prior to
or at the time of such repeal or modification.
NINTH: The Corporation reserves the right to amend, alter, change
or repeal any provision contained in this Certificate of Incorporation, in
the manner now or hereafter prescribed by statute, and all rights conferred
upon stockholders herein are granted subject to this reservation.
EXHIBIT B
TO THE MERGER AGREEMENT
Form of Affiliate Letter
Dear Sirs:
The undersigned, a holder of shares of common stock, par value
$0.01 per share ("Company Common Stock"), of Galileo International, Inc., a
Delaware corporation (the "Company"), acknowledges that the undersigned may
be deemed an "affiliate" of the Company within the meaning of Rule 145
("Rule 145") promulgated under the Securities Act of 1933, as amended (the
"Securities Act"), by the Securities and Exchange Commission (the "SEC"),
although nothing contained herein should be construed as an admission of
either such fact. Pursuant to the terms of the Agreement and Plan of Merger
dated as of June 15, 2001, among Cendant Corporation, a Delaware
corporation ("Parent"), Galaxy Acquisition Corp., a Delaware corporation
and a wholly owned subsidiary of Parent ("Merger Sub"), and the Company,
Merger Sub will be merged with and into the Company (the "Merger"), and in
connection with the Merger, the undersigned is entitled to receive common
stock, par value $0.01 per share ("Parent Common Stock"), of Parent.
If in fact the undersigned were an affiliate under the Securities
Act, the undersigned's ability to sell, assign or transfer the shares of
Parent Common Stock received by the undersigned in exchange for any shares
of Company Common Stock in connection with the Merger may be restricted
unless such transaction is registered under the Securities Act or an
exemption from such registration is available. The undersigned understands
that such exemptions are limited and the undersigned has obtained or will
obtain advice of counsel as to the nature and conditions of such
exemptions, including information with respect to the applicability to the
sale of such securities of Rules 144 and 145(d) promulgated under the
Securities Act. The undersigned understands that Parent will not be
required to maintain the effectiveness of any registration statement under
the Securities Act for the purposes of resale of Parent Common Stock by the
undersigned.
The undersigned hereby represents to and covenants with Parent
that the undersigned will not sell, assign or transfer any of the shares of
Parent Common Stock received by the undersigned in exchange for shares of
Company Common Stock in connection with the Merger except (i) pursuant to
an effective registration statement under the Securities Act, (ii) in
conformity with the volume and other limitations of Rule 145 or (iii) in a
transaction which, in the opinion of counsel to the undersigned, such
counsel to be reasonably satisfactory to Parent and such opinion to be in
form and substance reasonably satisfactory to Parent, or as described in a
"no-action" or interpretive letter from the Staff of the SEC specifically
issued with respect to a transaction to be engaged in by the undersigned,
is not required to be registered under the Securities Act.
In the event of a sale or other disposition by the undersigned of
the shares of Parent Common Stock pursuant to Rule 145, the undersigned
will supply Parent with evidence of compliance with such Rule, in the form
of a letter in the form of Annex I hereto or the opinion of counsel or
no-action letter referred to above. The undersigned understands that Parent
may instruct its transfer agent to withhold the transfer of any shares of
Parent Common Stock disposed of by the undersigned, but that (provided such
transfer is not prohibited by any other provision of this letter agreement)
upon receipt of such evidence of compliance, Parent shall cause the
transfer agent to effectuate the transfer of the shares of Parent Common
Stock sold as indicated in such letter.
Parent covenants that it will take all such actions as may be
reasonably available to it to permit the sale or other disposition of the
shares of Parent Common Stock by the undersigned under Rule 145 in
accordance with the terms thereof.
The undersigned acknowledges and agrees that the legend set forth
below will be placed on certificates representing the shares of Parent
Common Stock received by the undersigned in connection with the Merger or
held by a transferee thereof, which legend will be removed by delivery of
substitute certificates upon receipt of an opinion in form and substance
reasonably satisfactory to Parent from counsel reasonably satisfactory to
Parent to the effect that such legend is no longer required for purposes of
the Securities Act.
There will be placed on the certificates for Parent Common Stock
issued to the undersigned in connection with the Merger, or any
substitutions therefor, a legend stating in substance:
"The shares represented by this certificate were issued, in a
transaction to which Rule 145 promulgated under the Securities Act of 1933
applies. The shares have not been acquired by the holder with a view to, or
for resale in connection with, any distribution thereof within the meaning
of the Securities Act of 1933. The shares may not be sold, pledged or
otherwise transferred except in accordance with an exemption from the
registration requirements of the Securities Act of 1933."
It is understood and agreed that certificates with the legend set
forth above will be substituted by delivery of certificates without such
legends if (i) one year shall have elapsed from the date the undersigned
acquired the Parent Common Stock received in the Merger and the provisions
of Rule 145(d)(2) are then available, (ii) two years shall have elapsed
from the date the undersigned acquired the Parent Common Stock received in
the Merger and the provisions of Rule 145(d)(3) are then available or (iii)
Parent has received either a written opinion of counsel, which opinion of
counsel shall be reasonably satisfactory to Parent, or a "no-action" letter
obtained by the undersigned from the SEC, to the effect that the
restrictions imposed by Rule 145 under the Securities Act no longer apply
to the undersigned.
The undersigned acknowledges that (i) the undersigned has
carefully read this letter and understands the requirements hereof and the
limitations imposed upon the distribution, sale, transfer or other
disposition of Parent Common Stock and (ii) the receipt by Parent of this
letter is an inducement to Parent's obligations to consummate the Merger.
Very truly yours,
Dated: ______________, 2001
ANNEX I
TO EXHIBIT B
[Name] [Date]
On ____________, the undersigned sold the securities of Cendant
Corporation, a Delaware corporation ("Parent"), described below in the
space provided for that purpose (the "Securities"). The Securities were
received by the undersigned in connection with the merger of Galaxy
Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of
Parent, with and into Galileo International, Inc., a Delaware corporation.
Based upon the most recent report or statement filed by Parent
with the Securities and Exchange Commission, the Securities sold by the
undersigned were within the prescribed limitations set forth in paragraph
(e) of Rule 144 promulgated under the Securities Act of 1933, as amended
(the "Securities Act").
The undersigned hereby represents that the Securities were sold in
"brokers' transactions" within the meaning of Section 4(4) of the
Securities Act or in transactions directly with a "market maker" as that
term is defined in Section 3(a)(38) of the Securities Exchange Act of 1934,
as amended. The undersigned further represents that the undersigned has not
solicited or arranged for the solicitation of orders to buy the Securities,
and that the undersigned has not made any payment in connection with the
offer or sale of the Securities to any person other than to the broker who
executed the order in respect of such sale.
Very truly yours,
Exhibit 99.1
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT (this "Agreement"), dated June 15, 2001,
between Galileo International, Inc., a Delaware corporation (the "Company"),
and Cendant Corporation, a Delaware corporation ("Cendant").
RECITALS
WHEREAS, the Company, Cendant and Galaxy Acquisition Corp., a
Delaware corporation and a wholly-owned subsidiary of Cendant ("Merger Sub"),
are entering into an Agreement and Plan of Merger dated as of the date hereof
(the "Merger Agreement"), which provides, among other things, that, upon the
terms and subject to the conditions contained therein, Merger Sub shall be
merged (the "Merger") with and into the Company; and
WHEREAS, the Company has agreed, in order to induce Cendant to enter
into the Merger Agreement, to grant the Option (as hereinafter defined) to
Cendant upon the terms and subject to the conditions set forth herein; and
WHEREAS, simultaneously with the execution and delivery of this
Agreement, and as a condition to Cendant's willingness to enter into this
Agreement, Cendant and United Air Lines, Inc., a Delaware corporation ("UAL")
and Covia, LLC a Delaware limited liability company ("Covia" and, together
with UAL, "United") are entering into a transaction support agreement (the
"Transaction Support Agreement") pursuant to which Covia has agreed, among
other things, to grant Cendant a proxy to vote its shares of Company Common
Stock (as hereinafter defined) in favor of the Merger, upon the terms and
subject to the conditions set forth therein;
WHEREAS, capitalized terms used herein and not otherwise defined
herein shall have the respective meanings ascribed to them in the Merger
Agreement.
NOW, THEREFORE, in consideration of the premises and the
representations, warranties, mutual covenants and agreements set forth herein
and in the Merger Agreement, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound hereby, agree as follows:
1. Grant of Option. The Company hereby grants to Cendant an irrevocable
option (the "Option") to purchase, subject to the terms and
conditions set forth herein, up to 17,041,071 shares (subject to
adjustment as set forth herein, the "Company Shares") of common
stock, par value $0.01 per share, of the Company (the "Company
Common Stock"), together with the preferred stock purchase rights
(the "Rights") associated with such shares issued pursuant to the
Rights Agreement, dated as of February 22, 2001, between the Company
and LaSalle National Bank Association, as Rights Agent (the "Rights
Agreement"), in the manner set forth below at a price per share of
$33.00 (subject to adjustment as set forth herein, the "Exercise
Price"); provided, however, that in no event shall the number of
shares of Company Common Stock for which the Option is exercisable
exceed 19.5% of the Company's issued and outstanding shares of
Company Common Stock. References herein to the Company Shares shall
also be deemed to included the associated Rights.
2. Exercise of Option.
(a) The Option may be exercised by Cendant, in whole or in part, at any
time or from time to time after the Merger Agreement becomes
terminable by Cendant under circumstances which could entitle
Cendant to the Fee under Section 7.6(a) of the Merger Agreement
(regardless of whether the Merger Agreement is actually terminated),
any such event being referred to herein as a "Trigger Event";
provided, however, that the Trigger Event shall not have occurred
and the Option shall not be exercisable unless and until the
Transaction Support Agreement shall have been terminated in
accordance with its terms. In the event Cendant wishes to exercise
the Option, Cendant shall deliver to the Company a written notice
(an "Exercise Notice") specifying the total number of Company Shares
it wishes to purchase and a date and time for the closing of such
purchase (a "Closing"), which date shall not be less than two nor
more than three days after the later of (a) the date such Exercise
Notice is given and (b) the expiration or termination of any
applicable waiting period under the HSR Act and the making of all
required filings and receipt of all required approvals under foreign
competition laws. The Option shall terminate upon the earliest of:
(i) the Effective Time; (ii) the termination of the Merger Agreement
pursuant to Article VII thereof (other than a termination following
the occurrence of a Trigger Event); and (iii) 5:00 p.m., New York
City time, on the date that is the one-year anniversary of the
termination of the Merger Agreement following the occurrence of a
Trigger Event, or if, at the expiration of such one-year period, the
Option cannot be exercised by reason of any applicable judgment,
decree, order, law or regulation, ten Business Days after such
impediment to exercise shall have been removed or shall have become
final and not subject to appeal.
(b) If Cendant proposes to exercise the Option following the record date
of the Stockholders Meeting, the Company, at Cendant's request given
no later than five days prior to the Stockholders Meeting, shall
take all actions necessary to fix a new record date and to hold the
Stockholders Meeting at such time that provides Cendant the
opportunity to vote the Company Shares at the Stockholders Meeting;
provided, however, that the Company's Board of Directors shall not
be required to take such action in the event that the Company's
Board of Directors determines, in good faith (with due regard for
the intention of the parties hereto that, upon exercise of the
Option, Cendant be able to vote the Company Shares at the
Stockholders Meeting) and after consideration of advice it shall
have obtained from outside counsel, that taking such action would
create a substantial probability of violating the Company's Board of
Directors' fiduciary duties to the Company's Stockholders under
applicable law.
3. Conditions to Closing. The obligation of the Company to issue the
Company Shares to Cendant hereunder is subject to the conditions
that (a) all waiting periods, if any, under the HSR Act applicable
to the issuance of the Company Shares hereunder shall have expired
or shall have been terminated and all required filings shall have
been made and all required approvals shall have been obtained under
foreign competition laws and (b) no statute, rule or regulation
shall be in effect, and no order, decree or injunction entered by
any court of competent jurisdiction or governmental entity in the
United States shall be in effect, that prohibits or restrains the
exercise of the Option pursuant to the terms of this Agreement.
4. Closing. At any Closing, (a) upon receipt of the payment provided
for by this Section 4, the Company shall deliver to Cendant a single
certificate in definitive form representing the number of Company
Shares designated by Cendant in its Exercise Notice, such
certificate to be registered in the name of Cendant (or its
designee) and to bear the legend set forth in Section 12 of this
Agreement, and (b) Cendant shall deliver to the Company the
aggregate price for the Company Shares so designated in an amount
equal to the product obtained by multiplying the Exercise Price by
the number of Company Shares to be purchased by wire transfer of
immediately available funds payable to the Company pursuant to the
Company's instructions. At any Closing at which Cendant is
exercising the Option in part, Cendant shall present and surrender
this Agreement to the Company in exchange for the delivery to
Cendant by the Company of a duly executed new agreement with the
same terms as this Agreement evidencing the right to purchase the
balance of the Company Shares.
5. Representations and Warranties of the Company. The Company
represents and warrants to Cendant that:
(a) the Company is a corporation duly incorporated, validly existing
and in good standing under the laws of the State of Delaware and has the
corporate power and authority to enter into this Agreement and to perform its
obligations hereunder;
(b) the execution and delivery of this Agreement by the Company and
the consummation by the Company of the transactions contemplated hereby have
been duly authorized by all necessary corporate action on the part of the
Company and no other corporate proceedings on the part of the Company are
necessary to authorize this Agreement or any of the transactions contemplated
hereby;
(c) this Agreement has been duly executed and delivered by the
Company and, assuming this Agreement constitutes a valid and binding
obligation of Cendant, constitutes a valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, except
as enforcement may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting the enforcement of creditors'
rights generally, the availability of injunctive relief and other equitable
remedies, and limitations imposed by law on indemnification for liability
under securities laws;
(d) the Company has taken all necessary corporate action to
authorize and reserve for issuance and to permit it to issue, upon exercise
of the Option, and at all times from the date hereof through the expiration
of the Option shall have reserved, 17,041,071 unissued Company Shares and
such other shares of the Company Common Stock or other securities which may
be issued pursuant to Section 10 of this Agreement, all of which, upon their
issuance, payment and delivery in accordance with the terms of this
Agreement, shall be duly authorized, validly issued, fully paid and
nonassessable, and free and clear of all claims, liens, charges, encumbrances
and security interests of any nature whatsoever (other than those (i) created
by or through Cendant, or any of its affiliates, (ii) which arise under this
Agreement, or (iii) which arise under the Securities Act of 1933, as amended
(the "Securities Act"), or any applicable state securities laws); upon such
issuance, payment and delivery, Cendant shall have full and unrestricted
power to vote such Company Shares; and the 17,041,071 Company Shares
represent 19.5% of the issued and outstanding shares of Company Common Stock
on the date hereof;
(e) the execution and delivery of this Agreement by the
Company does not, and the performance of this Agreement by the Company shall
not, conflict with, or result in any violation of, or default (with or
without notice or lapse of time, or both) under, or give rise to a right of
termination, cancellation or acceleration of any obligation or the loss of a
material benefit under, or the creation of a lien, pledge, security interest
or other encumbrance on assets pursuant to (any such conflict, violation,
default, right of termination, cancellation or acceleration, loss or
creation, a "Violation"), (i) any provision of the Certificate of
Incorporation or By-laws of the Company, (ii) any provisions of any loan or
credit agreement, note, mortgage, indenture, lease or other material
contract, agreement, obligation, instrument, permit, concession, franchise,
license of or applicable to the Company (other than (A) restrictions
contained in the Company's debt, loan and credit agreements applicable to
Section 7 of this Agreement and (B) restrictions contained in the
Registration Rights Agreement, dated as of July 30, 1997, among the Company,
Covia, USAM Corp., RESNET Holdings, Inc., Distribution Systems, Inc., Roscor
A.G., Travel Industry Systems B.V., Retford Limited, Racom Teledata S.p.a.,
Travidata, Inc., Olynet, Inc. and Coporga, Inc. (the "Existing Registration
Rights Agreement") applicable to Section 9 of this Agreement), or (iii) any
judgment, order, decree, statute, law, ordinance, rule or regulation
applicable to the Company or its properties or assets (other than, with
respect to Section 9 of this Agreement, compliance with the Securities Act
and applicable state securities laws), except for such Violations, in the
case of each of clauses (ii) and (iii), (1) set forth on Schedule 3.6 of the
Company Disclosure Letter delivered pursuant to the Merger Agreement or (2)
that, individually or in the aggregate, has not had and would not reasonably
be expected to have a material adverse effect on the Company's ability to
consummate the transactions contemplated by this Agreement;
(f) the execution and delivery of this Agreement by the Company does
not, and the performance of this Agreement by the Company shall not, (i)
result in a "Triggering Event" under the Rights Agreement; or (ii) render
Section 203 of the General Corporation Law of the State of Delaware (the
"DGCL") applicable to this Agreement or the transactions contemplated hereby;
and
(g) except as described in this Agreement or in Section 3.6 of the
Merger Agreement and other than the HSR Act and applicable Regulatory Laws
and, with respect to Section 9 hereof, compliance with the provisions of the
Securities Act and any applicable state securities laws, the execution and
delivery of this Agreement by the Company does not, and the performance of
this Agreement by the Company shall not, require any consent, approval,
authorization or permit of, or filing with or notification to, any
Governmental Entity.
6. Representations and Warranties of Cendant. Cendant represents and
warrants to the Company that:
(a) Cendant is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware, and has the corporate
power and authority to enter into this Agreement and to perform its
obligations hereunder;
(b) the execution and delivery of this Agreement by Cendant and the
consummation by Cendant of the transactions contemplated hereby have been
duly authorized by all necessary corporate action on the part of Cendant and
no other corporate proceedings on the part of Cendant are necessary to
authorize this Agreement or any of the transactions contemplated hereby;
(c) this Agreement has been duly executed and delivered by Cendant
and, assuming this Agreement constitutes a valid and binding obligation of
the Company, constitutes a valid and binding obligation of Cendant
enforceable against Cendant in accordance with its terms, except as
enforcement may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting the enforcement of creditors'
rights generally and the availability of injunctive relief and other
equitable remedies and limitations imposed by law on indemnification for
liability under applicable securities laws;
(d) the execution and delivery of this Agreement by Cendant does
not, and the performance of this Agreement by Cendant shall not, result in
any Violation pursuant to (i) any provision of the Certificate of
Incorporation or By-laws of Cendant, (ii) any provisions of any loan or
credit agreement, note, mortgage, indenture, lease, or other material
contract, agreement, obligation, instrument, permit, concession, franchise,
license of or applicable to Cendant or (iii) any judgment, order, decree,
statute, law, ordinance, rule or regulation applicable to Cendant or its
properties or assets (other than, with respect to Section 9 of this
Agreement, compliance with the Securities Act and applicable state securities
laws), except for such Violations, in the case of each of clauses (ii) and
(iii), that, individually or in the aggregate, has not has and would not
reasonably be expected to have a material adverse effect on Cendant's ability
to consummate the transactions contemplated by this Agreement;
(e) except as described in this Agreement or in Section 4.5 of the
Merger Agreement, and other than the HSR Act and applicable Regulatory Laws
and, with respect to Section 9 hereof, compliance with the provisions of the
Securities Act and any applicable state securities laws, the execution and
delivery of this Agreement by Cendant does not, and the performance of this
Agreement by Cendant shall not, require any consent, approval, authorization
or permit of, or filing with or notification to, any Governmental Entity; and
(f) any Company Shares acquired upon exercise of the Option shall
not be, and the Option is not being, acquired by Cendant with a view to
public distribution or resale in any manner which would be in violation of
federal or state securities laws.
7. Put Right.
(a) Exercise of Put. At any time during which the Option is
exercisable pursuant to Section 2 or would be exercisable
but for the circumstances referred to in Section 3 (the
"Repurchase Period"), upon demand by Cendant, Cendant shall
have the right to sell to the Company (or any successor
entity thereof), and the Company (or such successor entity)
shall be obligated to repurchase from Cendant (the "Put"):
(i) all or any portion of the Option, at a price equal to
the product obtained by multiplying (A) the difference
between (1) the Market/Offer Price (as defined below) for
shares of Company Common Stock as of the date (the "Notice
Date") the notice of exercise of the Put is given to the
Company and (2) the Exercise Price, by (B) the number of
Company Shares purchasable pursuant to the Option (or
portion thereof with respect to which Cendant is exercising
the Put); or
(ii) all or any portion of the Company Shares purchased by
Cendant upon exercise of the Option pursuant hereto, at a
price equal to the product obtained by multiplying (A) the
higher of (1) the Exercise Price paid by Cendant for the
Company Shares acquired pursuant to the Option and (2) the
Market/Offer Price by (B) the number of Company Shares with
respect to which Cendant is exercising the Put.
As used herein, "Market/Offer Price" shall mean the higher of (x) the highest
price per share offered as of the Notice Date pursuant to any tender or
exchange offer or proposed pursuant to any other Third-Party Acquisition
proposal which was commenced or proposed prior to the Notice Date and not
terminated or withdrawn as of the Notice Date and (y) the average of the
closing sales prices of the Company Common Stock reported on the NYSE
Composite Tape for the 5 consecutive Trading Days ending on (and including)
the Trading Day immediately preceding the Notice Date. In determining the
Market/Offer Price, the value of consideration other than cash or stock as
provided above shall be determined by a nationally recognized investment
banking firm selected by Cendant and reasonably acceptable to the Company.
(b) Payment and Redelivery of Option or Shares. In the event Cendant
exercises the Put pursuant to this Section 7, the Company shall, within three
Business Days of the Notice Date, pay the required amount to Cendant in cash
by wire transfer of immediately available funds to an account specified by
Cendant two Business Days prior to the date that payment is due and Cendant
shall surrender to the Company the Option and/or the certificates evidencing
the Company Shares with respect to which Cendant is exercising the Put, and
Cendant shall warrant that it owns such Company Shares and that such Company
Shares are then free and clear of all liens, claims, charges and encumbrances
of any kind or nature whatsoever. Upon any exercise by Cendant of the Put
with respect to less than all of the Option, Cendant shall present and
surrender this Agreement to the Company in exchange for the delivery to
Cendant by the Company of a duly executed new agreement with the same terms
as this Agreement evidencing the right to purchase the balance of the Company
Shares.
8. Restrictions on Certain Actions. Until the termination of the
Option pursuant to Section 2, the Company shall not (a) amend the
Rights Agreement or adopt any shareholder rights plan or any
amendment thereto in any manner which would cause Cendant to become
an "Acquiring Person" under such Rights Agreement or shareholder
rights plan solely by reason of the beneficial ownership by Cendant
or any of its affiliates of the Company Shares subject to the Option
or by ownership by Cendant or any of its affiliates of any Company
Shares acquired pursuant to the Option; or (b) take any action, or
rescind any prior action, in any manner which would cause the Merger
or any other transaction contemplated by the Merger Agreement to
become subject to Section 203 of the DGCL solely by reason of the
beneficial ownership by Cendant or any of its affiliates of the
Company Shares subject to the Option or by ownership by Cendant or
any of its affiliates of any Company Shares acquired pursuant to the
Option.
9. Registration Rights.
(a) Demand. The Company shall, if requested in writing (a
"Registration Notice") by Cendant at any time and from time to time within
two years of the exercise of the Option (the "Registration Period"), as
expeditiously as possible, prepare and file registration statements under the
Securities Act if such registration is necessary in order to permit the sale
or other disposition of any or all shares of Company Common Stock or other
securities that have been acquired by or are issuable to Cendant upon
exercise of the Option ("Registrable Securities"); provided, however, that
Cendant shall be entitled to no more than an aggregate of two effective
registration statements hereunder. Any such Registration Notice must relate
to a number of Registrable Securities equal to at least twenty percent (20%)
of the Company Shares, unless the remaining number of Registrable Securities
is less than such amount, in which case Cendant shall be entitled to exercise
its rights hereunder but only for all of the remaining Registrable Securities
(a "Permitted Offering"). Cendant's rights hereunder shall terminate at such
time as Cendant shall be entitled to sell all of the remaining Registrable
Securities pursuant to Rule 144(k) under the Act. The Company (and/or any
person designated by the Company) shall upon receipt of the Registration
Notice relating to a proposed sale by Cendant of Registrable Securities in an
underwritten registration (subject to revocation of such Registration Notice)
have the option exercisable by written notice delivered to Cendant within 20
Business Days after the receipt of the Registration Notice, irrevocably to
agree to purchase all or any part of the Registrable Securities proposed to
be so sold for cash at a price (the "Option Price") equal to the product of
(i) the number of Registrable Securities to be so purchased by the Company
and (ii) the average of the daily closing sales price for such shares
reported on the NYSE Composite Tape for the 10 consecutive Trading Days
ending on (and including) the Trading Date immediately preceding the date
such notice was delivered by the Company to Cendant. Any such purchase of
Registrable Securities by the Company (or its designee) hereunder shall take
place at a closing to be held at the principal executive offices of the
Company or at the offices of its counsel at any reasonable date and time
designated by the Company and/or such designee in such notice within 20
Business Days after delivery of such notice. Any payment for the shares to be
purchased shall be made by delivery at the time of such closing of the Option
Price in immediately available funds. If the Company does not elect to
exercise its option pursuant to this Section 9 with respect to all
Registrable Securities, the Company shall use its reasonable best efforts to
qualify such shares of Company Common Stock or other securities not purchased
under any applicable state securities laws; provided, however, that the
Company shall not be required to qualify to do business, consent to general
service of process or submit to taxation in any jurisdiction by reason of
this provision. If the managing underwriters of such offering advise the
Company in writing that in their opinion the number of shares of the Company
Common Stock requested to be included in such registration or qualification
exceeds the number that could reasonably be expected to be sold by Cendant or
other Holders (as defined in the Existing Registration Rights Agreement), as
the case may be, in such offering, the Company shall, subject to the rights
of any Holders party to the Existing Registration Rights Agreement, include
the shares of Company Common Stock requested to be included therein by
Cendant and such other Holders pro rata (based on the number of shares of
Company Common Stock requested to be included therein). The Company shall use
reasonable efforts to cause each such registration statement to become
effective, to obtain all consents or waivers of other parties which are
required therefor, and to keep such registration statement or prospectus
effective for such period not in excess of 120 calendar days from the day
such registration statement first becomes effective as may be reasonably
necessary to effect such sale or other disposition. The obligations of the
Company hereunder to file a registration statement or prospectus and to
maintain its effectiveness may be suspended for up to 90 calendar days in the
aggregate during any 12-month period if the Company shall have determined, in
its reasonable judgment and upon the advice of outside counsel, that the
filing of such registration statement or prospectus or the maintenance of its
effectiveness would require premature disclosure of nonpublic information
that would materially and adversely affect the Company or otherwise interfere
with or adversely affect any pending or proposed offering of securities of
the Company or any other material transaction involving the Company, or the
Company would be required under the Securities Act to include audited
financial statements for any period in such registration statement or
prospectus and such financial statements are not yet available for inclusion
in such registration statement or prospectus. Subject to applicable law, the
expenses associated with the preparation and filing of any registration
statement or prospectus prepared and filed under this Section 9, and any sale
covered thereby, including the reasonable fees and expenses of one law firm
to act as Cendant's counsel ("Registration Expenses"), shall be paid by the
Company, except for underwriting discounts or commissions and brokers' fees.
In connection with any registration statement or prospectus prepared pursuant
to this Section 11, Cendant shall furnish, or cause any holder of the Option
or Company Shares (a "Holder") to furnish, the Company with such information
concerning itself and the proposed sale or distribution as shall reasonably
be required in order to ensure compliance with the requirements of the
Securities Act and to provide representations and warranties customary for
selling stockholders who are unaffiliated with the Company. In addition,
Cendant shall, and Cendant shall cause each Holder to contractually agree to,
indemnify and hold the Company, its underwriters and each of their respective
affiliates harmless against any and all losses, claims, damages, liabilities
and expenses (including, without limitation, investigation expenses and fees
and disbursements of counsel and accountants), joint or several, to which the
Company, its underwriters and each of their respective affiliates may become
subject under the Securities Act or otherwise, insofar as such losses,
claims, damages, liabilities or expenses (or actions in respect thereof)
arise out of or are based solely upon an untrue statement or alleged untrue
statement of a material fact contained in written information furnished by
Cendant or any Holder to the Company expressly for use in such registration
statement. Except for losses, claims, damages, liabilities or expenses (or
actions in respect thereof) arising out of or based solely upon an untrue
statement or alleged untrue statement of a material fact contained in written
information furnished by Cendant and any Holder to the Company expressly for
use in any registration statement, the Company shall indemnify and hold
Cendant and each Holder and each of its respective affiliates harmless
against any and all losses, claims, damages, liabilities and expenses
(including, without limitation, investigation expenses and fees and
disbursement of counsel and accountants), joint or several, to which Cendant
and each Holder and each of its respective affiliates may become subject
under the Securities Act or otherwise.
(b) Piggyback. If, during the Registration Period, the Company
effects a registration under the Securities Act of the Company Common Stock
for its own account or for the account of any other stockholders of the
Company pursuant to a firm commitment underwriting (other than on Form S-4 or
Form S-8, or any successor form), it shall use reasonable best efforts to
allow Cendant the right to participate in such registration or qualification
as long as Cendant participates in such underwriting on terms reasonably
satisfactory to the managing underwriters of such offering, and such
participation shall not affect the obligation of the Company to effect demand
registration statements for Cendant under Section 9(a); provided, that, if
the managing underwriters of such offering advise the Company in writing that
in their opinion the number of shares of the Company Common Stock requested
to be included in such registration or qualification exceeds the number that
could reasonably be expected to be sold by the Company or other stockholders,
as the case may be, in such offering, the Company shall, after fully
including therein all shares of Company Common Stock to be sold by the
Company or other stockholders, as the case may be, include the shares of
Company Common Stock requested to be included therein by Cendant pro rata
(based on the number of shares of Company Common Stock requested to be
included therein) with the shares of Company Common Stock requested to be
included therein by persons other than the Company and persons on whose
behalf the registration statement was proposed to be filed, including any
person to whom the Company owes a contractual obligation.
(c) In connection with any registration or qualification pursuant to
this Section 9, the Company and Cendant shall provide each other and any
underwriter of the offering with customary representations, warranties,
covenants, indemnification, and contribution in connection with such
registration or qualification. The Company shall provide to any underwriters
such documentation (including certificates, opinions of counsel and "comfort"
letters from auditors) as are customary in connection with underwritten
public offerings as such underwriters may reasonably require.
(d) If the Company's securities of the same type as the Company
Common Stock beneficially owned by Cendant are then authorized for quotation
or trading or listing on The New York Stock Exchange (the "NYSE") or any
other securities exchange or automated quotations system, the Company, upon
the request of Cendant, shall promptly file an application, if required, to
authorize for quotation, trading or listing such shares of the Company Common
Stock on such exchange or system and shall use its reasonable efforts to
obtain approval, if required, of such quotation, trading or listing as soon
as practicable.
(e) Cendant shall not effect any public sale or distribution
(including sales pursuant to Rule 144) of equity securities of the Company,
or any securities convertible into or exchangeable or exercisable for such
securities, during the seven days prior to, and the 90-day period beginning
on, the effective date of any underwritten registration statement relating to
shares of the Company's Common Stock (except to the extent such securities
are included in such underwritten registration), unless the underwriters
managing the registered public offering otherwise agree.
(f) Notwithstanding anything herein to the contrary, to the extent
there is a conflict between the provisions of this Section 9 and the
provisions of the Existing Registration Rights Agreement, the provisions of
the Existing Registration Rights Agreement shall control.
10. Adjustment Upon Changes in Capitalization.
(a) In the event of any change in the Company Common Stock by reason
of stock dividends, split-ups, mergers, recapitalizations, combinations,
exchange of shares or the like, the type and number of shares or securities
subject to the Option, and the Exercise Price, shall be adjusted
appropriately, and proper provision shall be made in the agreements governing
such transaction so that Cendant shall receive, upon exercise of the Option,
the number and class of shares or other securities or property that Cendant
would have received in respect of the Company Common Stock if the Option had
been exercised immediately prior to such event or the record date therefor,
as applicable. In the event that any additional shares of Company Common
Stock otherwise become outstanding after the date of this Agreement (other
than pursuant hereto), the number of shares of Company Common Stock subject
to the Option shall be increased to equal 19.5% of the number of shares of
Company Common Stock then issued and outstanding.
(b) In the event that the Company shall enter into an agreement: (i)
to consolidate with or merge into any person, other than Cendant, Merger Sub
or another direct or indirect wholly-owned subsidiary of Cendant, and shall
not be the continuing or surviving corporation of such consolidation or
merger; (ii) to permit any person, other than Cendant, Merger Sub or another
direct or indirect wholly-owned subsidiary of Cendant, to merge into the
Company and the Company shall be the continuing or surviving corporation,
but, in connection with such merger, the then-outstanding shares of Company
Common Stock shall be changed into or exchanged for stock or other securities
of the Company or any other person or cash or any other property or the
outstanding shares of Company Common Stock immediately prior to such merger
shall after such merger represent less than 50% of the outstanding shares and
share equivalents of the surviving corporation; or (iii) to sell or otherwise
transfer all or substantially all of its assets to any person, other than
Cendant, Merger Sub or another direct or indirect wholly-owned subsidiary of
Cendant, then, and in each such case, the Company shall immediately so notify
Cendant, and the agreement governing such transaction shall make proper
provisions so that, upon the consummation of any such transaction and upon
the terms and conditions set forth herein, Cendant shall, upon exercise of
the Option, receive for each Company Share with respect to which the Option
has not been exercised an amount of consideration in the form of and equal to
the per share amount of consideration that would be received by the holder of
one share of Company Common Stock less the Exercise Price (and, in the event
of an election or similar arrangement with respect to the type of
consideration to be received by the holders of Company Common Stock, subject
to the foregoing, proper provision shall be made so that the holder of the
Option would have the same election or similar rights as would the holder of
the number of shares of Company Common Stock for which the Option is then
exercisable).
11. Profit Limitation.
(a) Notwithstanding any other provision of this Agreement, in no
event shall the Total Payment (as hereinafter defined) received by Cendant
and its affiliates exceed $100 million and, if it otherwise would exceed such
amount, Cendant, at its sole election, shall either (i) reduce the number of
shares of Company Common Stock subject to the Option, (ii) deliver to the
Company for cancellation Company Shares previously purchased by Cendant
(valued, for the purposes of this Section 11(a) at the average of the closing
sales prices of the Company Common Stock reported on the NYSE Composite Tape
for the 20 consecutive Trading Days ending on (and including) the Trading Day
immediately preceding the day on which the Total Payment exceeds $100
million), (iii) pay cash to the Company, or (iv) any combination thereof, so
that the actually realized Total Payment shall not exceed $100 million after
taking into account the foregoing actions.
(b) As used herein, the term "Total Payment" shall mean the sum
(before taxes) of the following: (i) any amount received by Cendant pursuant
to Section 7 hereof, (ii) (x) the net (I) cash amounts received or (II) the
fair market value of securities received by Cendant pursuant to the sale,
disposition, conversion or exchange (including any sale, disposition,
conversion or exchange in connection with any Third Party Acquisition) of
Company Shares (or any securities into which the Company Shares shall be
converted or exchanged) to any unaffiliated party within twelve months
following exercise of the Option, less (y) the aggregate Exercise Price for
such shares, (iii) any amounts received by Cendant upon transfer of the
Option (or any portion thereof) to any unaffiliated party, and (iv) the
amount, if any, of the Fee actually received by Cendant pursuant to Section
7.6(a) of the Merger Agreement.
(c) Notwithstanding any other provision of this Agreement and
subject to Section 11(a) and Section 11(b) hereof, nothing in this Agreement
shall affect the ability of Cendant to receive, or the Company's obligation
to pay, the Fee and the Parent Expenses pursuant to Section 7.6 of the Merger
Agreement.
12. Restrictive Legends. Each certificate representing shares of
Company Common Stock issued to Cendant pursuant to the Option shall
include a legend in substantially the following form:
"THE TRANSFER OF THE SHARES REPRESENTED BY THIS CERTIFICATE
IS SUBJECT TO CERTAIN PROVISIONS OF AN AGREEMENT BETWEEN
THE REGISTERED HOLDER HEREOF AND THE COMPANY AND TO RESALE
RESTRICTIONS ARISING UNDER THE SECURITIES ACT OF 1933, AS
AMENDED. A COPY OF SUCH AGREEMENT IS ON FILE AT THE
PRINCIPAL OFFICE OF THE COMPANY AND SHALL BE PROVIDED TO
THE HOLDER HEREOF WITHOUT CHARGE UPON RECEIPT BY THE
COMPANY OF A WRITTEN REQUEST THEREFOR."
The Company shall, upon written request of the holder thereof, issue such
holder a new certificate evidencing such Company Shares without such legend
in the event (i) the sale of such Company Shares has been registered pursuant
to the Securities Act, or (ii) such holder shall have delivered to the
Company an opinion of counsel to the effect that subsequent transfers of such
Company Shares may be effected without registration under the Securities Act.
13. NYSE Listing and Antitrust Filings. The Company, upon request of
Cendant, shall as promptly as practicable file an application to
list Company Shares to be acquired upon exercise of the Option for
listing on the NYSE and shall use its reasonable efforts to obtain
approval for such listing as promptly as practicable. Promptly after
the date hereof, each of the parties hereto shall file all required
pre-merger notification and report forms and other documents and
exhibits required to be filed under the HSR Act and any foreign
competition laws to permit the acquisition of the Company Shares
subject to the Option at the earliest practicable date.
14. Binding Effect; No Assignment. This Agreement shall be binding
upon and inure to the benefit of the parties hereto and their
respective successors and permitted assigns. Except as expressly
provided for in this Agreement and except for any assignment by
Cendant, in whole or in part, to a wholly owned, direct or indirect,
subsidiary of Cendant (provided that any such subsidiary agrees in
writing to be bound by and liable for all of the terms, conditions
and provisions contained herein that would otherwise be applicable
to Cendant and provided further that Cendant shall remain liable for
all of its duties and obligations hereunder in the event such
subsidiary shall fail to perform hereunder), neither this Agreement
nor the rights or the obligations of either party hereto are
assignable in whole or in part (whether by operation of law or
otherwise), without the written consent of the other party and any
attempt to do so in contravention of this Section 14 shall be void.
Nothing contained in this Agreement, express or implied, is intended
to confer upon any person other than the parties hereto and their
respective permitted assigns any rights or remedies of any nature
whatsoever by reason of this Agreement.
15. Specific Performance. The parties recognize and agree that if for
any reason any of the provisions of this Agreement are not performed
in accordance with their specific terms or are otherwise breached,
immediate and irreparable harm or injury would be caused for which
money damages would not be an adequate remedy. Accordingly, each
party agrees that, in addition to other remedies, the other party
shall be entitled to an injunction or injunctions restraining any
violation or threatened violation of the provisions of this
Agreement and to enforce specifically the terms and provisions
hereof in the Delaware Courts (as hereinafter defined). In the event
that any action should be brought in equity to enforce the
provisions of this Agreement, neither party shall allege, and each
party hereby waives the defense that there is adequate remedy at
law.
16. Entire Agreement. This Agreement and the Merger Agreement (including
the Exhibits and Schedules thereto) constitute the entire agreement
among the parties with respect to the subject matter hereof and
supersede all other prior discussions, representations and
warranties, agreements and understandings, both written and oral,
among the parties or any of them with respect to the subject matter
hereof.
17. Further Assurances. Subject to the terms and conditions hereof, if
Cendant exercises the Option, or any portion thereof, in accordance
with the terms of this Agreement, each party shall execute and
deliver all such further documents and instruments and take all such
further action including obtaining necessary regulatory approvals
and making necessary filings (including, without limitation, filings
under the HSR Act and any Regulatory Laws, the Securities Act and
filings with the NYSE) as may be necessary in order to consummate
the transactions expressly contemplated hereby (including the
issuance, registration and listing of the Company Shares).
18. Interpretation. When a reference is made in this Agreement to
Sections, such reference shall be to a Section of this Agreement
unless otherwise indicated. Whenever the words "include," "includes"
or "including" are used in this Agreement, they shall be deemed to
be followed by the words "without limitation." The words "hereof,"
"herein" and "herewith" and words of similar import shall, unless
otherwise stated, be construed to refer to this Agreement as a whole
and not to any particular provision of this Agreement. All terms
defined in this Agreement shall have the defined meaning contained
herein when used in any certificate or other document made or
delivered pursuant hereto unless otherwise defined therein. The
definitions contained in this Agreement are applicable to the
singular as well as the plural forms of such terms and to the
masculine as well as to the gender and neuter genders of such term.
Any agreement or instrument defined or referred to herein or in any
agreement or instrument that is referred to herein means such
agreement or instrument as from time to time amended, modified or
supplemented and attachments thereto and instruments incorporated
therein. References to a person are also to its successors and
permitted assigns. The parties have participated jointly in the
negotiation and drafting of this Agreement. In the event an
ambiguity or question of intent or interpretation arises, this
Agreement shall be construed as if drafted jointly by the parties
and no presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any of the
provisions of this Agreement. Any reference to any federal, state,
local or foreign statute or law shall be deemed to also to refer to
any amendments thereto and all rules and regulations promulgated
thereunder, unless the context requires otherwise.
19. Severability. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of
the other provisions of this Agreement, which shall remain in full
force and effect. In the event any court or other competent
authority holds any provision of this Agreement to be null, void or
unenforceable, under any present or future law, public policy or
order, and if the rights or obligations of any party hereto under
this Agreement or the Merger Agreement, and the economic or legal
substance of the transactions contemplated hereby and thereby, shall
not be materially and adversely affected thereby, (i) such provision
shall be fully severable and (ii) this Agreement shall be construed
and enforced as if such illegal, invalid or unenforceable provision
had never comprised a part hereof. Upon such determination that any
term or other provision is invalid, illegal or incapable of being
enforced, the parties hereto shall negotiate in good faith the
execution and delivery of an amendment to this Agreement in order to
the maximum extent possible to effectuate, to the extent permitted
by law, the intent of the parties hereto with respect to such
provision. Each party agrees that, should any court or other
competent authority hold any provision of this Agreement or part
hereof to be null, void or unenforceable, or order any party to take
any action inconsistent herewith, or not take any action required
herein, the other party shall not be entitled to specific
performance of such provision or part hereof or to any other remedy,
including but not limited to money damages, for breach hereof or of
any other provision of this Agreement or part hereof as the result
of such holding or order.
20. Notices. Any notice, request, claim, demand or communication
required or permitted hereunder shall be in writing and either
delivered personally, telegraphed or telecopied or sent by certified
or registered mail, postage prepaid, and shall be deemed to be
given, dated and received (a) on the date of delivery if delivered
personally, including by courier, (b) upon receipt if delivered by
registered or certified mail, return receipt requested, postage
prepaid or (c) upon receipt if sent by facsimile transmission,
provided that any notice received by telecopy or otherwise at the
addressee's location on any Business Day after 5:00 p.m.
(addressee's local time) shall be deemed to have been received at
9:00 a.m. (addressee's local time) on the next Business Day. Any
party to this Agreement may notify any other party of any changes to
the address or any of the other details specified in this paragraph,
provided that such notification shall only be effective on the date
specified in such notice or five Business Days after the notice is
given, whichever is later. Rejection or other refusal to accept or
the inability to deliver because of changed address of which no
notice was given shall be deemed to be receipt of the notice as of
the date of such rejection, refusal or inability to deliver. All
notices hereunder shall be delivered to the parties to the addresses
or facsimile numbers set forth below, or pursuant to such other
instructions as may be designated in writing by the party to receive
such notice:
If to the Company, to:
Galileo International, Inc.
9700 West Higgins Road, Suite 400
Rosemont, Illinois 60018
Facsimile No.: (847) 518-4918
Attention: General Counsel
with a copy to (which shall not constitute notice):
Jones, Day, Reavis & Pogue
77 West Wacker Drive
Chicago, Illinois 60601
Facsimile No.: (312) 782-8585
Attention: Elizabeth C. Kitslaar, Esq.
If to Cendant, to:
Cendant Corporation
9 West 57th Street
New York, New York 10019
Facsimile No.: (212) 413-1922
Attention: General Counsel
with a copy to (which shall not constitute notice):
Skadden, Arps, Slate, Meagher & Flom LLP
One Rodney Square
Wilmington, Delaware 19801
Facsimile No.: (302) 651-3001
Attention: Patricia Moran, Esq.
21. Governing Law. This Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware applicable to
contracts executed and to be performed fully within such State,
without giving effect to the principles of conflicts or choice of
law thereof or any other jurisdiction.
22. Headings. The headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning
or interpretation of this Agreement.
23. Counterparts. This Agreement may be executed in one or more
counterparts, all of which shall be considered one and the same
agreement and shall become effective when one or more counterparts
have been signed by each of the parties and delivered to the other
parties. A facsimile copy of a signature page shall be deemed to be
an original signature page.
24. Expenses. Except as otherwise expressly provided herein or in the
Merger Agreement, all costs and expenses incurred by a party in
connection with the transactions contemplated by this Agreement,
including fees and expenses of its own financial consultants,
investment bankers, accountants and counsel, shall be paid by the
party incurring such expenses.
25. Amendments; Waiver. This Agreement may be amended by the parties
hereto and the terms and conditions hereof may be waived only by an
instrument in writing signed on behalf of each of the parties
hereto, or, in the case of a waiver, by an instrument in writing
signed on behalf of the party waiving compliance.
26. Consent to Jurisdiction. Each of the parties hereto irrevocably
agrees that any action, suit, claim or other legal proceeding with
respect to this Agreement or in respect of the transactions
contemplated hereby brought by any other party hereto or its
successors or assigns shall be brought and determined in any state
or federal court located in the State of Delaware or any appeals
courts thereof (the "Delaware Courts"), and each of the parties
hereto irrevocably submits with regard to any such proceeding for
itself and in respect to its property, generally and
unconditionally, to the exclusive jurisdiction of the Delaware
Courts. Each of the parties hereto irrevocably waives, and agrees
not to assert, by way of motion, as a defense, counterclaim or
otherwise, in any action or proceeding with respect to this
Agreement, (a) any claim that it is not personally subject to the
jurisdiction of the Delaware Courts for any reason, (b) that it or
its property is exempt or immune from jurisdiction of any Delaware
Court or from any legal process commenced in any Delaware Court
(whether through service of notice, attachment before judgment,
attachment in aid of execution of judgment, execution of judgment or
otherwise) and (c) to the fullest extent permitted by applicable
law, that (i) the proceeding in any Delaware Court is brought in an
inconvenient forum, (ii) the venue of such proceeding is improper or
(iii) this Agreement, or the subject matter hereof, may not be
enforced in or by a Delaware Court. Notwithstanding the foregoing,
each of the parties hereto agrees that the other party shall have
the right to bring any action or proceeding for enforcement of a
judgment entered by the Delaware Courts in any other court or
jurisdiction.
27. Remedies Cumulative. Except as otherwise herein provided, the
rights and remedies herein provided shall be cumulative and not
exclusive of any rights or remedies provided by applicable law.
28. Limitations on Warranties.
(a) Except for the representations and warranties contained in this
Agreement and the Merger Agreement, the Company makes no other express or
implied representation or warranty to Cendant. Cendant acknowledges that, in
entering into this Agreement, it has not relied on any representations or
warranties of the Company or any other person other than the representations
and warranties of the Company set forth in this Agreement or the Merger
Agreement.
(b) Except for the representations and warranties contained in this
Agreement and the Merger Agreement, Cendant makes no other express or implied
representation or warranty to the Company. The Company acknowledges that, in
entering into this Agreement, it has not relied on any representations or
warranties of Cendant or any other person other than the representations and
warranties of Cendant set forth in this Agreement and the Merger Agreement.
29. Date for Any Action. In the event that any date on which any action
is required to be taken hereunder by any of the parties hereto is
not a Business Day, such action shall be required to be taken on the
next succeeding day which is a Business Day.
IN WITNESS WHEREOF, the parties hereto have caused this Stock Option
Agreement to be executed by their respective duly authorized officers as of
the date first above written.
GALILEO INTERNATIONAL, INC.
By:/s/ James E. Barlett
--------------------------
Name: James E. Barlett
Title: Chairman, President and
Chief Executive Officer
CENDANT CORPORATION
By:/s/ Eric J. Bock
--------------------------
Name: Eric J. Bock
Title: Senior Vice President, Law
and Corporate Secretary
Exhibit 99.2
TRANSACTION SUPPORT AGREEMENT
THIS TRANSACTION SUPPORT AGREEMENT (this "Agreement"), dated as of
June 15, 2001, by and among Cendant Corporation, a Delaware corporation
("Cendant"), United Air Lines, Inc., a Delaware corporation ("United"), and
Covia LLC, a Delaware limited liability company and a wholly owned
subsidiary of United (the "Stockholder").
W I T N E S S E T H:
WHEREAS, simultaneously with the execution of this Agreement,
Cendant, Galaxy Acquisition Corp., a Delaware corporation and a
wholly-owned subsidiary of Cendant ("Merger Sub"), and Galileo
International, Inc., a Delaware corporation (the "Company"), have entered
into an Agreement and Plan of Merger dated the date hereof (the "Merger
Agreement"), which provides, among other things, for the merger (the
"Merger") of Merger Sub with and into the Company upon the terms and
subject to the conditions set forth therein;
WHEREAS, the Stockholder is the beneficial owner of, and has the
sole right to vote and dispose of, 15,940,000 shares of the Company's
common stock, par value $.01 per share (the "Company Common Stock"), and 2
shares of the Company's special preferred stock, par value $.01 per share
(the "Special Preferred Stock"); and
WHEREAS, as an inducement and a condition to its execution and
delivery of the Merger Agreement and performance of the obligations set
forth therein, including the Merger, Cendant has required that United and
the Stockholder enter into this Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual
promises, representations, warranties, respective covenants and agreements
of the parties contained herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged
by each of the parties hereto, the parties hereto, intending to be legally
bound hereby, agree as follows:
ARTICLE I
CERTAIN DEFINITIONS
Section 1.1 Capitalized Terms. Capitalized terms used in this
Agreement and not otherwise defined herein shall have the respective
meanings ascribed to such terms in the Merger Agreement.
Section 1.2 Other Definitions. For the purposes of this Agreement:
"Affiliate" means, with respect to any specified Person, any
Person that directly, or indirectly through one or more intermediaries,
controls, or is controlled by, or is under common control with, the Person
specified. For purposes of this Agreement, with respect to the Stockholder,
"Affiliate" shall not include the Company and the Persons that directly, or
indirectly through one or more intermediaries, are controlled by the
Company.
"Beneficial Owner" or "Beneficial Ownership" or "Beneficially
Owned" with respect to any securities means having "beneficial ownership"
of such securities as determined pursuant to Rule 13d-3 under the Exchange
Act, including pursuant to any agreement, arrangement or understanding,
whether or not in writing. Without duplicative counting of the same
securities by the same holder, securities Beneficially Owned by a Person
shall include securities Beneficially Owned by all Affiliates of such
Person and all other persons with whom such Person would constitute a
"group" within the meaning of Section 13(d) of the Exchange Act and the
rules promulgated thereunder.
"Company Common Stock" shall include all shares of capital stock
or other voting securities into which shares of Company Common Stock may be
reclassified, sub-divided, consolidated or converted and any rights and
benefits arising therefrom including any extraordinary distributions of
securities which may be declared in respect of the shares of Company Common
Stock and entitled to vote in respect of the matters contemplated by
Article II of this Agreement.
"Owned Shares" means the 15,940,000 shares of Company Common Stock
owned by the Stockholder on the date hereof, together with any other shares
of Company Common Stock or any other securities of the Company entitled, or
which may be entitled, to vote upon any of the matters referred to in
Section 2.1 hereof which may hereafter be owned by the Stockholder.
"Person" means any individual, corporation (including any
non-profit corporation), general or limited partnership, limited liability
company, joint venture, association, trust, estate, unincorporated
organization or other entity, including any governmental entity.
"Representative" means, with respect to any particular Person, any
officer, director, employee, agent, consultant, advisor or other
representative of such Person (including legal counsel, accountants, and
financial advisors).
"Restated Certificate of Incorporation" means the Restated
Certificate of Incorporation of the Company dated as of July 30, 1997.
"Stockholders' Agreement" means the Stockholders' Agreement among
the Company, the Stockholder, certain other stockholders of the Company and
certain related parties of such stockholders, dated as of July 30, 1997, as
amended.
"Transfer" means, with respect to any security, the sale,
transfer, pledge, hypothecation, encumbrance, assignment or disposition of
such security or the Beneficial Ownership thereof, the offer to make such a
sale, transfer or other disposition, and each option, agreement,
arrangement or understanding, whether or not in writing, to effect any of
the foregoing.
ARTICLE II
VOTING AGREEMENT AND PROXY
Section 2.1 Agreement to Vote. Upon the terms and subject to the
conditions hereof, the Stockholder irrevocably and unconditionally agrees
that, until this Agreement is terminated pursuant to Section 5.1 hereof, at
any meeting (whether annual or special, and whether or not an adjourned or
postponed meeting) of the Company's stockholders, however called, or in
connection with any written consent of the Company's stockholders, the
Stockholder shall vote, or cause to be voted (including by written consent,
if applicable) all of its Owned Shares (i) in favor of the adoption of the
Merger Agreement, (ii) against any Third Party Acquisition and (iii)
against any proposed action by the Company, the Company's stockholders or
any other Person the result of which action could prevent or materially
delay completion of the Merger. Each of United and the Stockholder agrees
not to enter into any agreement or commitment with any Person the effect of
which would be inconsistent with or violative of the provisions and
agreements contained in this Article II.
Section 2.2 Irrevocable Proxy.
THE STOCKHOLDER HEREBY GRANTS TO, AND APPOINTS CENDANT AND ANY
DESIGNEE OF CENDANT, EACH OF THEM INDIVIDUALLY, SUCH STOCKHOLDER'S
IRREVOCABLE PROXY AND ATTORNEY-IN-FACT (WITH FULL POWER OF SUBSTITUTION AND
RESUBSTITUTION) TO VOTE THE OWNED SHARES OF SUCH STOCKHOLDER (INCLUDING BY
WRITTEN CONSENT) (I) IN FAVOR OF THE ADOPTION OF THE MERGER AGREEMENT, (II)
AGAINST ANY THIRD PARTY ACQUISITION AND (III) AGAINST ANY PROPOSED ACTION
BY THE COMPANY, THE COMPANY'S STOCKHOLDERS OR ANY OTHER PERSON THE RESULT
OF WHICH ACTION COULD PREVENT OR MATERIALLY DELAY COMPLETION OF THE MERGER.
THE STOCKHOLDER SHALL TAKE SUCH FURTHER ACTION OR EXECUTE SUCH OTHER
INSTRUMENTS AS MAY BE NECESSARY TO EFFECTUATE THE INTENT OF THIS PROXY. THE
STOCKHOLDER HEREBY REVOKES ANY PROXIES PREVIOUSLY GRANTED BY SUCH
STOCKHOLDER WITH RESPECT TO THE STOCKHOLDER'S OWNED SHARES. THE PROXY
GRANTED IN THIS SECTION 2.2 SHALL AUTOMATICALLY EXPIRE UPON THE TERMINATION
OF THIS AGREEMENT.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
Section 3.1 Representations and Warranties of United and the
Stockholder.
Each of United and the Stockholder, jointly and severally,
represents and warrants to Cendant that the following statements are as of
the date of this Agreement, and shall be as of the date of the Stockholders
Meeting, true and correct:
(a) United is a corporation duly incorporated and validly
existing under the laws of the State of Delaware. The Stockholder is a
limited liability company duly formed and validly existing under the laws
of the State of Delaware.
(b) Each of United and the Stockholder has all necessary
power and authority to enter into this Agreement and to perform all of its
obligations hereunder. Each of United and the Stockholder has taken all
necessary action to authorize the execution, delivery and performance of
this Agreement and the consummation of the transactions contemplated hereby
by it.
(c) This Agreement has been duly and validly executed and
delivered by each of United and the Stockholder and constitutes a valid and
binding obligation of each of United and the Stockholder enforceable
against each of United and the Stockholder in accordance with its terms,
except as enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting creditors'
rights generally and by general equitable principles (regardless of whether
such enforceability is considered in a proceeding in equity or at law).
(d) As of the date of this Agreement, the Stockholder is the
record and beneficial owner of 15,940,000 shares of Company Common Stock
and 2 shares of Special Preferred Stock (together, the "Galileo Stock")
and, except as provided in this Agreement or by applicable law, the
Stockholders' Agreement or the Restated Certificate of Incorporation, has
full and unrestricted power to dispose of and vote all of the Galileo
Stock. The Stockholder has good and valid title to the Galileo Stock, free
and clear of any and all pledges, mortgages, liens, charges, proxies,
voting agreements, encumbrances, adverse claims, options, security
interests and demands of any nature or kind whatsoever, other than those
created by this Agreement or provided in the Stockholders' Agreement or the
Restated Certificate of Incorporation. As of the date of this Agreement,
the Galileo Stock constitutes all of the capital stock of the Company that
is Beneficially Owned by the Stockholder or by United (other than any such
capital stock owned by officers of UAL Corporation, a Delaware corporation,
or its subsidiaries) and, except for the Galileo Stock, none of United, the
Stockholder or any other subsidiary of United Beneficially Owns or has any
right to acquire (whether currently, upon lapse of time, following the
satisfaction of any conditions, upon the occurrence of any event or any
combination of the foregoing) any shares of Company Common Stock, Special
Preferred Stock or any other capital stock of the Company, or any
securities convertible into shares of Company Common Stock, Special
Preferred Stock or other capital stock of the Company.
(e) None of the execution and delivery of this Agreement by
United or the Stockholder, the consummation by United or the Stockholder of
the transactions contemplated hereby or compliance by United or the
Stockholder with any of the provisions hereof shall (i) result in a
violation or breach of, or constitute (with or without notice or lapse of
time or both) a default (or give rise to any third party right of
termination, cancellation, material modification or acceleration) under,
any note, loan agreement, bond, mortgage, indenture, license, contract,
commitment, arrangement, understanding, agreement or other instrument or
obligation of any kind to which United or the Stockholder is a party or by
which United or the Stockholder or any of their respective properties or
assets (including the Galileo Stock) may be bound or (ii) violate any
order, writ, injunction, decree, judgment, statute, rule or regulation
applicable to United or the Stockholder or any of their respective
properties or assets (including the Galileo Stock).
(f) No broker, investment banker, financial advisor or other
Person is entitled to any broker's, finder's, financial adviser's or other
similar fee or commission in connection with the transactions contemplated
hereby based upon arrangements made by or on behalf of United or the
Stockholder.
(g) Each of United and the Stockholder understands and
acknowledges that Cendant is entering into the Merger Agreement and is
incurring the obligations set forth therein in reliance upon the execution
and delivery of this Agreement by United and the Stockholder.
Section 3.2 Representations and Warranties of Cendant.
Cendant represents and warrants to United and the Stockholder that
the following statements are as of the date of this Agreement, and shall be
as of the date of the Stockholders Meeting, true and correct:
(a) Cendant is a corporation duly incorporated and validly
existing under the laws of the State of Delaware.
(b) Cendant has all necessary corporate power and authority
to enter into this Agreement and to perform all of its obligations
hereunder. The execution, delivery and performance of this Agreement and
the Merger Agreement by Cendant and the consummation of the transactions
contemplated hereby and thereby have been duly and validly approved by the
board of directors of Cendant and no other corporate proceedings on the
part of Cendant are necessary to authorize the execution, delivery and
performance of this Agreement or the Merger Agreement or the consummation
of the transactions contemplated hereby or thereby.
(c) This Agreement has been duly and validly executed and
delivered by Cendant and constitutes a valid and binding obligation of
Cendant enforceable against Cendant in accordance with its terms, except as
enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting the enforcement of creditors'
rights generally and by general equitable principles (regardless of whether
such enforceability is considered in a proceeding in equity or at law).
(d) None of the execution and delivery of this Agreement by
Cendant, the consummation by Cendant of the transactions contemplated
hereby or compliance by Cendant with any of the provisions hereof shall (i)
result in a violation or breach of, or constitute (with or without notice
or lapse of time or both) a default (or give rise to any third party right
of termination, cancellation, material modification or acceleration) under,
any note, loan agreement, bond, mortgage, indenture, license, contract,
commitment, arrangement, understanding, agreement or other instrument or
obligation of any kind to which Cendant is a party or by which Cendant or
any of its properties or assets may be bound or (ii) violate any order,
writ, injunction, decree, judgment, statute, rule or regulation applicable
to Cendant or any of its properties or assets.
ARTICLE IV
COVENANTS OF THE STOCKHOLDER
Section 4.1 General. Each of United and the Stockholder (each, a
"United Party"), jointly and severally, covenants and agrees with Cendant
that, during the period commencing on the date hereof and ending on the
date this Agreement is terminated under Article V hereof:
(a) The Stockholder shall not, directly or indirectly,
Transfer to any Person any or all of the Owned Shares or the Special
Preferred Stock.
(b) Such United Party shall promptly notify Cendant in
writing upon any representation or warranty of such United Party contained
in this Agreement becoming untrue or incorrect in any material respect
during the term of this Agreement and, for the purposes of this provision,
each representation and warranty shall be deemed to be given at and as of
all times during such term (irrespective of any language which suggests
that it is only being given as at a particular date).
(c) Such United Party shall execute and deliver such other
documents and instruments and take such further actions as may be necessary
in order to ensure that Cendant receives the full benefit of this
Agreement.
Section 4.2 Standstill Obligations. Each of United and the
Stockholder, jointly and severally, covenants and agrees with Cendant that,
during the period commencing on the date hereof and ending on the date this
Agreement is terminated under Article V hereof:
(a) Such United Party shall not, nor shall such United Party
permit any Affiliate of such United Party to, nor shall such United Party
act in concert with or permit any such Affiliate to act in concert with any
Person to, solicit or participate in any solicitation of proxies with
respect to any shares of Company Common Stock, nor shall they seek to
advise or influence any Person with respect to the voting of any shares of
Company Common Stock, other than to recommend that stockholders of the
Company vote in favor of the Merger and the Merger Agreement and otherwise
as expressly provided in Article II of this Agreement.
(b) Such United Party shall not, nor shall such United Party
permit any Affiliate of such United Party to, nor shall such United Party
act in concert with or permit any such Affiliate to act in concert with any
Person to, deposit any shares of Company Common Stock or Special Preferred
Stock in a voting trust or subject any shares of Company Common Stock or
Special Preferred Stock to any arrangement or agreement with any Person
with respect to the voting of such shares of Company Common Stock or
Special Preferred Stock, except as provided by Article II of this
Agreement.
(c) Such United Party shall not, nor shall such United Party
permit any Affiliate of such United Party to, nor shall such United Party
act in concert with or permit any such Affiliate to act in concert with any
Person to, otherwise act, alone or in concert with others, to seek control
of the management, Board of Directors or policies of the Company, except to
the extent such activities arise in connection with discussions and
negotiations permitted pursuant to the proviso to subsection 4.2(d) below.
(d) Such United Party shall not, nor shall such United Party
permit any Affiliate of such United Party to, nor shall such United Party
act in concert with or permit any such Affiliate to act in concert with any
Person, nor shall it permit any Representative of such United Party or any
such Affiliate to (i) encourage, invite, initiate or solicit any inquiries
relating to or the submission or making of a proposal by any Person with
respect to a Third-Party Acquisition or (ii) participate in or encourage,
invite, initiate or solicit negotiations or discussions with, or furnish or
cause to be furnished any information to, any Person relating to a
Third-Party Acquisition; provided, however, that, prior to the Stockholders
Meeting, if (x) such United Party, without being in violation of the terms
of this Section 4.2, or the Company, without being in violation of Section
5.1 of the Merger Agreement, receives an unsolicited bona fide written
proposal from any Person or group with respect to a Third-Party Acquisition
which United determines in good faith could reasonably be expected to
result in a Superior Proposal, or (y) there is a Superior Proposal which
has been made by any Person, then such United Party and its Affiliates and
Representatives may, directly or indirectly, furnish information and access
to such Person or group pursuant to an appropriate confidentiality
agreement and may participate in discussions and negotiations with such
Person or group.
(e) Such United Party shall not request a waiver of any of
the terms or provisions hereof in any manner that would require a public
disclosure by Cendant, the Company or United.
(f) Notwithstanding the foregoing provisions of this Section
4.2, Cendant acknowledges that United has two representatives on the
Company's Board of Directors and, subject to the terms of the Merger
Agreement, such persons may act in their capacities as directors of the
Company in accordance with their fiduciary duties to the Company and its
stockholders.
ARTICLE V
TERMINATION
Section 5.1 Termination. This Agreement shall terminate upon the
earlier of (i) the Effective Time or (ii) the termination of the Merger
Agreement or (iii) a Change in the Company Recommendation as a result of a
Superior Proposal or (iv) if an amendment, modification or waiver of or
with respect to any provision of the Merger Agreement is effected and
United reasonably determines in good faith that such amendment,
modification or waiver is adverse in a material respect to United, the
delivery of a notice by United to Cendant in respect of such determination
under this clause (iv) at least five days prior to the Stockholders Meeting
to the effect that United and the Stockholder are terminating this
Agreement as a result of such amendment, modification or waiver.
Section 5.2 Effect of Termination. Upon termination of this
Agreement, the covenants, representations, warranties, agreements and
obligations of the parties shall terminate and become void without further
action by any party.
ARTICLE VI
GENERAL
Section 6.1 Notices. All notices, requests, claims, demands and
other communications hereunder shall be in writing and shall be deemed to
have been duly given (a) on the date of delivery if delivered personally,
(b) on the first Business Day following the date of dispatch if delivered
by a nationally recognized next-day courier service, (c) on the fifth
Business Day following the date of mailing if delivered by registered or
certified mail, return receipt requested, postage prepaid or (d) if sent by
facsimile transmission, with a copy mailed on the same day in the manner
provided in (a) or (b) above, when transmitted and receipt is confirmed by
telephone; provided, that any notice received by facsimile or otherwise at
the addressee's location on any Business Day after 5:00 p.m. (addressee's
local time) shall be deemed to have been received at 9:00 a.m. (addressee's
local time) on the next Business Day. Any party to this Agreement may
notify any other party of any changes to the address or any of the other
details specified in this paragraph, provided that such notification shall
only be effective on the date specified in such notice or five (5) Business
Days after the notice is given, whichever is later. Rejection or other
refusal to accept or the inability to deliver because of changed address of
which no notice was given shall be deemed to be receipt of the notice as of
the date of such rejection, refusal or inability to deliver. All notices
hereunder shall be delivered to the parties as set forth below, or pursuant
to such other instructions as may be designated in writing by the party to
receive such notice:
if to United and/or the Stockholder:
United Air Lines, Inc.
1200 East Algonquin Road
Elk Grove Township, Illinois 60007
Attention: Senior Vice President, Finance
Facsimile No.: (847) 700-4412
with a copy to (which shall not constitute notice):
Cravath, Swaine & Moore
Worldwide Plaza
825 Eighth Avenue
New York, New York 10019
Attention: Scott A. Barshay, Esq.
Facsimile No.: (212) 474-3700
if to Cendant:
Cendant Corporation
9 West 57th Street
New York, New York 10019
Attention: General Counsel
Facsimile No.: (212) 413-1922
with a copy to (which shall not constitute notice):
Skadden, Arps, Slate, Meagher & Flom LLP
One Rodney Square
Wilmington, Delaware 19801
Attention: Patricia Moran, Esq.
Facsimile No.: (302) 651-3001
Section 6.2 No Third-Party Beneficiaries. This Agreement is not
intended to confer third-party beneficiary rights upon any Person.
Section 6.3 Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware applicable
to contracts executed and to be performed fully within such State, without
giving effect to the principles of conflicts or choice of law thereof or
any other jurisdiction.
Section 6.4 Severability. In the event that any one or more of the
provisions contained herein, or the application thereof in any
circumstances, is held to be invalid, illegal or unenforceable in any
respect for any reason under any present or future law, public policy or
order, (i) such provision shall be fully severable and (ii) this Agreement
shall be construed and enforced as if such illegal, invalid or
unenforceable provision had never comprised a part hereof. Upon such
determination that any term or other provision is invalid, illegal or
incapable of being enforced, the parties shall negotiate in good faith with
a view to the substitution therefor of a suitable and equitable solution in
order to carry out to the maximum extent possible, so far as may be valid,
legal and enforceable, the intent and purpose of such invalid provision;
provided, however, that the validity, legality and enforceability of any
such provision in every other respect and of the remaining provisions
contained herein shall not be in any way impaired thereby, it being
intended that all of the rights and privileges of the parties hereto shall
be enforceable to the fullest extent permitted by law.
Section 6.5 Assignment. Except for any assignment by Cendant, in
whole or in part, to a direct or indirect subsidiary of Cendant (provided
that any such subsidiary agrees in writing to be bound by and liable for
all of the terms, conditions and provisions contained herein that would
otherwise be applicable to Cendant and provided further that Cendant shall
remain liable for all of its duties and obligations hereunder in the event
such subsidiary shall fail to perform hereunder), neither this Agreement
nor the rights or the obligations of either party hereto are assignable in
whole or in part (whether by operation of law or otherwise), without the
written consent of the other party and any attempt to do so in
contravention of this Section 6.5 shall be void.
Section 6.6 Successors. This Agreement shall inure to the benefit
of and be binding upon the parties hereto and their respective successors
and permitted assigns.
Section 6.7 Interpretation. When a reference is made in this
Agreement to Sections, such reference shall be to a Section of this
Agreement unless otherwise indicated. Whenever the words "include,"
"includes" or "including" are used in this Agreement, they shall be deemed
to be followed by the words "without limitation." The words "hereof,"
"herein" and "herewith" and words of similar import shall, unless otherwise
stated, be construed to refer to this Agreement as a whole and not to any
particular provision of this Agreement. The definitions contained in this
Agreement are applicable to the singular as well as the plural forms of
such terms and to the masculine as well as to the feminine and neuter
genders of such term. Any agreement or instrument defined or referred to
herein or in any agreement or instrument that is referred to herein means
such agreement or instrument as from time to time amended, modified or
supplemented and attachments thereto and instruments incorporated therein.
References to a Person are also to its successors and permitted assigns.
The parties have participated jointly in the negotiation and drafting of
this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted
jointly by the parties and no presumption or burden of proof shall arise
favoring or disfavoring any party by virtue of the authorship of any of the
provisions of this Agreement. Any reference to any federal, state, local or
foreign statute or law shall be deemed to also to refer to any amendments
thereto and all rules and regulations promulgated thereunder, unless the
context requires otherwise.
Section 6.8 Amendments. This Agreement may not be amended except
by written agreement signed by the parties to this Agreement.
Section 6.9 Fees and Expenses. Except as expressly provided in
this Agreement, each of the parties shall be responsible for his or its own
fees and expenses (including, without limitation, the fees and expenses of
financial consultants, investment bankers, accountants and counsel) in
connection with the entry into of this Agreement and the consummation of
the transactions contemplated hereby.
Section 6.10 Entire Agreement. This Agreement constitutes the
entire agreement between the parties with respect to the subject matter
hereof and supersedes all prior agreements, understandings, negotiations,
representations and warranties, and discussions, whether oral or written,
among the parties hereto, with respect to the subject matter hereof.
Section 6.11 Time of Essence. Time shall be of the essence in this
Agreement.
Section 6.12 Remedies Cumulative. Except as otherwise herein
provided, the rights and remedies provided herein shall be cumulative and
not exclusive of any rights or remedies provided by applicable law.
Section 6.13 Counterparts. This Agreement may be executed in
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument and shall become
effective when one or more counterparts have been signed by each of the
parties and delivered to the other parties.
Section 6.14 Execution. This Agreement may be executed by
facsimile signatures by any party and such signature shall be deemed
binding for all purposes hereof, without delivery of an original signature
being thereafter required.
Section 6.15 Jurisdiction. Each of the parties hereto irrevocably
agrees that any action, suit, claim or other legal proceeding with respect
to this Agreement or in respect of the transactions contemplated hereby
brought by any other party hereto or its successors or assigns shall be
brought and determined in any state or federal court located in the State
of Delaware or any appeals courts thereof (the "Delaware Courts"), and each
of the parties hereto irrevocably submits with regard to any such
proceeding for itself and in respect to its property, generally and
unconditionally, to the exclusive jurisdiction of the Delaware Courts. Each
of the parties hereto irrevocably waives, and agrees not to assert, by way
of motion, as a defense, counterclaim or otherwise, in any action or
proceeding with respect to this Agreement, (a) any claim that it is not
personally subject to the jurisdiction of the Delaware Courts for any
reason, (b) that it or its property is exempt or immune from jurisdiction
of any Delaware Court or from any legal process commenced in any Delaware
Court (whether through service of notice, attachment before judgment,
attachment in aid of execution of judgment, execution of judgment or
otherwise) and (c) to the fullest extent permitted by applicable law, that
(i) the proceeding in any Delaware Court is brought in an inconvenient
forum, (ii) the venue of such proceeding is improper or (iii) this
Agreement, or the subject matter hereof, may not be enforced in or by a
Delaware Court. Notwithstanding the foregoing, each of the parties hereto
agrees that the other party shall have the right to bring any action or
proceeding for enforcement of a judgment entered by the Delaware Courts in
any other court or jurisdiction.
Section 6.16 United Guarantee. United hereby fully and
unconditionally guarantees the full performance and discharge by the
Stockholder of its obligations hereunder.
IN WITNESS WHEREOF, each party hereto has caused this Transaction
Support Agreement to be signed as of the date first above written.
CENDANT CORPORATION
By: /s/ Eric J. Bock
----------------------------
Name: Eric J. Bock
Title: Senior Vice President, Law
and Corporate Secretary
UNITED AIR LINES, INC.
By: /s/ Rono J. Dutta
------------------------------
Name: Rono J. Dutta
Title: President
COVIA, LLC
By: /s/ Frederic F. Brace
------------------------------
Name: Frederic F. Brace
Title: Vice President and Treasurer
Exhibit 99.3
CENDANT TO ACQUIRE GALILEO FOR APPROXIMATELY $2.9 BILLION IN STOCK AND CASH
Acquisition Expected to Add $0.10 to $0.14 Cents to
Cendant's 2002 Earnings Per Share
Combination Extends Cendant's Global Platform To Include Full
Range of Services in Travel Sector
New York, NY and Rosemont, IL, June 18, 2001--Cendant Corporation (NYSE:
CD) and Galileo International, Inc. (NYSE: GLC) today announced that they
have signed a definitive agreement for Cendant to acquire all of the
outstanding common stock of Galileo at an expected value of $33 per share,
or approximately $2.9 billion. Cendant will also assume approximately $600
million of Galileo net debt. For the year ended December 2000, Galileo
reported revenues of $1.64 billion and EBITDA of approximately $570
million. The transaction will combine Galileo, one of the leading providers
of electronic global distribution services (GDS) for the travel industry,
with Cendant, a diversified global provider of business and consumer
services, with a significant presence in the travel sector. The
transaction, which is expected to close in the fall of 2001, is subject to
customary regulatory approvals and the approval of Galileo's stockholders.
United Air Lines, Inc. (UAL), the largest stockholder of Galileo with
approximately 18% of the outstanding shares, has entered into an agreement
with Cendant to support the transaction and has provided Cendant with a
proxy to vote the Galileo shares owned by UAL in favor of the transaction.
Under the terms of the agreement, Galileo stockholders will receive a
combination of Cendant common stock and cash with an expected value of $33
per Galileo share. Galileo stockholders will receive 80.5 percent or more
of the purchase price through a tax-free exchange of Cendant common stock
with a market value of $26.565 per Galileo share, subject to a collar. The
number of shares will fluctuate within a collar of $17 to $20 per Cendant
share from 1.563 Cendant shares per Galileo share if the average price of
Cendant shares is $17 per share during the measurement period to 1.328
Cendant shares per Galileo share if the average price per Cendant share is
$20 during the measurement period. Therefore, the total number of Cendant
shares to be issued will be between 116 million and 137 million shares. If
the average price per share of Cendant stock during the measurement period
is below or above the collar, the value of the transaction will be greater
or less than $33 per Galileo share since the exchange ratios, as noted
above, are fixed for stock consideration outside the collar. For purposes
of determining the exchange ratio, the exchange ratio will be based on the
average Cendant stock price for the period of 20 trading days preceding the
third trading day prior to the Galileo stockholder meeting to approve this
transaction (measurement period). Under certain circumstances, if the
closing of the transaction has not been consummated within 30 days of the
Galileo stockholders meeting a 20-day measurement period closer to the
actual closing will be used.
The remainder of the purchase price, up to $6.435 per Galileo share or
approximately $562 million in the aggregate, will be paid in cash. The cash
portion of the consideration is limited to 19.5 percent of the value of the
total consideration on the closing date to be paid to Galileo stockholders.
The effect of the 19.5 percent limitation is that the cash portion of the
consideration will be reduced if it ever exceeds 19.5 percent of the value
of the total consideration on the closing date to be paid to Galileo
stockholders. This limitation is intended to preserve the tax-free nature
of the stock portion of the consideration being paid to Galileo
stockholders.
If the average Cendant stock price per share is at or below $14 over a
20-day trading period preceding the third trading day prior to the Galileo
stockholder meeting to approve this transaction, Galileo will have a right
to terminate the transaction. Under certain circumstances, if the closing
of the transaction has not been consummated within 30 days of the Galileo
stockholders meeting a 20-day measurement period closer to the actual
closing will be used.
Cendant expects that the acquisition of Galileo will be immediately
accretive to Cendant's earnings and cash flow. The Company expects Galileo
to add between $0.10 and $0.14 cents to Cendant's 2002 earnings per share,
depending upon the number of shares issued, the closing date of the
acquisition and the timing of achieving certain synergies. Included in the
projected accretion is about $70 million to $80 million of merger synergies
in 2002, primarily from the utilization of Galileo's GDS by Cendant's
travel agency and its travel portal affiliate, the reduction of certain
information technology spending, and the reduction of general and
administrative expenses. The synergies are anticipated to grow to over $100
million in 2003. The transaction is expected to increase Cendant's free
cash flow by about $350 million to $400 million in 2002.
The acquisition is also expected to significantly enhance Cendant's growth
prospects in the rapidly expanding global market for travel services, for
several reasons:
o Cendant, a leader in road-based travel, will now be able to generate
transaction fees from air travel, the largest component of travel
spending;
o Galileo will diversify Cendant's travel revenue base geographically
with no foreign currency risk, as over 60% of Galileo's revenues come
from faster-growing international markets but are paid in U.S.
dollars;
o Cendant's worldwide customer base will expand significantly, giving
Cendant greater opportunity to market its Preferred Alliance services
to Galileo-connected travel agencies in 43,000 locations around the
world. Cendant's Preferred Alliance business has built relationships
with more than 100 world-class companies that provide its customers
with exceptional prices on high quality products and services such as
long distance phone service, insurance, computers, furniture and other
office products;
o Cendant's existing membership travel businesses will utilize Galileo's
GDS service and Cendant's extensive network of travel Web sites will
also use Galileo's GDS service to book non Cendant-branded services
such as airline tickets;
o Galileo's TRIP.com with its technological capabilities will enhance
the capabilities of Cendant's comprehensive travel portal affiliate,
reducing its cost of operation and allowing it to capitalize on the
growth in online travel bookings.
Henry R. Silverman, Cendant's Chairman, President and Chief Executive
Officer, said, "This combination will create attractive new growth
opportunities for stockholders of both companies because it substantially
broadens the range of our service offerings and our geographic reach. The
global travel industry is benefiting from favorable demographic trends in
the U.S. and strong international growth. Galileo's fee-for-services
business model, customer relationships and customer base are highly
complementary to Cendant's. Galileo's major presence in air travel bookings
and substantial international reach are an excellent strategic fit with
Cendant and will facilitate our ability to capitalize on future growth
opportunities within the travel industry."
Galileo's Chairman, President and Chief Executive Officer, James E.
Barlett, said, "Galileo's experience in managing a vast global network and
providing innovative technology solutions is an ideal strategic fit with
Cendant's core competencies of providing business and consumer services.
The two companies together will be able to provide large corporations,
small businesses, travel agencies and individual consumers around the world
with the broadest possible range of travel services. Galileo's extensive
international infrastructure will also enable Cendant to more easily take
advantage of attractive diversification opportunities in global travel
markets."
Cendant's Chief Strategic Officer, Samuel L. Katz, said, "Galileo's
technology expertise and Internet capabilities will accelerate Cendant's
ability to take advantage of the growth in online travel bookings.
Cendant's initiative to develop a comprehensive travel portal will now be
combined with Galileo's TRIP.com, providing us with superior technology, a
world-class URL and lower cost of operations. Substantially enhanced
distribution of Cendant's travel brands in the online space is an example
of the virtuous circle this transaction creates for our travel businesses.
Within this virtuous circle, we expect to build on Cendant's core
competencies to strengthen the businesses of our distribution customers
while creating additional value for our supplier partners."
To maintain the highest service levels to Galileo's customers and
suppliers, the Companies have agreed to work together during the period
prior to closing to assure a seamless integration of Galileo into Cendant
after closing. Therefore, Cendant does not anticipate changes in Galileo's
operational management or a reduction in the employee base that would
impact service to customers.
Following the closing of the transaction, Galileo's CEO, James E. Barlett,
has decided to pursue other opportunities outside of Cendant.
Mr. Silverman said, "We are going to bring in a new CEO, similar to when we
brought Bob Pittman into Century 21 to change the paradigm of that company,
who together with a number of current Cendant managers will augment
Galileo's operational management team. We have a long history of
revitalizing companies, and we're confident we can do it again."
The merger agreement requires, among other things, that Galileo suspend
payment of its regular quarterly cash dividend and terminate its $250
million stock repurchase program. Galileo declared and paid a dividend of
$0.09 per share to its stockholders during each of the first and second
quarters of 2001. As of May 31, 2001, Galileo had repurchased approximately
$71 million in shares of its common stock under the stock repurchase
program, which was authorized by the Board of Directors in April 2000.
JPMorgan acted as the exclusive financial advisor to the Board of Directors
of Galileo. Salomon Smith Barney acted as a financial advisor to Cendant.
Cendant will host a conference call to discuss its acquisition of Galileo
on Monday, June 18, 2001 at 10:30 a.m. (EDT). Individuals dialing into the
conference call at (913) 981-4911 are encouraged to do so beginning at
10:15 a.m. as the call will begin promptly at 10:30 a.m. The conference
call will also be available through a live Webcast at www.cendant.com. To
access the call online, go to the Investor Center portion of
www.cendant.com prior to the call to install the necessary audio software.
A replay of the call will be available from June 18, 2001 at 1:00 p.m.
(EDT) until June 20, 2001 at 6:00 p.m. (EDT). The replay phone number and
access code are (719) 457-0820 and 716332, respectively.
Galileo will host a conference call to discuss its acquisition by Cendant
on Monday, June 18, 2001 at 12 noon (EDT). To access the call, investors
should dial (703) 871-3086. The conference call will also be available
through a live Webcast at www.Galileo.com/investor/webcast. To access the
Webcast, your computer must have RealPlayer software installed. A replay of
the call will be available from June 18, 2001 at 3:00 p.m. (EDT) until June
22, 2001 at 11:59 a.m. (EDT). The replay phone number and access code are
(703) 925-2533 and 5326412, respectively. The Webcast will be archived for
those who would like to listen at a later time.
About Galileo
Galileo is a leading provider of electronic global distribution services
(GDS) for the travel industry through its computerized reservation systems
and its Internet-based solutions, including its online travel service
TRIP.com. The company's systems connect more than 43,000 travel agency
locations, which serve the needs of millions of corporate and individual
travelers, to approximately 500 airlines, 40 car rental companies, 45,000
hotel properties, 360 tour operators and all major cruise lines throughout
the world.
About Cendant
Cendant is a diversified global provider of business and consumer services
primarily within the real estate and travel sectors. The Company's
fee-for-service businesses include hotel, real estate and tax preparation
franchising; rental cars, fleet leasing and fuel cards; mortgage
origination and employee relocation; customer loyalty programs; vacation
exchange and rental services and vacation interval sales. Other business
units include the UK's largest private car park operator and electronic
reservations processing for the travel industry. With headquarters in New
York City, the Company has approximately 60,000 employees and operates in
over 100 countries.
Statements about future results made in this release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements are based on current
expectations and the current economic environment. Each of Cendant and
Galileo cautions that these statements are not guarantees of future
performance. Actual results may differ materially from those expressed or
implied in the forward-looking statements. Important assumptions and other
important factors that could cause actual results to differ materially from
those in the forward-looking statements are specified in Cendant's Form
10-Q for the quarter ended March 31, 2001 and Galileo's Form 10-K for its
year ended December 31, 2000. References to accretion concerning Cendant in
this press release assume that the Financial Accounting Standards Board's
(FASB) proposed changes in GAAP for goodwill amortization become effective.
In addition, such forward looking statements are based upon many estimates
and are inherently subject to significant economic and competitive
uncertainties and contingencies, including the uncertainty regarding
consummating any possible acquisition of Galileo International, Inc., many
of which are beyond the control of management of Cendant, Galileo and their
affiliates. Accordingly, actual results may be materially higher or lower
than those projected. The inclusion of such statements herein should not be
regarded as a representation by Cendant, Galileo or their affiliates that
the statements will prove to be correct.
This press release is being filed pursuant to Rule 425 under the Securities
Act of 1933 and is deemed filed pursuant to Rule 14a-12 under the
Securities Exchange Act of 1934.
Cendant and Galileo will file a proxy statement/prospectus and other
relevant documents concerning the proposed merger transaction with the SEC.
Investors are urged to read the proxy statement/prospectus when it becomes
available and any other relevant documents filed with the SEC because they
will contain important information on the proposed transaction. You will be
able to obtain the documents filed with the SEC free of charge at the Web
site maintained by the SEC at www.sec.gov. In addition, you may obtain
documents filed with the SEC by Galileo free of charge by requesting them
in writing from Galileo, 9700 West Higgins Road, Suite 400, Rosemont, Ill,
60018 Attention: Investor Relations, or by telephone at (847) 518-4000.
Galileo and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from Galileo's stockholders. A
list of the names of those directors and executive officers and
descriptions of their interests in Galileo is contained in Galileo's proxy
statement dated April 3, 2001, which is filed with the SEC. Stockholders
may obtain additional information about the interests of the directors and
executive officers in this transaction by reading the proxy
statement/prospectus when it becomes available.
Cendant Media Contact: Cendant Investor Contacts:
Elliot Bloom Sam Levenson
212-413-1832 212-413-1834
Denise Gillen
212-413-1833
Galileo Media Contact: Galileo Investor Contact:
Andrea Steffy Tammy Bobbitt
847-518-4973 847-518-4771
###